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Abstract 
          In cardiac patients, life-threatening tachyarrhythmia is often precipitated by abnormal 
changes in ventricular repolarization and refractoriness. Repolarization abnormalities 
typically evolve as a consequence of impaired function of outward K+ currents in cardiac 
myocytes, which may be caused by genetic defects or result from various acquired 
pathophysiological conditions, including electrical remodeling in cardiac disease, ion channel 
modulation by clinically-used pharmacological agents, and systemic electrolyte disorders seen 
in heart failure, such as hypokalemia. Cardiac electrical instability attributed to abnormal 
repolarization relies on the complex interplay between a provocative arrhythmic trigger and 
vulnerable arrhythmic substrate, with a central role played by the excessive prolongation of 
ventricular action potential duration, impaired intracellular Ca2+ handling, and slowed impulse 
conduction. This review outlines the electrical activity of ventricular myocytes in normal 
conditions and cardiac disease, describes classical electrophysiological mechanisms of cardiac 
arrhythmia, and provides an update on repolarization-related surrogates currently used to 
assess arrhythmic propensity, including spatial dispersion of repolarization, activation-
repolarization coupling, electrical restitution, TRIaD (triangulation, reverse use dependence, 
instability, and dispersion), and the electromechanical window. This is followed by a 
discussion of the mechanisms that account for the dependence of arrhythmic vulnerability on 
the location of the ventricular pacing site. Finally, the review clarifies the electrophysiological 
basis for cardiac arrhythmia produced by hypokalemia, and gives insight into the clinical 
importance and pathophysiology of drug-induced arrhythmia, with particular focus on class Ia 
(quinidine, procainamide) and Ic (flecainide) Na+ channel blockers, and class III 
antiarrhythmic agents that block the delayed rectifier K+ channel (dofetilide). 
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1. Introduction 
          Cardiovascular disease is the leading cause of mortality in developed countries. In 
cardiac patients, about 50% of deaths are sudden, and typically caused by fatal 
tachyarrhythmia such as ventricular fibrillation (VF). The rapid and highly disorganized 
electrical activation in VF contributes to inefficient cardiac systole, which provokes acute 
circulatory failure and leads to death within minutes, unless the arrhythmia is immediately 
terminated by electrical cardioversion. The risk stratification parameters for sudden 
arrhythmic death largely remain empirical, and the existing preventive therapies are often not 
effective. Consequently, malignant ventricular tachyarrhythmia (VT) represents a major 
health problem that requires the development of novel adequate and patient-specific therapies 
based on in-depth knowledge of the contributing electrophysiological mechanisms.  
          The focus of the present thesis is on the detailed description of abnormal cardiac 
repolarization mechanisms that drive electrical derangements in VT, with particular emphasis 
on arrhythmias provoked by hypokalemia and antiarrhythmic drugs. Initially, the ionic basis 
for the electrical activity of ventricular myocytes (chapter 2) and the classical 
electrophysiological mechanisms for cardiac arrhythmia, such as abnormal automaticity, early 
and delayed afterdepolarizations, and re-entry (chapter 3) will be outlined. The next few 
chapters will provide information on repolarization-related arrhythmic surrogates, including 
spatial repolarization gradients (chapter 4), activation-repolarization coupling (chapter 5), 
electrical restitution (chapter 6), TRIaD (triangulation, reverse use dependence, instability, 
and dispersion) (chapter 7), and electromechanical window (chapter 8). Chapter 9 highlights 
the importance of the location of ventricular pacing site for inducing arrhythmia, when 
electrical stimulation protocol is applied at the endocardium vs. the epicardium, or in the LV 
vs. the RV chamber. Chapter 10 overviews the clinical impact and the electrophysiological 
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mechanisms of arrhythmia caused by hypokalemia, a side effect of diuretic therapy in cardiac 
patients. Chapter 11 provides insight into the clinical aspects and electrophysiological 
mechanisms of arrhythmia provoked by antiarrhythmic drugs, with major focus on Na+ 
channel blockers (quinidine, procainamide, and flecainide) and class III agents (dofetilide). 
Finally, the summary of research findings and conclusions are given in chapter 12. 
 2. Electrical activity of ventricular cells  
2.1 Ventricular action potential and the ionic basis for repolarization 
          Ventricular contraction is promoted by a synchronous excitation of cardiac myocytes, 
which is accomplished via generation and fast myocardial spread of the electrical signal called 
action potential. From biophysical point of view, action potential is a transient alteration in 
transmembrane voltage in cardiac cell that is produced by the orchestrated activity of multiple 
voltage-gated ion channels embedded in the sarcolemma (for review see Amin et al. 2010; 
Schmitt et al. 2014; Bartos et al. 2015). The human cardiac action potential includes five 
phases (indicated by the numbers 0 through 4), and its configuration is determined by the 
precise balance between inward (depolarizing) and outward (repolarizing) ionic currents, as 
schematically outlined in Figure 1. Electrical activation starts with fast depolarization (phase 
0) of the cardiac myocyte up to the voltage level of +30 to +40 mV, which is initiated by Na+ 
influx contributing to the action potential upstroke. The inward Na+ current (INa) is very rapid 
and transient, as the most Na+ channels inactivate within one millisecond, thus terminating 
phase 0. Subsequent activation of the transient outward K+ current (Ito) contributes to a brief 
early repolarization (phase 1). The Ito inscribes a notch on the action potential waveshape, 
and sets the level of take-off potential for subsequent activation of ion channels involved into 
the plateau phase. The plateau (phase 2), or slow repolarization, is characterized by a balance 
between an inward current generated by the influx of Ca2+ ions via the L-type Ca2+ channels  
14 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of the human ventricular action potential and contributing inward 
and outward ionic currents 
The numbers above the action potential shape refer to the five phases of the action potential, as 
outlined in the text. Adapted from Amin, A.S. et al. 2010. Cardiac ion channels in health and disease. 
Heart Rhythm 7, 117-126, with permission from publisher.  
 
(ICa), and outward K+ currents, such as the rapid and slow components of the delayed rectifier 
(IKr and IKs, respectively). Other contributors to the plateau phase are the late Na+ current and 
the Na+/Ca2+ exchanger. The late Na+ current (INaL) is maintained by a small fraction of Na+ 
channels (0.1-1%) that remain open after completing phase 0. The sarcolemmal Na+/Ca2+ 
exchanger is an electrogenic transporter that can function either in the forward mode (Ca2+ 
efflux, Na+ influx) or in the reverse mode (Na+ efflux, Ca2+ influx), with a stoichiometry of 3 
Na+/1 Ca2+ (for review see Bers 2002). The reversed mode is favored by positive membrane 
potentials and increased intracellular Na+ levels, whereas the forward mode is favored by 
negative membrane potentials and increased intracellular Ca2+ levels.  
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          Increased Ca2+ entry via L-type Ca2+ channels subsequently promotes additional Ca2+ 
release from the sarcoplasmic reticulum (SR) via stimulation of the ryanodine receptor, an 
effect called Ca2+-induced Ca2+ release. This, in turn, provokes Ca2+-dependent inactivation 
of ICa, thus limiting further Ca2+ influx and terminating the plateau phase.  The membrane 
voltage then proceeds to change in the negative direction owing to the ongoing activation of 
outward K+ currents such as IKr and IKs, which accounts for the late repolarization (phase 3). 
In its final portion, the phase 3 is also maintained by IK1, the inward rectifier K+ current, until 
the membrane potential is stabilized at the level of -80 to -90 mV. This resting membrane 
potential (phase 4) persists in ventricular cells until the next electrical activation is initiated by 
cardiac pacemaker (sinoatrial node). 
          The mechanism of electrical activation outlined above presumes that ventricular 
repolarization is controlled by several outward K+ currents, including Ito, IKr, IKs, and IK1. This 
redundancy of repolarizing currents has been termed the repolarization reserve (Roden 1998; 
for review see Varro & Baczko 2011), meaning that a blockade of one of these currents can 
be partly compensated by recruiting others, which would ensure timely ordered repolarization. 
In this context, the relative importance of each individual repolarizing current can be related 
to the functional state of other K+ channels. For example, in normal conditions, IKs is thought 
to play only little role in ventricular repolarization in humans and most animal species (one 
exception is guinea-pig: see Sanguinetti & Jurkiewicz 1990; Zeng et al. 1995; Bosch et al. 
1998; O’Hara & Rudy 2012). Pharmacological blockade of IKs has been found to produce 
only small or no lengthening of action potential duration (APD) in rabbit (Lengyel et al. 2001; 
Lu Z. et al. 2001; Guerard et al. 2008; So et al. 2006, 2008), canine (Varro et al. 2000; Stengl 
et al. 2003; Jost et al. 2013) and undiseased human ventricular myocytes (Jost et al. 2005, 
2013). However, IKs becomes much more important when APD is prolonged by blocking 
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other repolarizing K+ currents. It was shown that preserved IKs current may prevent an 
excessive APD prolongation in circumstances wherein IKr is significantly reduced (Biliczki et 
al. 2002; Volders et al. 2003; Guerard et al. 2008). Once APD is prolonged upon IKr 
blockade, the IKs has more time to activate at positive voltages during the plateau phase, 
thereby limiting further APD lengthening. Accordingly, IKs is thought to serve as a negative 
feedback safety mechanism that reduces the risk for arrhythmogenic responses associated 
with interventions that delay ventricular repolarization (Varro et al. 2000). 
          Apart from conditions that reduce repolarization reserve, there are at least two other 
physiological regulations that increase the contribution of IKs to ventricular repolarization. 
First, IKs is increased upon β-adrenergic activation, thus causing APD to shorten (Sanguinetti 
et al. 1991; Volders et al. 2003; Overholser et al. 2009; O’Hara & Rudy 2012). When IKs is 
blocked with chromanol 293B, the adrenergic agonist-induced reduction in APD is 
completely abolished, or even reversed to APD lengthening, which is likely mediated via 
increased L-type Ca2+ current (Schreieck et al. 1997). This change facilitates early and 
delayed afterdepolarizations (to be discussed in sections 3.3. and 3.4). Based on this principle, 
the combination of an IKs blocker and β-adrenergic agonist has been used to develop the 
canine model of arrhythmia associated with the long-QT1 syndrome (Shimizu & Antzelevitch 
1998; Gallacher et al. 2007). Second, IKs can importantly contribute to APD shortening at 
rapid cardiac beating rates. Because of slow deactivation kinetics, the IKs can accumulate at 
short pacing intervals, which accounts for APD reduction (Jurkiewicz & Sanguinetti 1993; Lu 
Z. et al. 2001; Overholser et al. 2009; O’Hara & Rudy 2012).  
          Various outward K+ currents play dissimilar role in maintaining ventricular 
repolarization in different mammalian species. In mouse and rat, the major repolarizing K+ 
current is Ito, and the ventricular action potential has a triangular shape, with short 
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repolarization and no high plateau phase (Watanabe et al. 1983; Varro et al. 1993; Knollmann 
et al. 2001). A reduction in Ito is associated with prolonged APD in these animal species. In 
contrast, in larger mammalian species, including humans, ventricular repolarization is 
primarily governed by IKr and IKs, although their relative contribution is variable (O’Hara & 
Rudy 2012). In human and canine ventricular cells, repolarization is controlled to a greater 
extent by IKr than IKs (the IKr to IKs ratio is about 3-5 to 1; human: Li et al. 1996; Jost et al. 
2005; canine: Gintant 1996; Varro et al. 2000), whereas it almost entirely depends on IKr in 
rabbit (the IKr to IKs ratio is about 13:1; Lengyel et al. 2001). IKr is also the predominant 
repolarizing current in feline ventricular myocytes (Follmer & Colatsky 1990). On the other 
hand, in guinea-pig, ventricular myocytes do not express Ito (Varro et al. 1993; Zicha et al. 
2003), and the repolarization is mostly controlled by IKs (the IKs to IKr ratio is about 8-11 to 1; 
Sanguinetti & Jurkiewicz 1990; Zeng et al. 1995; Bosch et al. 1998). These findings imply 
important interspecies differences in pharmacological responsiveness to IKr blockers, with the 
largest APD lengthening, and hence a greater tendency to develop arrhythmogenic early 
afterdepolarizations, to be expected to occur in rabbit and cat.  
          Based on similarities in IKr density and kinetics, canine cardiac tissue is commonly 
considered an optimal model to reproduce drug-induced repolarization abnormalities observed 
clinically in human patients. Nevertheless, this opinion has been challenged in recent studies 
that revealed much lower repolarization reserve in human vs. canine ventricular cells. The 
simulation studies suggest that IKr block results in APD increase by 80% in human myocytes 
vs. only 30% increase in canine cells (O’Hara & Rudy 2012). In experimental works, APD 
lengthening produced by a given concentration of IKr blocker was found to be about three-fold 
greater in human vs. canine myocytes (Jost et al. 2013). This difference has been attributed to 
a greater expression of two other repolarizing K+ channels, IK1 and IKs, in dogs than humans, 
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which may significantly resist APD prolongation upon IKr blockade in the canine heart. In a 
practical context, these findings indicate that the clinical impact of drug-induced 
repolarization delay may be underestimated when solely based on assessments in canine 
ventricular tissue. Recent studies have raised the point that the clinically relevant pattern of 
arrhythmic susceptibility in the setting of reduced repolarization reserve could be more 
adequately reproduced when using the rabbit rather than canine models (Husti et al. 2015). 
The interspecies differences, therefore, should be carefully considered when extrapolating 
repolarization assessments from animal experiments to humans. 
2.2 Ventricular effective refractory period 
          Immediately upon completing phase 0, Na+ channels enter the inactivated state, and 
hence could not be recruited in order to produce a new depolarization. As a result, ventricular 
muscle fails to respond to electrical stimulations applied during the entire plateau phase and 
throughout the most of phase 3. This lack of excitability is called refractoriness. It could be 
quantified by measuring the effective refractory period (ERP), which refers to the portion of 
action potential over which the ventricular muscle is rendered non-excitable.  
          The recovery of Na+ channels from inactivation is voltage-dependent, meaning that 
once the myocyte membrane repolarizes back to the level of resting potential, increasingly 
more Na+ channels become available for activation. It is presumed that at least 25% of Na+ 
channels must recover from inactivation, before the cardiac cell can be re-excited (Roden 
1996). Under normal conditions, myocardial excitability typically recurs by the end of phase 3 
(i.e., at membrane potentials of -65 to -80 mV), and an electrical stimulation applied at this 
time point can evoke a premature action potential. Based on this principle, the ERP could be 
measured by programmed electrical stimulation, wherein a train of regular (S1) pulses is 
followed by a premature (S2) stimulus applied at progressively reducing coupling intervals.  
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The longest S1S2 interval producing no extrasystolic beat is then taken as the refractory 
period.  
          A prolongation of ERP could be potentially achieved in two ways (Roden 1996). The 
ERP would be increased in the setting of reduced INa availability (e.g., upon Na+ channel 
blocker administration), as the recovery of excitability in this case will occur at more negative 
membrane potentials. The ERP is also increased upon prolongation of APD (e.g., upon IKr 
blocker administration), as this would indicate that longer time is required in order to reach 
the level of repolarization at which a critical number of Na+ channels has recovered from 
inactivation. Therefore, the variations in the steady-state APD value, for example, upon 
changing the cardiac beating frequency, are always accompanied by parallel and proportional 
changes in ERP (Guss et al. 1976; Morgan et al. 1990; Lee et al. 1992).  
          In a normal heart, a recovery of ventricular excitability typically occurs at a membrane 
voltage that corresponds to 80-90% of total repolarization, meaning that the ERP-to-APD 
ratio is 0.8-0.9 (Franz & Costard 1988; Koller et al. 1995; Schreieck et al. 1997; Knollmann 
et al. 2001; Fabritz et al. 2003). An increase in ERP by INa blockers may result in post-
repolarization refractoriness, which is defined as a condition wherein ERP is greater than 
APD measured at 90% repolarization (APD90) (Franz & Costard 1988; Kirchhof et al. 1998; 
Franz et al. 2014). The post-repolarization refractoriness is considered an antiarrhythmic 
change, because it protects the heart from premature activation in early diastole, which would 
otherwise trigger VT. Therefore, antiarrhythmic agents that produce a greater increase in ERP 
compared to an increase in APD90, can be an effective therapy for preventing VT (Kirchhof et 
al. 2003; Frommeyer et al. 2012, 2014; Milberg et al. 2012a; Franz et al. 2014).  
          The opposite change, i.e. ERP reduction relative to APD90, indicating a decreased ERP-
to-APD ratio, could be observed in hypokalemia (Sabir et al. 2007; Osadchii & Olesen 2009), 
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or could be induced by the application of several closely-coupled premature pulses during 
programmed ventricular stimulation (Koller et al. 1995). This change is considered to be a 
state of “facilitated excitability” that allows ventricular capture to be produced at an earlier 
repolarization time point (the “encroachment” effect), resulting in increased inducibility of 
tachyarrhythmia (Koller et al. 1995; Franz et al. 2014).  
2.3 Propagation of ventricular action potential 
          Once the electrical signal is generated by the cardiac cell, it should be rapidly 
conducted to other myocytes in order to promote a synchronous ventricular contraction. This 
process is governed by the source-sink relationships (for review see Kleber & Rudy 2004; 
Spector 2013; Dhein et al. 2014; Veeraraghavan et al. 2014). The source refers to the 
depolarizing current available for activation (i.e., generated by the proximal excited cell), and 
the sink is the current needed to activate the distal myocytes along the propagation path. The 
source-to-sink ratio is called the safety factor. The electrical impulse could successfully 
propagate from the site of its origin only when the source is larger than sink, meaning that 
safety factor should always be greater than 1.  
          The source is a local circuit current that originates from a voltage difference between 
the excited myocyte and the adjacent quiescent cell. This current is flowing via gap junctions, 
specialized low-resistance intercellular connections. Once the adjacent cell is activated, it will 
in turn generate a depolarizing current to excite the next, more distal myocyte. In this way, the 
excitation propagates across myocardial syncytium in a wave-like manner. The amplitude of 
the depolarizing current is largely determined by the maximal velocity of the action potential 
upstroke (Vmax), which is directly proportional to the inward Na+ flux during phase 0. 
Therefore, when Na+ channel availability is reduced, the conduction velocity is slowed.  
21 
 
          Apart from the active properties of the myocyte sarcolemma determined by Na+ 
channel density, the impulse conduction depends on the passive electrical properties of 
myocardial tissue (for review see King et al. 2013; Dhein et al. 2014). That is, a certain 
fraction of the depolarizing current has to be used in order to discharge the membrane 
capacitance in the distal quiescent cell. Likewise, the impulse propagation is partly opposed 
by the resistance of extracellular and intracellular spaces. Hence, in real conditions, a certain 
critical number of cells, rather than just one single myocyte, must be excited in order to 
generate a depolarizing current that is sufficiently strong for initiating a propagating response. 
These depolarized cells form the original excitation focus, or liminal area, which normally 
has a radius of at least 200-250 µm (Lindemans & van der Gon 1978). 
         When considering the impulse conduction in a three-dimensional excitable media, the 
source is partly determined by the geometric characteristics of the depolarization wave, such 
as the wave curvature (Fast & Kleber 1997). When the wavefront is convexed, i.e. curved 
outward, the excitatory current it supplies is distributed over a larger downstream myocardial 
area. This dispersion of electrical current then contributes to a slower conduction velocity 
compared to that determined with a flat excitation wavefront. These relationships are 
particularly important during re-entrant arrhythmia (to be discussed in section 3.5), which is 
driven by a spiral depolarization wave with a curved leading edge. 
          The sink depends on the excitability of cardiac cells located ahead of the propagating 
action potential. This is determined by the difference between the resting membrane potential 
and the membrane voltage for activation of the fast inward Na+ current. When this difference, 
called the excitation threshold, is increased (e.g. upon increased IK1 conductance which causes 
the resting membrane potential to become more negative), a greater excitatory current is 
required to depolarize the myocyte. The sink is also increased in conditions associated with a 
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reduced density of gap junctional channels, which contributes to increased axial resistance to 
the excitatory circuit current flow. 
3. Electrophysiological mechanisms of ventricular tachyarrhythmia  
3.1 Cardiac arrhythmia: definition and overview of contributing mechanisms  
          In a broad sense, arrhythmia refers to any irregularities in cardiac beating, or to 
abnormal heart rates, or both. As such, cardiac arrhythmia embraces various types of 
electrical disturbances, ranging from clinically asymptomatic single extrasystolic beats, to 
malignant, life-threatening tachyarrhythmias such as torsade de pointes and ventricular 
fibrillation. Classically, the mechanism of tachyarrhythmia relies on the dynamic interplay of 
a provocative trigger, the vulnerable tissue substrate, and the modulating factors, such as 
autonomic balance, plasma electrolytes, and pharmacological treatments, which influence 
both (Keefe et al. 1987; Surawicz 1989; Yan et al. 2001b; Fabritz et al. 2003; Gallacher et al. 
2007; Merchant & Armoundas 2012; Qu & Weiss 2015).  
          Holter ECG recordings in victims of sudden cardiac arrest demonstrate that VT is 
typically triggered by a closely-coupled premature cardiac contraction or a series of rapid 
ectopic beats (Lewis et al. 1983; Panidis & Morganroth 1983; Kempf & Josephson 1984; 
Milner et al. 1985; Locati et al. 1995). The ectopic beat that serves as the initiating event for 
VT could either originate in myocardial regions with abnormal automaticity, or develop from 
early and delayed afterdepolarizations provoked by an excessive APD lengthening and/or 
intracellular Ca2+ overload.  
          The vulnerable substrate for arrhythmia is typically created by regional structural and 
functional heterogeneities in ventricular tissue (for review see Wolk et al. 1999a; Antzelevitch 
2007a, b), either intrinsic or induced by cardiac disease. Most commonly, the favorable milieu 
for VT is formed by ventricular scarring following acute myocardial infarction, wherein 
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surviving myocardial fibers are interspersed in areas of patchy fibrosis. These changes 
contribute to the non-uniform propagation of the triggered action potential, with electrical 
conduction being preserved in some directions, but significantly slowed or even blocked in 
others. Under certain circumstances, the electrical impulse may start to circulate within a 
closed conducting pathway, thus perpetuating tachyarrhythmia via a mechanism called re-
entry (to be discussed in section 3.5). 
          With functional tissue heterogeneities, the substrate for arrhythmia can be created upon 
non-uniform lengthening of APD, and hence effective refractory period, at distinct myocardial 
regions (Kuo et al. 1983, 1985; Laurita & Rosenbaum 2000; Akar & Rosenbaum 2003). This 
may be a consequence of electrical remodelling in cardiac disease, or produced by IKr blocker 
infusion, or caused by the inherited loss-of-function mutations of repolarizing ion channels. A 
premature depolarization generated by ectopic pacemaker then successfully propagates across 
myocardial regions with short ERP, whereas conduction in the direction of cells with 
prolonged ERP will be slowed and eventually die out, which would set a stage for re-entry. 
          Based on the underlying electrophysiological mechanisms, arrhythmias are traditionally 
categorized into those attributed to abnormal impulse formation and those resulting from 
abnormal impulse conduction. Classification of ventricular arrhythmias, nevertheless, is 
continuously evolving upon accumulation of novel findings from both experimental and 
clinical studies. For example, very recently, Weiss et al. (2015) proposed a dynamics-based 
classification, which subdivides cardiac arrhythmias into three primary categories related to 
unstable Ca2+ cycling, reduced repolarization, and excess repolarization, respectively. The 
following sections provide a more detailed overview of classic arrhythmogenic mechanisms. 
3.2 Abnormal automaticity 
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          Abnormal automaticity refers to the initiation of spontaneous firing in myocardial sites 
(ectopic pacemakers) that do not exhibit pacemaker activity in normal conditions (for review 
see Qu & Weiss 2015). This might originate from the downstream parts of the cardiac 
conduction system, such as Purkinje fibers, which normally exhibit only very slow 
spontaneous diastolic depolarization rate and are therefore suppressed by rapid firing from the 
sinoatrial node. Alternatively, abnormal automaticity may be acquired by atrial or ventricular 
cells that are quiescent in physiological conditions. The abnormal ventricular activations that 
occur in this setting are categorized as escaped ectopic rhythms that develop as a consequence 
of the sinus node dysfunction, and accelerated ectopic rhythms attributed to enhanced 
automaticity in the latent pacemaker. In both cases, the ectopic pacemaker is capable to 
generate premature depolarization that interferes with regular activation rate set by the 
sinoatrial node.  
          The enhanced automaticity in ectopic pacemakers is often a consequence of the partial 
depolarization of the myocyte sarcolemma, which brings the resting membrane potential 
closer to the threshold voltage for activation of the inward Na+ current; this change facilitates 
premature action potential. The same is observed when the threshold voltage becomes more 
negative, or upon an increase in slope of the spontaneous diastolic depolarization in 
pacemaker cells.  Antiarrhythmic drugs therefore may suppress abnormal automaticity by 
either reducing the slope of phase 4 depolarization, or increasing the maximum diastolic 
potential, or shifting the threshold potential to less negative values (Roden 2006). 
          The common pathophysiological factors that facilitate spontaneous firing in ectopic 
pacemakers include ischemia, acidosis, hypokalemia, increased adrenergic tone, and 
myocardial stretch. In these conditions, premature depolarization is produced either by 
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increasing the inward electrical current, such as If (a mixed Na+-K+ current contributing to 
spontaneous diastolic depolarization), or by reducing the outward K+ current via IK1 channels.  
3.3 Early afterdepolarizations 
          Early afterdepolarizations (EADs) are the positive voltage deflections that interrupt the 
smooth course of repolarization during phase 2 or phase 3 of the action potential (for review 
see El-Sherif et al. 1990; Antzelevitch & Sicouri 1994; Volders et al. 2000; Weiss et al. 2010; 
Qu et al. 2013; Qu & Weiss 2015). When EAD increases in amplitude, it may reach threshold 
voltage level for generating a propagating action potential, called a triggered beat (Figure 2), 
which is manifested on ECG as the extrasystolic complex. It is noteworthy, however, that in a  
well-coupled cardiac tissue, EAD generated in a single myocyte is unlikely to give a rise to 
the propagating response, because the depolarizing EAD current is dissipated in a large 
volume of surrounding myocardial tissue, thus causing the source-sink mismatch. The 
generation of triggered beat, therefore, requires the EAD to develop in a large number 
(hundreds to thousands) of ventricular cells localised in the same anatomical region (for 
review see Weiss et al. 2010).  
          EADs are typically precipitated by an excessive APD lengthening, which increases the 
time spent over the voltage window (-40 to 0 mV) for recovery from inactivation of the L-
type Ca2+ current. Accordingly, shaping biophysical properties of ICa has been proposed as a 
powerful therapeutic strategy to suppress EADs-dependent arrhythmia (Madhvani et al. 
2011). Other inward currents that contribute to EAD are the late INa (Horvath et al. 2013; 
Edwards et al. 2014; Pezhouman et al. 2015) and the Na+-Ca2+ exchange current, INa/Ca (Szabo 
et al. 1994; Spencer & Sham 2003). EADs most commonly originate in Purkinje fibers and 
midmyocardial cells (Burashnikov & Antzelevitch 1998; Yan et al. 2001b), which is 
attributed to reduced repolarization reserve in these types of cells compared to epicardial and 
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Figure 2. Afterdepolarizations and triggered beats in ventricular myocytes 
In panels A and B, the left fragment shows ventricular action potentials recorded in basal conditions 
(solid line) and after inducing delayed (A) and early (B) afterdepolarizations (DAD and EAD, 
respectively). The right fragment in both panels shows that DAD and EAD may give a rise to the 
propagating premature action potential (a triggered beat; highlighted by arrow). Adapted from Khan, 
R. 2004. Identifying and understanding the role of pulmonary vein activity in atrial fibrillation. 
Cardiovasc Res 64, 387-394, with permission from publisher. 
 
endocardial myocytes (to be discussed in section 4.3).  
          The EADs play a pivotal role in arrhythmogenesis in patients with long QT syndrome, 
a clinical condition characterized by congenital or acquired defects in repolarizing ion 
channels (for review see Keating & Sanguinetti 2001). Because cardiac cells enrol multiple 
ionic currents to ensure timely ordered repolarization, a single electrical defect would unlikely 
to result in a clinical long QT phenotype. An excessive APD lengthening that increases 
propensity for EAD is thought be the result of multiple hits on repolarization, including 
genetic predisposition, drug-induced blockade of repolarizing ion currents, low resting heart 
rates, and electrolyte abnormalities that cause APD to prolong, such as hypokalemia and 
hypomagnesiemia. Female patients are more susceptible to these electrical derangements 
compared to males owing to the gender-related differences in cardiac repolarization reserve.  
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          A critical degree of APD prolongation that evokes EADs could be attained by 
decreasing outward currents, or by increasing inward currents, or via combinations of the two.  
The ionic mechanisms contributing to EADs are species dependent; in simulation studies, 
90% IKr block has been shown to promote EADs in canine but not human or guinea-pig 
myocytes, whereas 90% IKs block promoted EADs in guinea-pig but not in humans or dog 
(O’Hara & Rudy 2012). Apart from IKr/IKs blockers, the agents that promote EADs include 
those that increase Ca2+ influx, or enhance the late Na+ current by delaying its inactivation 
(for review see El-Sherif et al. 1990). The lengthening and flattening of the action potential 
plateau provoked by these agents represents the conditioning EAD phase (January & Riddle 
1989; Zeng & Rudy 1995). This provides more time at plateau potentials for ICa to recover 
from inactivation, which contributes to the transmembrane depolarizing current. Because ICa 
reactivation is voltage-dependent and regenerative, it develops as a positive feedback process, 
whereby a small initial Ca2+ entry via L-type channels causes a further increase in ICa. This 
initiates the EAD upstroke (the depolarizing EAD phase). Taken together, these changes 
constitute the sarcolemma-dependent mechanism for EAD generation. In addition, there is 
convincing evidence that at least some types of EADs could be promoted by spontaneous SR 
Ca2+ release, with subsequent stimulation of the forward mode of the Na+/Ca2+ exchange 
(Priori & Corr 1990; Volders et al. 1997; Zhao et al. 2012). The sarcolemma-dependent and 
sarcoplasmic reticulum-dependent mechanisms are not mutually exclusive, and may act 
synergistically in inducing EADs (Weiss et al. 2010). 
3.4 Delayed afterdepolarizations 
          Delayed afterdepolarizations (DADs) are oscillations of the membrane potential that 
arise after a full repolarization has been attained in a preceding beat. As with EADs, the 
amplitude of DADs may become sufficiently large in order to trigger a premature ventricular 
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activation (Figure 2, panel A), and precipitate tachyarrhythmia. While suprathreshold DADs 
provide an arrhythmic trigger, the subthreshold DADs may importantly contribute to the 
vulnerable tissue substrate by elevating the diastolic membrane potential and inactivating Na+ 
channels, changes that facilitate conduction slowing (Liu et al. 2015).  
          The mechanism of DADs is related to Ca2+ overload in cardiac cells, which promotes 
depolarization of sarcolemma via an increase in the forward mode Na+/Ca2+ exchange current, 
with a smaller contribution provided by the Ca2+-activated chloride current, ICl(Ca), and the 
non-selective cation channels (Marban et al. 1986; Zygmunt et al. 1998; Verkerk 2001). 
DADs are often provoked by interventions that either increase systolic Ca2+ fluxes, or reduce 
Ca2+ elimination in diastole. The former is typically observed at rapid cardiac activation rates, 
especially in the presence of Ca2+-mobilizing agents, such as cardiac glycosides, or 
catecholamines, and the latter can be a consequence of downregulation of the SR Ca2+ 
ATPase in heart failure. Elevated cytosolic Ca2+ levels, in turn, contribute to increased SR 
Ca2+ load, which facilitates spontaneous oscillatory Ca2+ release in diastole. The probability 
of uncontrolled SR Ca2+ release is markedly increased in patients with mutant (i.e., “leaky”) 
cardiac ryanodine receptors that exhibit increased sensitivity to luminal Ca2+. This genetic 
defect is often associated with catecholaminergic polymorphic VT phenotype (Paavola et al. 
2007). The arrhythmia is typically provoked by sympathetic overactivation during exercise or 
emotional stress, which promotes spontaneous Ca2+ waves and DADs via β-adrenoreceptor-
cAMP-dependent mechanism. 
          It should be emphasized that a separation of electrophysiological mechanisms 
underlying DADs vs. EADs is quite conventional, as there are a variety of pathophysiological 
factors capable of inducing both types of afterdepolarizations, including hypokalemia, 
catecholamines, ischemia and reperfusion, etc. In an experimental setting, both EADs and 
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DADs can often be induced in the same cardiac preparation (Priori & Corr 1990; Volders et 
al. 1997; Pott et al. 2012; Zhao et al. 2012). 
3.5 Re-entry 
          Re-entry, or circus movement, refers to the circulation of electrical impulse within a 
closed pathway (the re-entrant circuit), which allows the impulse to repetitively excite the site 
of its origin (for review see El-Sherif 1988; Rudy 1995; Kleber & Rudy 2004; Comtois et al. 
2005; Roden 2006; Qu & Weiss 2015). This type of abnormal activation is based on several 
prerequisites. First, there must be an obstacle, which interrupts normal propagation of the 
action potential, thus causing the impulse to move around. The obstacle is the non-conductive 
medium that could be either anatomic (e.g. post-infarction scar) or functional (e.g. ischemic 
tissue with depressed excitability). Second, re-entry requires the transient unidirectional 
conduction block to be present at the proximal part of the circuit. The cells in this area 
typically have a prolonged refractory period, and therefore are not able to support conduction 
following upstream stimulation. The electrical impulse therefore starts to move around the 
obstacle in the opposite direction. While making a circle, the impulse can retrogradely 
approach the proximal area that imposed conduction block, and excite it, providing that 
myocytes in this area have already recovered from refractoriness. Therefore, the third 
requirement for re-entry to occur is that the impulse conduction time within the circuit should 
be longer than the effective refractory period. In this case, the impulse can return to the site of 
its origin, and start another circle.  Depending on the number of round trips the impulse will 
make before dying out, the arrhythmic episode may be manifested either as a short series of 
several ectopic beats or as sustained tachycardia.   
          In order to support re-entry, the anatomical pathway available for impulse conduction 
must be long enough to ensure that each site within the circuit has regained excitability before  
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Figure 3. Different models of re-entry in cardiac tissue 
Panel A: circus movement around an anatomical obstacle (central white circle). The area of 
depolarized cells (wavelength) is less than the size of the anatomical pathway available for impulse 
conduction, which creates a fully excitable gap separating the head of the depolarization wave (black 
part of the arrow shape) and its refractory tail (grey part of the arrow shape). Panel B: leading circle 
re-entry around a refractory central core, whereby depressed excitability is maintained by centripetal 
wavelets (curved arrows). The head of depolarization wave encroaches its partially refractory tail, 
indicating a lack of the fully excitable gap. Panel C: spiral depolarization wave (colored in yellow) 
rotates around the central core (red dot) which is excitable, but not excited, because the high wave 
front curvature at the tip of the spiral wave creates a source-sink mismatch that stops further 
propagation of depolarization. Panel D: a three-dimensional scroll wave rotating counterclockwise. 
Adapted from Jalife, J. 2009. Inward rectifier potassium channels control rotor frequency in 
ventricular fibrillation. Heart Rhythm 6, S44-S48, with permission from publisher. 
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the return of the circulating impulse. This creates a spatial excitable gap which separates the 
head of the depolarization wave and its refractory tail (Figure 3, panel A). Historically, this 
principle stems from the classical work by Garrey (1914) who postulated that VF could be 
maintained only when the amount of available cardiac tissue exceeds a certain critical size 
(the critical mass hypothesis). In human RV, VF is not inducible if the tissue mass is reduced 
below 20% of the cardiac weight (Wu et al. 1999). More specifically, the size of anatomical 
pathway must be greater than the excitation wavelength, which is the area of depolarized cells 
formed as the electrical impulse travels forward. The wavelength could be found as a product 
of conduction velocity and ERP. The interventions that reduce the excitation wavelength, 
either by slowing conduction or by decreasing ERP, would allow the re-entry to sustain in a 
smaller mass of cardiac tissue, indicating a proarrhythmic effect. In contrast, a prolongation of 
ERP may increase the excitation wavelength to such an extent that it no longer fits the size of 
the available anatomic pathway, indicating antiarrhythmic effect. 
          Traditionally, re-entry is categorized as anatomical and functional. The major 
difference is that the anatomical re-entry relies on the underlying tissue structure, meaning 
that the re-entrant pathway has a fixed location and length (typically determined by a 
perimeter of the anatomic obstacle), whereas with functional re-entry, the circuits may vary in 
size and appear at random locations. The prototypical model of anatomical re-entry was 
proposed more than a century ago by Mayer (1906) who performed experiments on the ring-
like fragments from the muscular tissue of jellyfish. Upon single point electrical stimulation, 
he successfully induced a wave of contraction that propagated in one direction and 
continuously circulated around the muscular ring. Mines (1913) reproduced this phenomenon 
using the ring-like strips of cardiac tissue, and applied the concept of re-entry to explain the 
mechanism of fibrillation.  
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          The model of functional re-entry, as formulated in the “leading circle” concept, was 
developed by Allessie et al. (1977), who showed that tachyarrhythmia could be induced in 
isolated rabbit atria by premature electrical stimulation without involving any anatomical 
obstacle. In this model, the functional obstacle around which the wavefront is rotating is a 
small area of refractory but potentially excitable cardiac tissue that forms the central core. 
The state of depressed excitability in the core is attributed to Na+ channel inactivation 
secondary to sustained depolarization induced by centripetal wavelets (Figure 3, panel B).  
Another important attribute of this model is a lack of the fully excitable spatial gap; because 
the rate of atrial activation is as rapid as it can be, the head of the circulating wavefront 
always encounters relatively refractory tissue. 
          When represented on a two-dimensional scale, for example, in a thin layer of epicardial 
tissue, the functional re-entry is driven by a spiral wave, or rotor (Pertsov et al. 1993). In this 
model (Figure 3, panel C), the central core could not be excited, because the wavefront at the 
tip of the spiral wave is very convex. This provokes the source-sink mismatch, and stops 
impulse propagation, despite the presence of excitable tissue ahead of it. 
          The re-entry in a three-dimensional excitable medium, for instance, in a thick LV wall, 
is maintained by a scroll wave (Figure 3, panel D). The scroll waves may be stationary or 
drifting from the site of their origin; these features determine the electrophysiological 
phenotype of cardiac arrhythmia (Pertsov et al. 1993; Fast & Kleber 1997). For example, 
monomorphic VT is typically caused by a stationary scroll wave that is anchored to a small 
anatomical obstacle, e.g. papillary muscle, whereas polymorphic VT, like torsade de pointes, 
is often caused by a drifting scroll wave. The drifting scroll waves are generally short-lived. 
They either extinguish spontaneously after a few rotations owing to collision with the tissue 
border, or degenerate to a more complex form of electrical activation such as ventricular 
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fibrillation. In VF, electrical activation is typically driven by multiple scroll waves that 
propagate randomly around islets of refractory tissue. The scroll waves may either emanate 
from a stable, high-frequency source of activation (the mother rotor hypothesis; for review 
see Jalife 2000, 2009; Pandit & Jalife 2013), or be formed as a result of instability of the 
original single spiral wave, which can spontaneously break up and produce several daughter 
wavelets (the multiple wavelet hypothesis; for review see Weiss et al. 2005).  
4. Spatial repolarization gradients 
          Because amplified regional heterogeneities in repolarization importantly contribute to 
the substrate for re-entry, the assessments of spatial APD dispersion are receiving increasing 
attention in studies on inherited and acquired cardiac arrhythmia syndromes (for review see 
Burton & Cobbe 2001; Antzelevitch 2007a, b). The intrinsic non-uniformities in APD could 
be subdivided into interventricular, i.e. determined at corresponding RV vs. LV recording 
sites, and intraventricular, whereby APD variations are determined over the apico-basal axis 
or transmural (epicardial-to-endocardial) axis.  
4.1 Interventricular repolarization heterogeneities 
          In human subjects, the duration of repolarization is longer in the LV than the RV 
chamber, as evidenced by non-invasive electrocardiographic imaging (Ramanathan et al. 
2006), and electrogram recordings from multiple LV and RV endocardial sites (Bueno-Orovio 
et al. 2012). These repolarization heterogeneities are explained by greater RV than LV mRNA 
expression levels of HERG1 and KCNQ1, the proteins that encode the pore-forming α-
subunit of IKr and IKs channels, respectively (Luo et al. 2008). The LV-to-RV dispersion of 
repolarization is transiently increased upon abrupt heart rate acceleration, an effect which is 
attributed to slower APD rate adaptation in the LV vs. RV chamber (Bueno-Orovio et al. 
2012).  
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          Similar to human studies, a greater LV than RV action potential duration has been 
determined at epicardial (Janse et al. 2005; Gallacher et al. 2007; Meijborg et al. 2015) and 
endocardial (Verduyn et al. 1997a, b; van Opstal et al. 2001) recording sites in anesthetized 
dogs. The LV-to-RV APD dispersion in canine hearts is attributed to the increased density of 
IKs in RV myocytes (Volders et al. 1999). Owing to the reduced repolarization reserve in LV 
cells, pharmacological blockade of IKs or IKr provokes a greater APD prolongation in the LV 
vs. RV chamber, thus increasing the interventricular repolarization gradient (Gallacher et al. 
2007; Meijborg et al. 2015). 
          Apart from regional variations in final repolarization time, the interventricular 
heterogeneities are manifested in different configurations of the action potential in RV vs. LV 
cells. In canine epicardial and midmyocardial layers, action potential exhibits a deeper notch 
and therefore more pronounced spike-and-dome configuration in RV compared to LV 
myocytes, which is accounted for by a greater density of Ito, the transient outward K+ current, 
in RV cells (Di Diego et al. 1996; Volders et al. 1999). The same pattern of Ito distribution is 
present in the rodent heart (Brunet et al. 2004). A greater expression of Ito in RV myocytes 
contributes to a shorter APD in the RV compared to the LV chamber in rats (Watanabe et al. 
1983; Casis et al. 1998) and mice (Knollmann et al. 2001; Waldeyer et al. 2009; Martin et al. 
2011). 
          In contrast, in the guinea-pig heart, epicardial APD is longer in RV vs. LV myocytes 
(Poelzing & Veeraraghavan 2007; Osadchii et al. 2009; but see Pandit et al. 2011), a 
difference which is attributed to the greater expression of IK1, the inward rectifier K+ current, 
in LV cells (Warren et al. 2003; Veeraraghavan & Poelzing 2008). In rabbit heart, the 
published data on interventricular difference in repolarization are quite inconclusive, with 
APD shown to be similar in both ventricular chambers (Myles et al. 2012; Smith et al. 2012; 
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Ovechkin et al. 2015), or to exhibit a greater value in either RV (Wolk et al. 1999b; Azarov et 
al. 2008) or LV myocytes (Qi et al. 2015).  
          A significant increase in interventricular APD dispersion could be induced upon no-
flow global ischemia in rabbit (Kurz et al. 1993; Smith et al. 2012) and guinea-pig hearts 
(Pandit et al. 2011), an effect which is attributed to substantially greater APD shortening in 
the LV vs. RV chamber. This change is likely to be caused by activation of the ATP-sensitive 
K+ channels (IKATP), which is more prominent in LV myocytes owing to a larger IKATP 
expression compared to RV cells (Pandit et al. 2011). These findings indicate that an 
amplified RV-to-LV repolarization gradient can importantly contribute to arrhythmogenesis 
in ischemic hearts. 
4.2 Apico-basal repolarization heterogeneities 
          Apico-basal non-uniformities in APD have been most thoroughly characterized in 
guinea-pig (Kanai & Salama 1995; Laurita et al. 1996; Salama et al. 1998; Choi & Salama 
2000; Restivo et al. 2004), rabbit (Choi et al. 2002; Liu et al. 2005; Mantravadi et al. 2007), 
mouse (Baker et al. 2000, 2004; London et al. 2007), and rat hearts (Weber dos Santos et al. 
2009) using high-resolution optical mapping. In these animal species, APD is the shortest at 
the ventricular apex, and becomes progressively longer toward the base, with APD dispersion 
being greater in females than in males (Liu et al. 2005).  
          In canine hearts, although heterogeneities in repolarization along the apico-basal axis 
were determined in several studies, there is no common opinion regarding the direction of this 
gradient. In single ventricular myocytes, APD was found to be shorter in cells dissociated 
from apical compared to basal regions (Szentadrassy et al. 2005). Nevertheless, in vivo 
recordings in anesthetized dogs suggest the opposite, i.e. both APD and ERP are longer at the 
LV apex than at the base (Bauer et al. 2002; Janse et al. 2005; Stoll et al. 2008; Tsvetkova et 
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al. 2011; Izumi et al. 2012). These observations imply that cellular electrotonic interactions in 
electrically coupled cardiac tissue, as well as the presence of intact autonomic innervation, 
could be important in shaping the apico-basal gradient.  
          There are substantial interspecies differences in the nature of mechanisms contributing 
to apico-basal APD dispersion. In mouse (Brunet et al. 2004; London et al. 2007), and rat 
(Casis et al. 1998), the latter is attributed to the increased density of Ito in apical vs. basal 
myocytes. In contrast, in rabbit heart, APD variations along this axis are accounted for by the 
asymmetric distribution of IKr and IKs, with IKr density being two-fold higher at the ventricular 
apex vs. the base, whilst IKs is more abundant at the basal regions (Cheng et al. 1999; Ng et 
al. 2009). Therefore, there is a large apico-basal difference in the IKs-to-IKr ratio.  
          In canine hearts, the apico-basal repolarization heterogeneities are attributed to larger 
IKs and Ito expression at the apex vs. the base (Szentadrassy et al. 2005). The same study also 
revealed a similar pattern of apico-basal asymmetry in IKs and Ito expression in non-diseased 
human hearts. These findings are congruent with electrocardiographic repolarization imaging 
in healthy human subjects which demonstrates a progressive delay in repolarization from the 
epicardial apex toward the base (Ramanathan et al. 2006). Interestingly, in cardiac disease, 
this pattern is preserved in about 60% of patients, whereas the remainder shows the opposite 
direction of the gradient (Chauhan et al. 2006). 
          In cardiac disease, the apico-basal APD dispersion can be modulated by many factors 
including electrical remodeling, impaired cardiac autonomic regulation, and altered 
ventricular loads. The role played by downregulation of outward K+ channels was addressed 
in studies that utilized the animal models of the long QT syndrome (Cheng et al. 1999; Baker 
et al. 2000; Choi et al. 2002; Liu et al. 2005; London et al. 2007). In rabbit heart, IKr blocker 
infusion has been shown to produce a greater APD lengthening in apical compared to basal 
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myocytes (Cheng et al. 1999; Choi et al. 2002; Liu et al. 2005; but see Guerard et al. 2014), 
thus reversing the repolarization gradient, and markedly increasing epicardial APD 
dispersion. In transgenic mice with a loss of the slowly inactivating 4-aminopyridine-sensitive 
K+ current (Islow) (Baker et al. 2000), or a lack of both slow and fast components of Ito 
(London et al. 2007), the long QT phenotype is associated with increased apico-basal gradient 
in APD and refractoriness, and increased susceptibility to torsade de pointes upon 
extrasystolic stimulation.    
        The apico-basal repolarization gradient is substantially modified by changes in cardiac 
autonomic balance. In rabbit hearts, sympathetic nerve stimulation evokes a significant APD 
reduction at the base, while producing no effect at the apex (Mantravadi et al. 2007). In 
contrast, bilateral vagal stimulation significantly prolongs APD at the apex, while producing 
no effect at the base. In both cases, autonomic stimulation reverses the direction of the 
repolarization gradient. Non-uniform APD shortening in apical vs. basal regions has been 
observed following the infusion of adrenergic agonist in human patients (Selvaraj et al. 2009), 
and upon stellate ganglia stimulation (Vaseghi et al. 2013) or vagal stimulation (Yamakawa et 
al. 2014) in anesthetized, open-chest pigs. These findings are likely accounted for by the non-
uniform distribution of autonomic innervation and/or adrenergic and muscarinic receptors 
throughout the apico-basal axis.  
          The apico-basal disparities in repolarization are amplified in the presence of increased 
LV afterload and associated myocardial stretch. An acute LV pressure overload produced by 
aortic clamping in anesthetized, open-chest rabbits (Ovechkin et al. 2015) and pigs (Dean & 
Lab 1990), was found to evoke a greater shortening of APD and ERP at the apex compared to 
the base, thus resulting in an increased apico-basal gradient. Similar changes have been 
reported to develop in Langendorff-perfused rabbit hearts in response to acute LV dilatation 
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caused by an increase in the volume of a fluid-filled balloon anchored within LV (Reiter et al. 
1988). These experimental works suggest a role played by accentuated apico-basal gradients 
in refractoriness in stretch-induced arrhythmias seen in clinical conditions associated with 
elevated cardiac loads, for instance, in heart failure. 
4.3 Transmural repolarization heterogeneities 
           Repolarization heterogeneities across the LV wall are attributed to the presence of 
three electrophysiologically distinct cell types - epicardial, endocardial, and M cells (for 
review see Antzelevitch et al. 1991, 1999; Anyukhovsky et al. 1999; Wilson et al. 2011). The 
longest APD is determined in the M cells, and the shortest APD is measured in epicardial 
myocytes. 
          The M cells were originally described in studies on canine ventricular tissue, wherein 
they are identified as a unique subpopulation of myocytes that are distributed uniformly 
(Sicouri & Antzelevitch 1991, 1995; Yan et al. 1998) or in the form of circular islands (Akar 
et al. 2002) in deep subepicardial to midmyocardial layers (the M-region). The hallmark of 
the M cell is a disproportionately greater APD prolongation upon heart rate deceleration, or 
the infusion of pharmacological agents that delay ventricular repolarization, such as IKr 
blockers, compared to the relative APD changes at the epicardium or endocardium (Sicouri & 
Antzelevitch 1991; Drouin et al. 1995; El-Sherif et al. 1996; Antzelevitch et al. 1999; Yan et 
al. 2001b; Akar et al. 2002). The M cells exhibit lower levels of IKs, the slow component of 
the delayed rectifier (Liu & Antzelevitch 1995; Szabo et al. 2005), and a greater density of the 
late Na+ current (Zygmunt et al. 2001), and the Na+-Ca2+ exchange current (INa/Ca) (Zygmunt 
et al. 2000), compared to epicardial and endocardial myocytes. These features contribute to a 
larger net inward current during the plateau phase, which prolongs APD in M cells.   
39 
 
         Distinct electrophysiological characteristics of the M cells play a pivotal role in the 
mechanism of arrhythmias associated with long QT syndrome (Akar et al. 2002; Antzelevitch 
2005). In this setting, a reduction of the net repolarizing current causes much greater APD 
prolongation in M cells than in epicardial myocytes, thus increasing transmural dispersion of 
repolarization. The excessive APD lengthening markedly increases the propensity to develop 
EADs in M cells, especially at slow cardiac beating rates. These changes set a stage for 
intramural re-entry in canine hearts. Nevertheless, the clinical implications of these findings 
remain a matter of debate, as the presence of M cells within human LV wall was confirmed 
by some (Drouin et al. 1995; Li et al. 1998; Glukhov et al. 2010), but not other studies 
(Taggart et al. 2001; Conrath et al. 2004; Boukens et al. 2015).  
          Transmural heterogeneities, apart from regional variations in APD, also refer to the 
differences in action potential waveform in cells spanning the ventricular wall. Action 
potentials from canine epicardial myocytes, in contrast to endocardial cells, have smaller 
amplitude of phase 0, but a prominent phase 1 notch, and display a clear spike-and-dome 
configuration (Litovsky & Antzelevitch 1988; Liu et al. 1993). This feature is attributed to the 
much higher expression levels of Ito, the transient outward K+ current, in epicardial myocytes. 
The M cells show a prominent spike-and-dome morphology of the action potential that is 
typical of epicardial myocytes.  
          The data in support of the role played by M cells in transmural repolarization 
heterogeneities were mostly obtained in studies on muscle strips shaved from the LV wall 
(Sicouri & Antzelevitch 1991; Drouin et al. 1995), or perfused ventricular wedge preparations 
(Yan et al. 1998; Akar et al. 2002; Akar & Rosenbaum 2003; Xu et al. 2012), or single 
cardiac myocytes (Liu & Antzelevitch 1995; Li et al. 1998; Zygmunt et al. 2000, 2001). 
These findings, however, are challenged by electrophysiological recordings from the intact 
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heart in situ, obtained in anesthetized, open-chest dogs (Anyukhovsky et al. 1996; Bauer et al. 
1999, 2002; Janse et al. 2005; Voss et al. 2009), and in human patients during cardiac surgery 
(Taggart et al. 2001). These studies strongly suggest that under in vivo conditions, transmural 
repolarization heterogeneities are smoothed, owing to electrotonic current flow between 
adjacent myocytes. This causes a shortening of APD in M cells, while prolonging APD in 
epicardial and endocardial myocytes, thus decreasing the transmural gradient. The 
aforementioned studies are therefore lending support to the notion that transepicardial (e.g. 
apico-basal or interventricular) APD dispersion provides much greater contribution to the 
spatial repolarization heterogeneities in the intact heart compared to the transmural gradient 
(for review see Taggart et al. 2003b; Opthof et al. 2009; Janse et al. 2012), although this 
remains a matter of debate (Patel et al. 2009).  
          The contribution of M cells into genesis of the transmural repolarization gradient may 
depend on species-related differences. In contrast to canines, the largest transmural gradient in 
the heart of smaller animal species like rabbit (Yan et al. 2001a; Myles et al. 2010), guinea-
pig (Bryant et al. 1998; Main et al. 1998; Wan et al. 2003), rat (Shipsey et al. 1997), and 
mouse (Wang et al. 2006) has been measured between the endocardium (the longest APD) 
and epicardium (the shortest APD). Although the M cells were found in guinea-pig 
ventricular muscle strips (Sicouri et al. 1996), subsequent studies on single myocytes 
dissociated from different transmural layers reported similar APD values in the 
subendocardial and midmyocardial cells (Main et al. 1998), or even longer APD measured at 
the subendocardium (Bryant et al. 1998; Wan et al. 2003). Furthermore, Main et al. (1998) 
found no difference in either IKr or IKs current density in subendocardial vs. midmyocardial 
cells from guinea-pig ventricles. In rabbit, similar APD values were determined in 
endocardium compared to the M region in perfused LV wedge preparations (Yan et al. 2001a; 
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Myles et al. 2010), whereas in mice, APD was found to be greater in subendocardial than 
midmyocardial myocytes (Wang et al. 2006). These studies therefore challenge the role 
played by M cells in shaping the maximal transmural repolarization gradient in small animal 
species. 
4.4 Modifications of the spatial repolarization gradients in cardiac disease 
          Heart failure is associated with electrical remodeling, the hallmark of which is the 
prolongation of ventricular APD. This change is accounted for by the downregulation of 
multiple repolarizing K+ currents such as Ito, IKr, IKs, and IK1, as well as the up-regulation of 
depolarizing currents, such as the late INa, ICa, and INa/Ca (for review see Nabauer & Kaab 
1998; Tomaselli & Marban 1999; Sipido et al. 2002; Nattel et al. 2007; Nass et al. 2008; Luo 
& Anderson 2013). The contributing molecular mechanisms are likely to be multifactorial, 
and related to impaired transcription, translation, subunit assembly, membrane trafficking, or 
degradation of ion channel proteins in cardiac cells.  
          APD prolongation in the diseased heart initially evolves as an adaptive effect aimed at 
prolonging the plateau phase of action potential, therefore increasing the overall time for Ca2+ 
entry. This allows to compensate for reduced contractility during early stages of cardiac 
disease (Michael et al. 2009). The APD prolongation nevertheless becomes maladaptive in 
the longer term, because it facilitates arrhythmogenic EADs, especially in the presence of 
APD prolonging agents, such as class III antiarrhythmic drugs. Furthermore, an increase in 
APD in diseased hearts tends to be non-uniform, thus contributing to abnormal spatial 
repolarization gradients. The latter could be categorized as two major electrophysiological 
phenotypes, including (i) amplified APD dispersion, and (ii) eliminated or even reversed 
physiological APD gradient.  
42 
 
          Amplified spatial APD dispersion is a common finding in both clinical studies and in 
animal models of volume- and/or pressure-overload-induced cardiac hypertrophy and failure. 
An increase in apico-basal APD dispersion has been reported to occur in cardiac patients 
prone to tachyarrhythmia upon programmed electrical stimulation vs. those with no inducible 
arrhythmia (Chauhan et al. 2006). Likewise, a considerable enhancement in LV-to-RV APD 
dispersion has been observed in a canine model of biventricular hypertrophy induced by 
chronic AV block (Verduyn et al. 1997a, b; Volders et al. 1998; van Opstal et al. 2001), 
which is accounted for by a greater APD prolongation at LV compared to RV sites. In this 
model, the application of a “short-long-short” pacing modality in the presence of an IKr 
blocker has been found to induce torsade de pointes in more than 50% of dogs. The increased 
LV-to-RV dispersion in APD and ERP, and a greater vulnerability to ventricular fibrillation, 
have been found in a feline aortic-banding model of cardiac hypertrophy (Kowey et al. 1991), 
and in rat RV hypertrophy induced by pulmonary hypertension (Benoist et al. 2011). Over the 
transmural plane, APD dispersion is amplified in cardiac hypertrophy induced by chronic AV 
block (Kozhevnikov et al. 2002), and rapid cardiac pacing (Akar & Rosenbaum 2003; Pajouh 
et al. 2005; Zhou et al. 2012) in dogs, and in renovascular hypertension-induced cardiac 
hypertrophy in rabbit (Yan et al. 2001a). A greater APD lengthening in M cells than 
epicardial myocytes upon IKr blocker infusion seen in normal hearts, appears to be markedly 
accentuated in hypertrophied myocardium, thus amplifying transmural dispersion of 
repolarization and increasing the occurrence of torsades de pointes (Kozhevnikov et al. 2002; 
Milberg et al. 2011).  
          Collectively, the aforementioned studies strongly suggest that amplified spatial 
gradients in APD, either over the transepicardial or the transmural plane, serve as an 
important proarrhythmic determinant in cardiac disease.  
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          Nevertheless, another line of evidence points out the role played by eliminated or 
reversed repolarization gradients in diseased hearts. Spatial repolarization gradients existing 
in the normal heart can be important for setting an ordered sequence of ventricular activation 
and relaxation, hence maintaining optimal mechanical function (Sengupta et al. 2006; Zhu et 
al. 2009; Odening et al. 2013). This implies that elimination, or even reversal, of the 
physiological APD difference at distinct myocardial regions may lead to impaired contractile 
performance, and provoke arrhythmia via mechanisms related to mechano-electrical feedback. 
In connection with this principle, the greater LV than RV APD difference seen in normal 
human heart (Ramanathan et al. 2006; Bueno-Orovio et al. 2012), was shown to be reversed 
in patients with RV hypertrophy associated with pulmonary hypertension (Hardziyenka et al. 
2009). With regards to transmural heterogeneities in failing human hearts, APD was found to 
be prolonged to a greater extent in subepicardial than midmyocardial or endocardial 
myocytes, thus leading to a considerable reduction of APD dispersion across the LV wall 
(Glukhov et al. 2010, 2012). It is also noteworthy that although M-cell islands, the major 
determinants of transmural gradient, can be frequently found in non-failing human ventricles 
(Glukhov et al. 2010; Lou et al. 2011), they are very uncommon in LV wedge preparations 
from failing hearts (Yu et al. 2015). A reduction in transmural APD dispersion has been 
observed in various animal models, including pressure overload-induced cardiac hypertrophy 
in mouse (Wang et al. 2006, 2007), rat (Volk et al. 2001; McCrossan et al. 2004), guinea-pig 
(Bryant et al. 1997), and rabbit (McIntosh et al. 1998; Wolk et al. 2000), and tachypacing-
induced heart failure in dog (Li et al. 2002) and pig (Lacroix et al. 2002). Both RV-to-LV 
transepicardial and LV epicardial-to-endocardial APD difference were found to be lost in 
rodent models of cardiomyopathy induced by chronic adrenergic over-activation (Shipsey et 
al. 1997; Bryant et al. 1999; Soltysinska et al. 2011).  
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          Shi et al. (2013) recently suggested that distinct electrophysiological phenotypes seen 
in heart failure, that is, either an increase or attenuation with the subsequent reversal of spatial 
repolarization gradients, may well reflect the temporal evolution of electrical remodeling 
upon progression of the cardiac disease from early hypertrophic to the late failing stage. In the 
aortic banded mouse model, both downregulation of outward K+ currents and the resulting 
APD prolongation have been shown to evolve in a non-parallel manner in subepicardial and 
subendocardial myocytes, which leads to a reduction in transmural APD dispersion at the 
stage of cardiac hypertrophy, followed by a subsequent increase in repolarization gradients 
whilst developing heart failure.  
5. Activation-repolarization coupling 
          At the whole heart level, the final repolarization time at any recording site represents a 
sum of the local activation latency and the action potential duration. Therefore, with a given 
intrinsic difference in APD between the two myocardial regions, a spatial disparity in the final 
repolarization time could be either amplified or attenuated depending on whether these 
regions are activated at the same time point, or the activation in one region is postponed 
relative to the other. High-resolution mapping of ventricular depolarization in human subjects 
(Franz et al. 1987; Cowan et al. 1988; Yuan et al. 2001; Yue et al. 2005; Chauhan et al. 2006; 
Hanson et al. 2009; Selvaraj et al. 2009; Subramanian et al. 2011) and various animal models 
(dog: Osaka et al. 1987; Furukawa et al. 2000; rabbit: Costard-Jackle et al. 1989; pig: 
Gepstein et al. 1997; Yuan et al. 2001; rat: Walton et al. 2013) suggests the presence of close 
relationships between the sequence of electrical activation and the distribution of APD along 
the propagation path. Under physiological conditions, the impulse propagation from the site 
of earliest activation is associated with progressive shortening of APD, which is attributed to 
electrotonic interactions between adjacent cardiac cells. Once the excitation wavefront 
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spreads over, the upstream myocytes repolarize earlier, and hence exhibit more negative 
membrane voltage during phase 3 of the action potential, compared to the cells in the 
surrounding area. For instance, in guinea-pig epicardium, the myocytes along the propagation 
path exhibit membrane potential values ranging from -60 mV in cells close to the pacing 
electrode, to -5 mV in remote cells (Laurita et al. 1997). This voltage difference generates a 
local depolarizing circuit current that flows from the downstream to upstream myocytes, and 
contributes to APD lengthening in the latter (Osaka et al. 1987; Laurita et al. 1997; Furukawa 
et al. 2000). As a result, during electrical activation, the longest APD is invariably determined 
in cells at the pacing site, and the APD in more peripheral cells is reduced upon increasing the 
activation delay. The inverse correlation between local APD and activation time seen in 
normal hearts is called the activation-repolarization coupling.  
          The presence of the activation-repolarization coupling has been validated by 
reconstructing the epicardial (Franz et al. 1987; Osaka et al. 1987; Cowan et al. 1988; 
Costard-Jackle et al. 1989; Chauhan et al. 2006; Subramanian et al. 2011; Walton et al. 
2013), endocardial (Franz et al. 1987; Gepstein et al. 1997; Yuan et al. 2001; Yue et al. 2005; 
Hanson et al. 2009; Selvaraj et al. 2009; Subramanian et al. 2011), and transmural (Myles et 
al. 2010; Boukens et al. 2015) maps of ventricular activation.  Quantitatively, it could be 
assessed by plotting APD90 values measured in distinct ventricular recording sites vs. 
corresponding activation times (Figure 4), and calculating the linear slope value of the APD90 
to activation time relationship. A negative slope indicates an inverse relationship, wherein the 
intrinsic difference in APD between two myocardial regions is compensated for by setting an 
appropriate difference in activation time between them. Consequently, the spatial dispersion 
of final repolarization time tends to be less than the intrinsic difference in APD. In this way, 
the activation-repolarization coupling allows to minimize the spatial repolarization 
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Figure 4. Epicardial action potential duration to the activation time relationships determined upon 
regular pacing and extrasystolic stimulation in perfused guinea-pig hearts  
Panel A shows representative recordings of the volume-conducted ECG (upper trace), right ventricular 
(RV) monophasic action potential (MAP) (middle trace), and left ventricular (LV) monophasic action 
potential (lower trace). The dashed lines on ECG show the moments of regular (S1) and premature (S2) 
stimulus application. On the MAP recordings, the dashed lines indicate the beginning of the MAP 
upstroke, the solid lines indicate 90% repolarization time point (APD90), and the numbers under the 
trace indicate APD90 (in ms) in the RV and the LV chamber. Panels B and D show linear regression 
relations obtained by plotting individual APD90 values vs. corresponding activation times determined 
at six epicardial recording sites (three sites in each chamber) in 18 perfused heart preparations, during 
regular pacing (panel B) and upon extrasystolic stimulation (panel D).  Panel C shows the mean RV 
and LV APD90 plotted vs. corresponding mean activation times. Panel E shows the slope values of 
APD90 to the activation time relationships during regular pacing and upon extrasystolic stimulation. 
Adapted from study X (Osadchii, O.E. 2014. Impaired epicardial activation-repolarization 
coupling contributes to the proarrhythmic effects of hypokalemia and dofetilide in guinea-pig 
ventricles. Acta Physiol (Oxf.) 211, 48-60), with permission from publisher. 
 
heterogeneities, and therefore to eliminate the arrhythmic substrate. In contrast, a positive 
slope indicates a direct APD to activation time relationship, meaning that a ventricular region 
with delayed activation exhibits a longer APD compared to the region with the earliest 
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activation. In this situation, the dispersion of final repolarization time originating from the 
intrinsic APD difference is further accentuated owing to the conduction delay along the 
activation path. Impaired activation-repolarization coupling may develop as a consequence of 
electrical remodeling in cardiac disease, as evidenced by electrophysiological assessments in 
cardiac patients (Cowan et al. 1988; Chauhan et al. 2006), and in animal model of heart 
failure (Soltysinska et al. 2011).  
          Overall, these considerations suggest that the proarrhythmic tendency is likely to be 
increased upon elimination of the inverse correlation between the local APD and activation 
time values in a given myocardial region. This applies to interventions that either flatten the 
negative slope of the activation-repolarization coupling, or even reverse its direction (i.e. 
impose a positive slope value). One proarrhythmic challenge that could be used to illustrate 
this principle is the closely coupled extrasystolic stimulation. Figure 4 shows the data based 
on assessments of the activation-repolarization coupling in perfused guinea-pig hearts 
(Osadchii 2014c: study X), wherein local monophasic APDs and corresponding activation 
times were measured at multiple epicardial recording sites, both during steady-state pacing 
and extrasystolic stimulations. The pacing protocols were applied at RV endocardium, the 
stimulation site that is commonly used in a clinical setting. During regular pacing (the first 
beat in panel A), the final repolarization times in RV and LV epicardium are synchronized (as 
highlighted by an arrow), because the site with shorter APD (LV) is activated later than the 
site with longer APD (RV). This indicates the inverse APD to activation time relationships 
(panel B and the upper line in panel C). However, a positive RV-to-LV APD90 difference 
(+15 ms) determined upon S1-pacing (first beat in panel A) is reversed to a negative value (-
18 ms) during premature activation (last beat in panel A) owing to greater APD shortening in 
the RV than the LV epicardium. This contributes to the markedly increased spatial difference 
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in the final repolarization time (highlighted by arrow), which results from impaired activation-
repolarization coupling (panel D and the lower line in panel C). The negative slope of APD to 
activation time relationship determined during regular pacing is reversed to a positive slope in 
the extrasystolic beat (panel E). Similar changes have been shown to develop upon 
extrasystolic stimulation in human patients (Yue et al. 2005; Hanson et al. 2009; 
Subramanian et al. 2011), which underscores the clinical value of the impaired activation-
repolarization coupling as the arrhythmogenic mechanism. 
          The impaired activation-repolarization coupling may also contribute to abnormal 
repolarization gradients during steady-state beating, an effect that has been invoked to explain 
proarrhythmic effects produced by adrenergic agonist infusion (Selvaraj et al. 2009), 
hypokalemia (Osadchii 2014c: study X), and class I and III antiarrhythmic drugs (Osadchii 
2012e, 2014a, 2014c: studies VI, VIII and X, respectively). Collectively, these findings raise 
the point that the slope of APD to activation time relationships may serve as a sensitive metric 
of arrhythmic susceptibility, and the therapies that improve activation-repolarization coupling 
are likely to prevent arrhythmia.   
6. Electrical restitution 
          Electrical restitution refers to the shortening of ventricular APD immediately upon a 
reduction in cardiac cycle length. This change contributes to prolongation of the following 
diastolic interval, which allows to maintain an appropriate ventricular filling and coronary 
flow in diastole at fast beating rates. Although the adaptive effects related to APD restitution 
have been recognized for decades, its implication in arrhythmia research has started to gain a 
growing attention only during the last years. This led to formulation of the restitution 
hypothesis, which postulates that increased steepness of APD rate adaptation may promote a 
wave break, and initiate VF, even in the absence of pre-existing structural or electrical 
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heterogeneities. Flattening the electrical restitution may therefore constitute a novel 
antiarrhythmic principle (Riccio et al. 1999; Garfinkel et al. 2000; Omichi et al. 2002).   
6.1 Electrical restitution slope, repolarization alternans, and ventricular fibrillation 
          The APD rate adaptation could be assessed by measuring the amount of APD 
shortening evoked either by a single premature activation, or a sustained increase in cardiac 
beating rate. These assessments are performed using the standard and the dynamic cardiac 
pacing protocols (Figure 5). With the standard protocol, a train of regular (S1) stimuli is 
followed by a premature pulse (S2) applied at progressively reducing coupling stimulation 
intervals (S1-S2) until refractoriness is reached (Figure 5, panel A). With the dynamic 
protocol, the heart is paced at progressively increasing regular rates until a 2:1 conduction 
block is induced at pacing intervals shorter than ERP (Figure 5, panel B). The electrical 
restitution curve obtained from these stimulations shows exponential APD shortening upon 
reduction of the preceding diastolic interval (Figure 5, panel C). At any segment of the 
curve, the slope of electrical restitution reflects the relative amount of APD shortening, and 
its maximum value is attained at the shortest diastolic interval (Figure 5, panel D). 
          According to the restitution hypothesis (for review see Weiss et al. 1999, 2005; Qu 
& Weiss 2006), a steep (greater than 1) APD restitution slope contributes to initiation of VF 
by    promoting   repolarization   alternans   at    rapid    cardiac   activation  rates   (Figure  6).  
Repolarization alternans is the regular beat-to-beat oscillations in APD, which create a 
sequence of pairs of long-short, or short-long, action potentials. The genesis of repolarization 
alternans is attributed to the reciprocal relations between APD and the following diastolic 
interval, as originally determined by Nolasco & Dahlen (1968). Once the heart is paced at a 
constant cycle length, a sudden APD shortening in one beat contributes to prolongation of the 
following diastolic interval, and therefore, increased APD in the next beat. This, in turn, is 
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Figure 5. Methodology of electrical restitution assessments in perfused guinea-pig hearts  
Panel A and B show representative LV epicardial monophasic action potential recordings obtained 
upon extrasystolic stimulation (standard protocol) and progressive increase in steady-state pacing rate 
(dynamic protocol). The vertical dotted lines show the moments of regular stimulus (S1) application, 
and the dashed lines show the moments of premature pulse (S2) application. The numbers below each 
trace indicate the duration (ms) of S1-S2 and S1-S1 stimulation intervals. With standard protocol (A), a 
premature pulse is applied after a train of regular stimuli at progressively reduced coupling stimulation 
intervals (fragments 1-4) until the effective refractory period is reached (fragment 5). With dynamic 
protocol (B), the steady-state pacing rate is progressively increased (fragments 1-4) until 2:1 
conduction block is induced at S1-S1 intervals shorter than the effective refractory period (fragment 5). 
S2-evoked APD90 values from stimulations shown in panel A were plotted as a function of preceding 
diastolic interval (DI) in panel C. The restitution plot was fitted by a double-exponential function, and 
then differentiated in order to assess changes in APD90 restitution slope value over the range of 
diastolic intervals used (panel D). 
 
followed by reduced diastolic interval and hence shortened APD in the following beat, thus 
initiating repolarization alternans. If the APD restitution slope is greater than 1, then the 
amplitude of repolarization alternans is incrementally amplified over successive cardiac 
cycles. As a result, in one of those cycles, the APD could be prolonged to such an extent, that 
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Figure 6. Repolarization alternans and ventricular tachyarrhythmia induced by rapid cardiac pacing in 
perfused guinea-pig hearts  
Panels 1-6 show left ventricular epicardial monophasic action potential recordings obtained upon 
reducing the S1-S1 pacing interval from 240 to 80 ms. The heart preparation was perfused with 
hypokalemic (2.5 mM K+) solution in order to increase arrhythmic susceptibility. Note that 
tachyarrhythmia induction (panel 6) is preceded by alternans in action potential duration (panels 4-5), 
which amplitude is increasing upon reduction in pacing interval from 100 to 90 ms. The numbers 
above traces in panels 4-5 indicate the action potential duration at 60% repolarization (APD60, ms) in 
each pair of long-short monophasic action potentials. Adapted from study I (Osadchii, O.E. et al.  
2010. Predictive value of electrical restitution in hypokalemia-induced ventricular 
arrhythmogenicity. Am J Physiol Heart  Circ  Physiol 298, H210-H220). 
 
the following diastolic interval is totally eliminated, meaning that the next depolarizing pulse 
would fall in the refractory period of the preceding beat. This leads to the local conduction 
block at some point of the excitation wavefront, which precipitates wavefront fragmentation 
and hence initiates VF. In contrast, low values (<1) of the restitution slope prevent the 
induction of persistent repolarization alternans, because the initial APD change will be 
dampened over the following cardiac cycles due to the flat relationships between APD and the 
preceding diastolic interval.  
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          High resolution optical mapping in perfused guinea-pig hearts revealed a characteristic 
pattern of developing APD alternans upon progressive increase in pacing rate (Pastore et al. 
1999). Submaximal heart rate acceleration first promotes concordant APD alternans whereby 
APD in each beat is either simultaneously prolonged or shortened at all epicardial sites. A 
further increase in pacing rate may promote discordant alternans whereby APDs recorded at 
LV base alternate in a long-short pattern, and APDs recorded at LV apex alternate in a short-
long pattern (Pastore et al. 1999). When APDs alternate with the opposite phase, spatial 
dispersion of repolarization is increased up to 13-fold, which facilitates unidirectional 
conduction block and re-entry.  
6.2 Ionic basis for the restitution of action potential duration  
          Restitution of APD is attributed to the incomplete recovery of ionic currents after 
previous excitation (for review see Boyett & Jewell 1980; Carmeliet 2004). An electrical 
pulse applied shortly after previous beat recruits less inward current due to the incomplete 
recovery of ICa from inactivation. Furthermore, due to slow time decay of outward K+ 
currents, a premature pulse activates more IKr and IKs. These effects account for APD 
abbreviation in extrasystolic beats or upon a sustained increase in cardiac activation rate. The 
APD restitution also partly relies on recovery of Ito (Litovsky & Antzelevitch 1989) and INa/Ca 
current (Janvier et al. 1997). 
          In guinea-pig ventricular myocytes, the activation of the delayed rectifier K+ current 
was shown to be the most important determinant of APD restitution over a range of short 
diastolic intervals, corresponding to the initial steep portion of the restitution curve (Zeng et 
al. 1995). The relative APD change depends on interplay between the fast and the slow 
component of the delayed rectifier, and an increase in IKr-to-IKs ratio contributes to a greater 
maximum APD restitution slope (Zeng et al. 1995). Another important determinant of the 
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maximum slope is availability of the L-type Ca2+ current. Elimination of ICa restitution (i.e., 
making ICa recovery from inactivation instantaneous) contributes to a decreased maximal 
slope of APD restitution (Qu et al. 1999; Fox et al. 2002), whereas an increase in conductance 
of the L-type Ca2+ channel is associated with steepened restitution and enhanced amplitude of 
APD alternans (Xie et al. 2001; Fox et al. 2002). Consistently, Ca2+ channel blockers have 
been found to flatten the restitution slope in Purkinje cells (Colatsky & Hogan 1980; Elharrar 
et al. 1984; Saitoh et al. 1988) and ventricular myocytes (Riccio et al. 1999; Wu et al. 2002; 
Tolkacheva et al. 2006), and suppress APD alternans during rapid cardiac pacing (Saitoh et 
al. 1988; Riccio et al. 1999; Gelzer et al. 2008).  
6.3 Spatial heterogeneities in electrical restitution 
          With significant heterogeneities in the expression of repolarizing ionic currents (see 
sections 4.1 to 4.3), it is conceivable that the degree of APD shortening upon rate adaptation 
is not uniform at distinct ventricular sites. Study I (Osadchii et al. 2010) showed that in 
perfused guinea-pig hearts, spatial heterogeneities in electrical restitution exist both over the 
RV-to-LV transepicardial plane, and transmurally across the ventricular wall. Monophasic 
APD during steady-state pacing has been found to be longer at RV compared to LV 
epicardium. During extrasystolic stimulations, the APD restitution curve obtained from RV 
epicardium is shifted upwards, and shows a larger maximum-to-minimum APD change, and a 
greater maximum slope value compared to that from the LV epicardium (Figure 7, panels A, 
B and C). Over the transmural axis, the maximum slope of APD restitution is greater at the 
endocardium than the epicardium (Figure 7, panels D, E and F). The same differences were 
determined when exploring restitution of the effective refractory period (Figure 8).  
          In rabbit heart, the basal APD is longer, and the slope of APD rate adaptation is steeper 
in  the  LV  compared  to  the  RV  chamber  (Qi  et al. 2015). These dissimilarities are  likely  
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Figure 7. Restitution of monophasic action potential duration (APD90) assessed at distinct ventricular 
sites upon extrasystolic stimulations applied in perfused guinea-pig hearts  
Average APD90 values determined at three epicardial recording sites in each ventricular chamber  
(panel A), or epicardial and endocardial APD90 determined at two opposite recording sites across the 
LV wall (panel D) were plotted as a function of the preceding diastolic interval (DI). Changes in the 
restitution slope over the range of DIs used (panels B and E) were assessed by differentiating the 
corresponding restitution curves shown in panels A and D. Mean values of the maximum restitution 
slope (panels C and F) were calculated from individual measurements obtained in each experiment. 
*P<0.05 vs. LV epi value (in panels C and F). Adapted from study I (Osadchii, O.E. et al. 2010. 
Predictive value of electrical restitution in hypokalemia-induced ventricular 
arrhythmogenicity. Am J Physiol Heart  Circ  Physiol 298, H210-H220). 
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Figure 8. Restitution of the effective refractory period assessed at distinct ventricular sites in perfused 
guinea-pig hearts  
The data shown were obtained in experiments wherein a complete atrioventricular block was induced 
mechanically in order to allow a stable pacing over a wide range of S1-S1 intervals without escaped 
beats.  Effective refractory periods (ERP) were assessed at different S1-S1 intervals at the LV 
epicardium and RV epicardium (panel A), and at the LV epicardium and LV endocardium (panel D), 
and plotted as a function of the preceding diastolic interval (DI). The details for panels B, C, E and F 
are the same as indicated in the legend for Figure 7. Adapted from study I (Osadchii, O.E. et al. 
2010. Predictive value of electrical restitution in hypokalemia-induced ventricular 
arrhythmogenicity. Am J Physiol Heart  Circ  Physiol 298, H210-H220). 
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attributed to a greater density of the late Na+ current in LV myocytes. Overall, the findings 
from both the guinea-pig and rabbit models demonstrate that ventricular sites with longer 
basal APD exhibit a greater percentage APD shortening, and hence a steeper restitution, upon 
changes in the cardiac activation rate, compared to the sites with shorter basal APDs, as 
originally proposed by Laurita et al. (1996).  
          In human heart, the presence of spatial heterogeneities in electrical restitution was 
validated by using multielectrode ventricular mapping (Yue et al. 2005; Nash et al. 2006). On 
a global scale, the APD restitution slopes were found to be distributed non-uniformly 
throughout both the epicardial and endocardial surface, with 25-to-45% of recording sites 
showing slope values greater than 1. The maximum restitution slope was shown to be greater  
in the LV than the RV chamber, with no difference determined between the apex and the 
base. Spatial dispersion in APD restitution slope value is markedly increased in cardiac 
patients compared to controls (Pak et al. 2004).  
6.4 Modifications of electrical restitution in cardiac disease 
          Although vulnerability to VF is increased in diseased hearts, it is uncertain as to 
whether this change could be accounted for by steepened electrical restitution. Morgan et al. 
(1992) have shown that the maximal shortening of ventricular APD upon extrasystolic 
stimulation is greatly exaggerated in patients with structural heart disease compared to control 
subjects, indicating an increased steepness of electrical restitution in the former. The electrical 
restitution slope appears to be steeper in a subgroup of high-risk patients susceptible to VT 
upon programmed stimulation compared to low-risk patients (Selvaraj et al. 2007). Cardiac 
patients also exhibit a reduced threshold for APD alternans induction by rapid pacing, a 
greater amplitude of APD alternans, and a wider range of diastolic intervals over which the 
alternans is present (Koller et al. 2005; Bayer et al. 2010). In contrast, transmural APD 
57 
 
recordings in perfused human ventricular wedge preparations demonstrate that electrical 
restitution slope is flattened in failing vs. non-failing hearts (Glukhov et al. 2010). Narayan et 
al. (2007) have shown that the maximum restitution slope is similar in heart failure patients 
and control subjects, and in the study-group, the slope values were the same in patients with 
and without inducible arrhythmia. Finally, neither steepness of electrical restitution slopes nor 
the width of the range of diastolic intervals over which the slope value is greater than 1 were 
found to have prognostic value regarding long-term survival in cardiac patients (Narayan et 
al. 2007; Dorenkamp et al. 2013).   
          These contrasting observations could be partly attributed to a variety of factors that may 
potentially affect the APD rate adaptation in cardiac disease. Downregulation of repolarizing 
K+ currents in the diseased heart is likely to contribute to the increased steepness of electrical 
restitution. Indeed, in a canine model, the slope of APD rate adaptation is significantly 
increased upon IKr blocker administration (Yamauchi et al. 2002). The same effect is 
produced by sympathetic activation; catecholamine infusion in human patients (Taggart et al. 
2003a) as well as sympathetic nerve stimulation in perfused rabbit hearts (Ng et al. 2007) 
have been shown to considerably increase the maximum restitution slope, and facilitate 
occurrence of APD alternans. Steepening of the electrical restitution in the diseased heart can 
also be caused by increased LV loading and myocardial stretch (Horner et al. 1996). In 
contrast, the electrical restitution curve is flattened by myocardial ischemia (Dilly & Lab 
1988; Lukas & Antzelevitch 1993; Kurz et al. 1994; Taggart et al. 1996), and some 
medications commonly used in heart failure, such as beta-blockers (Pak et al. 2003; Hao et al. 
2003), class I antiarrhythmics (Varro et al. 1985, 1987), and amiodarone (Omichi et al. 2002). 
Downregulation of L-type Ca2+ channels, which is often observed in advanced heart failure 
(Horiuchi-Hirose et al. 2011), contributes to the reduced APD restitution slope (Qu et al. 
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1999; Xie et al. 2001; Fox et al. 2002). It is therefore plausible to assume that when the 
aforementioned factors are acting in combination, their contrasting effects may translate to 
variable profiles of APD rate adaptation in cardiac patients, ranging from steepening to no 
change or even flattening the restitution slope, depending on which factors prevail.   
6.5 The relative value of standard and dynamic pacing protocols in electrical restitution  
      assessments 
          In cardiac patients, the electrical restitution is invariably assessed by extrasystolic 
stimulations (Taggart et al. 1996, 2003a; Nash et al. 2006; Narayan et al. 2007; Selvaraj et al. 
2007), because dynamic pacing at rapid rates may increase myocardial oxygen demands and 
precipitate acute ischemia. These assessments largely rely on the assumption that when an 
increased APD restitution slope is seen with extrasystolic stimulations, the same outcome 
would have been obtained upon implementing the dynamic pacing. The latter, however, 
disagrees with studies (Goldhaber et al. 2005) which suggest that cellular 
electrophysiological changes invoked with these pacing protocols are not the same. A 
sustained increase in cardiac activation rate, as replicated with the dynamic protocol, is 
associated with significantly increased cytosolic Ca2+ levels, an effect that may abbreviate 
APD via either increased Ca2+-dependent outward K+ currents, or inactivation of the L-type 
Ca2+ current, or both (for review see Eisner 2014). These effects are of much less relevance to 
the standard protocol, whereby a reduction in cardiac cycle is imposed in just a single beat. 
Hence it is reasonable to expect that electrical restitution kinetics may show dissimilar 
patterns when assessed by dynamic pacing compared to extrasystolic stimulations. In canine 
endocardial slices and isolated Purkinje fibers, a profibrillatory tendency was found to be 
well-predicted by dynamic APD restitution curve because it shows a steep (>1) maximum 
slope, whereas standard extrasystolic protocol was much less informative as it elicited flat 
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APD restitution (Koller et al. 1998; Riccio et al. 1999). Nevertheless, it may be questioned as 
to whether the same relations exist at the whole heart level wherein electrical restitution is 
influenced by a variety of physiological factors including spatial repolarization gradients, 
electrotonic effects, and mechanoelectrical feedback.  
          These issues were addressed in study III (Osadchii 2012b). Figure 9 (panel A) shows 
that in the perfused guinea-pig heart, APD measured at any given point over a range of 
diastolic intervals less than 150 ms is shorter during dynamic pacing compared to 
extrasystolic stimulation. The maximum slope of APD restitution is steeper when assessed 
by extrasystolic stimulation than dynamic pacing (Figure 9, panels B and C). This difference 
was related to the impact of the previous pacing history (to be discussed in section 6.6.2), and  
to the ability to preserve LV capture at shorter minimum diastolic intervals during 
extrasystolic stimulation. An increase in the ERP-to-APD90 ratio upon administration of 
flecainide, a Na+ channel blocker, was found to flatten the electrical restitution curve obtained 
by extrasystolic stimulation, while producing no change in the dynamic APD restitution. The 
two stimulation protocols also had a dissimilar value in predicting hypokalemia-induced 
arrhythmogenicity, wherein a reduction in the VF threshold was associated with the increased 
steepness of the dynamic restitution curve, while no change in the maximum restitution slope 
was revealed by extrasystolic stimulations.   
          Taken together, these findings demonstrate that changes in APD restitution revealed by 
extrasystolic stimulation may dissociate from those obtained upon dynamic pacing. 
Importantly, flattening of the standard restitution curve may not necessarily indicate a reduced 
arrhythmogenic tendency. For instance, a decrease in the maximum APD restitution slope 
during extrasystolic stimulation has been observed in acute myocardial ischemia (Dilly & Lab 
1988; Lukas & Antzelevitch 1993; Kurz et al. 1994; Taggart et al. 1996), and in a heart 
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Figure 9. Impact of the pacing protocol on electrical restitution assessments in perfused guinea-pig 
hearts  
Epicardial monophasic action potential duration at 90% repolarization (APD90) was determined over a 
wide range of diastolic intervals (DI) using extrasystolic stimulations (S1-S2 stim; basic drive cycle 
length of 550 ms) and dynamic pacing. The details related to panels B and C are the same as indicated 
in the legend for Figure 7. Adapted from study III (Osadchii, O.E. 2012. Effects of ventricular 
pacing protocol on electrical restitution assessments in guinea-pig heart. Exp Physiol 97, 807-
821), with permission from publisher. 
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failure model induced by chronic adrenergic over-activation (Soltysinska et al. 2011), despite 
a marked increase in arrhythmic susceptibility in both settings. These findings therefore 
challenge the value of electrical restitution assessments by extrasystolic stimulation alone, 
which is commonly used to evaluate the proarrhythmic risk in cardiac patients. 
6.6 Other determinants of the dynamic instability   
          Apart from a steep slope of APD rate adaptation, instability of the spiral wave can be 
caused by other factors, including conduction velocity restitution, cardiac memory, 
electrotonic currents, and abnormal Ca2+ cycling (Weiss et al. 2005; Qu & Weiss 2015). 
6.6.1 Conduction velocity restitution 
          Conduction velocity restitution is attributed to incomplete recovery from inactivation of 
the fast Na+ channels when a premature pulse is applied during phase 3 repolarization. This 
accounts for reduced Vmax, and hence slowed conduction in extrasystolic beats. Because the 
excitation wavelength is a product of APD and conduction velocity, the wavelength 
oscillations leading to the wave break could be produced by steepening conduction velocity 
restitution, an effect that may develop independently of APD restitution kinetics (Qu et al. 
1999; Cherry & Fenton 2004; Mironov et al. 2008). In particular, when spontaneous wave 
break is prevented by flattening APD restitution, an increase in the slope of the conduction 
velocity restitution may restore the wavefront fragmentation (Wu et al. 2002). Therefore, it 
appears that VF could be promoted both by instability of the waveback, i.e. repolarization 
phase (promoted by steep APD restitution) and instability of the wavefront, i.e. action 
potential upstroke (promoted by steep conduction velocity restitution). 
          These relations play a role in shaping the electrophysiological phenotype of VF. 
Depending on the frequency of electrical activation, VF could be categorized as fast and slow 
(Wu et al. 2002; Chen et al. 2003). The fast (or type I) VF is associated with a steep APD  
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restitution, normal ventricular excitability, and a flat restitution of conduction velocity. In 
contrast, the slow (or type II) VF is associated with flat APD restitution, depressed tissue 
excitability, and steep restitution of conduction velocity. The fast VF could be converted to 
slow VF by reducing tissue excitability, e.g. upon infusion of the INa blocker. In ischemic 
hearts, both types of VF may co-exist (Liu et al. 2004), suggesting that steep APD restitution 
and depressed tissue excitability can act synergistically in promoting wavebreaks.  
6.6.2 Short-term cardiac memory 
          During changes in the cardiac activation rate, APD alterations may not necessarily be 
solely determined by the preceding diastolic interval, as prescribed by the restitution 
hypothesis. APD restitution also depends on the past pacing history, an effect called short-
term cardiac memory (Gilmour et al. 1997; Watanabe & Koller 2002; Choi et al. 2004; Wu & 
Patwardhan 2004). Specifically, the degree of APD shortening in extrasystolic beat is 
influenced by APD in the preceding regular beat – for a given diastolic interval, extrasystolic 
APD is abbreviated to a lesser extent if it is generated after a long APD, and vice versa. These 
relations can be illustrated by assessments of electrical restitution with extrasystolic 
stimulations applied at two different S1-S1 intervals (550 vs. 300 ms) in a train of regular 
pulses (Figure 10). At a given S1-S2 coupling interval (panel A: S1-S2=400 ms; panel B: S1-
S2=260 ms), APD in the extrasystolic beat is longer (panel A: 167 ms vs. 146 ms; panel B: 
160 ms vs. 137 ms) when S2 is applied after a train of long S1-evoked action potentials (S1-
S1=550 ms) compared to a train of short APDs (S1-S1=300 ms).  
          In a graphical form, the impact of past stimulation history is illustrated in Figure 11 
(panel A), which shows that the plateau portion of the standard restitution curve is 
progressively shifted  downwards  following  a  reduction  in  pacing  interval  in  a train of S1  
pulses (Osadchii 2012b: study III). This change contributes to the reduced maximum 
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Figure 10. Extrasystolic stimulation protocol applied at variable basic drive cycle lengths in perfused 
guinea-pig hearts  
Left ventricular epicardial monophasic action potentials were recorded upon extrasystolic (S2) 
stimulations applied after a train of regular (S1 pulses). The S1-S1 interval in a basic drive train varied 
from 550 ms (upper fragment in each panel) to 300 ms (lower fragment in each panel). The numbers 
(ms) above recordings indicate action potential duration at 90% repolarization (APD90) in regular and 
extrasystolic beats. Note that APD90 in regular beats is longer while pacing at S1-S1 cycle length of 550 
ms as compared to 300 ms.  Also note that at comparable S1-S2 coupling stimulation intervals (panel 
A: 400 ms; panel B: 260 ms), APD90 in extrasystolic beat is greater when S2 is applied after a train of 
pulses with S1-S1=550 ms, as compared to stimulations at S1-S1=300 ms. Adapted from Osadchii, O.E. 
2016. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart. Scand 
Cardiovasc J 50, 28-35, with permission from Taylor & Francis Ltd (www.tandfonline.com). 
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Figure 11. Electrical restitution plots obtained when using variable basic drive cycle lengths during 
extrasystolic stimulations in perfused guinea-pig hearts  
Restitution of monophasic action potential duration (APD90) was assessed at the LV epicardium by 
using the standard pacing protocol applied at basic drive stimulation intervals of 550 ms, 300 ms and 
200 ms. In panel C, *P<0.05 vs slope value measured at S1-S1=550 ms. Adapted from study III 
(Osadchii, O.E. 2012. Effects of ventricular pacing protocol on electrical restitution 
assessments in guinea-pig heart. Exp Physiol 97, 807-821), with permission from publisher. 
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restitution slope (Figure 11, panels B and C). Overall, these measurements suggest that apart 
from the previous diastolic interval, APD change upon sudden reduction in the activation 
cycle length is determined by other physiological factors.  
          The mechanisms involved in short-term cardiac memory are thought to be related to 
slowly developing alterations in ionic concentrations on both sides of the myocyte membrane, 
which result from changes in the cardiac activation rate (for review see Boyett & Jewell 1980; 
Carmeliet 2004; Eisner et al. 2009). Fast activation rates are associated with K+ accumulation 
in extracellular clefts, which may accentuate APD shortening in the extrasystolic beat owing 
to the increased conductance of IKr and IK1 channels (Scamps & Carmeliet 1989; Sanguinetti 
& Jurkiewicz 1992). Rapid S1-S1 pacing also increases intracellular Na+ levels, which 
stimulate the reversed mode of the Na+-Ca2+ exchange and Na+-K+ pump, thus contributing to 
enhanced APD shortening in the S2-beat. The same effect could be produced owing to faster 
inactivation of ICa in response to elevated intracellular Ca2+ concentrations in rapidly paced 
LV (Goldhaber et al. 2005; Eisner 2014). In summary, it appears that these ionic alterations 
contribute to a greater net repolarizing current across the cardiac myocyte sarcolemma, which 
explains why, for a given diastolic interval, the APD shortening in the premature beat is 
greater when it is preceded by a train of pulses with short compared to long S1-S1 intervals. 
          Memory effects have important implications in cardiac arrhythmia. VF can be 
precipitated by excessive APD shortening upon transient cardiac acceleration, because a 
segment of the wavefront with critically short APD carries insufficient current strength to 
depolarize downstream cardiac cells (Kim et al. 1999; Harada et al. 2011). This translates to 
the source-sink mismatch, which causes local conduction block and leads to wave 
fragmentation. From this perspective, preventing an excessive APD shortening via short-term 
memory can contribute to the antiarrhythmic effect. Nevertheless, the short-term memory may 
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also have proarrhythmic consequences. Memory effects contribute to protracted QT interval 
adaptation to sudden changes in heart rate, for example those associated with the onset or 
termination of atrial fibrillation (Grom et al. 2005; Pueyo et al. 2010; Bueno-Orovio et al. 
2012). This may result in a “too long” or “too short” QT interval value for a given heart rate, 
which would transiently increase arrhythmic susceptibility by facilitating EADs and 
increasing spatial repolarization gradients.  
6.6.3 Electrotonic effects  
          In contrast to isolated myocytes, wherein APD restitution is primarily determined by 
the recovery of repolarizing ionic currents, in a coupled cardiac tissue, APD restitution is also 
influenced by the axial current flow from surrounding cells. This can account for variations in 
shape of the APD restitution curve at a given recording site depending on its proximity to the 
pacing electrode. When the pacing site is remote, APD exhibits exponential shortening upon 
progressive reduction of preceding diastolic interval (Laurita et al. 1997). However, when the 
pacing site is close (within 3 mm) to the recording site, the APD change at short diastolic 
intervals deviates from the expected exponential course (“atypical restitution”), thus causing 
the maximum restitution slope to flatten (Laurita et al. 1997). Because the axial current flow 
is proportional to the membrane voltage difference in coupled myocytes, the most pronounced 
changes of APD restitution kinetics are likely to occur in cells located close to the steep 
repolarization gradients imposed by ectopic activation. 
6.6.4 Abnormal Ca2+ cycling  
          APD alternans, in addition to being linked to the steep slope of electrical restitution, 
could also result from abnormal Ca2+ cycling (for review see Clusin 2008; Laurita & 
Rosenbaum 2008; Qu et al. 2010; Merchant & Armoundas 2012; Qu & Weiss 2015). Rapid 
cardiac activation rates are associated with increased systolic Ca2+ fluxes that may perturb the 
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activity of Ca2+-dependent sarcolemmal ion channels and exchangers, and impair SR Ca2+ 
handling via effects on SERCA and Ca2+/Calmodulin-dependent kinase II. These changes 
may cause beat-to-beat oscillations in cytosolic Ca2+ levels, i.e. Ca2+ transient alternans, 
which then promotes beat-to-beat APD changes via either positive or negative coupling (for 
review see Weiss et al. 2005). A large Ca2+ transient in a given beat may cause APD to 
prolong (positive coupling) by activating the forward mode of Na+-Ca2+ exchange, or may 
cause APD to shorten (negative coupling) by inducing the Ca2+-dependent inactivation of ICa. 
It is noteworthy that the membrane voltage to intracellular Ca2+ relations are bidirectional – 
the APD prolongation in a current cardiac cycle contributes to increased time for Ca2+ entry, 
which primes SR Ca2+ stores, and thus ensures a large Ca2+ transient in the following beat 
(Pruvot et al. 2004).  
7. TRIaD concept 
7.1 The relevance of TRIaD as a surrogate marker of arrhythmic liability 
         In cardiac patients, life-threatening VT, such as torsade de pointes, can be promoted by 
drugs that possess IKr blocking effects and hence prolong ventricular repolarization. 
Therefore, at a preclinical stage of drug development, the potential torsadogenic risks are 
commonly assessed by using IKr channel binding assays and detecting QT interval 
prolongation in animal models. Nevertheless, clinically, not all drugs that prolong the QT 
interval can cause arrhythmia, and the absence of QT interval lengthening does not 
necessarily indicate a good safety profile (for review see Shah & Hondeghem 2005; 
Hondeghem 2008). This indicates that assessments based solely on QT interval measurements 
are likely to reject some safe agents and overlook those that are proarrhyrhmic.  
          Hondeghem et al. (2001a) proposed that arrhythmogenic risks should be evaluated 
based on more refined criteria that include action potential triangulation (T), reverse use 
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dependence (R), instability (I), and dispersion (D). Taken together, these modifications form 
the TRIaD approach for an integrated assessment of torsadogenic tendency (Hondeghem & 
Hoffmann 2003; Hondeghem et al. 2003; Shah & Hondeghem 2005). APD (and QT interval) 
prolongation in the absence of TRIaD is antiarrhythmic; in contrast, agents inducing TRIaD 
are likely to promote arrhythmia, regardless of whether they prolong the QT interval or not. 
The associated change in QT interval, however, may determine the phenotype of drug-
induced arrhythmia – TRIaD in association with prolonged QT typically leads to torsade de 
pointes, whereas TRIaD in association with shortened QT is most likely to promote 
ventricular fibrillation. 
7.2 Action potential triangulation 
          APD prolongation could be produced in different ways. It may involve lengthening of 
the plateau, without any change in phase 3, which would contribute to the rectangular action 
potential waveform (Figure 12). This modification is thought to be antiarrhythmic 
(Hondeghem et al. 2001a, b), because it contributes to prolonged ERP and hence increased 
excitation wavelength, changes that eliminate a substrate for re-entry. Alternatively, APD 
could be prolonged by slowing phase 3, without any change in plateau, which would render 
the action potential more triangular (Figure 12). This modification is proarrhythmic, because 
it contributes to the increased difference between the total APD and the end of ERP, thus 
widening the time window over which the left ventricle could be re-excited in final 
repolarization. Furthermore, slowing phase 3 contributes to increased time spent over the 
voltage window for ICa reactivation, which increases the propensity for arrhythmogenic EADs 
(Lu et al. 2002; Guo et al. 2007; Guerard et al. 2008). 
          It is noteworthy that triangulation should be regarded as characteristics of the action 
potential configuration rather than an attribute of prolonged APD. Indeed, although 
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Figure 12. Antiarrhythmic and proarrhythmic modifications of the ventricular action potential 
waveform upon drug administration 
Representative monophasic action potential recordings were taken from perfused rabbit heart 
preparations at baseline (blue) and following administration of sotalol (yellow) and amiodarone 
(violet). A triangular action potential configuration is associated with proarrhythmia, whereas a 
rectangular configuration contributes to antiarrhythmic effect. Adapted from Frommeyer, G. & 
Eckardt, L. 2016. Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat 
Rev Cardiol 13, 36-47, with permission from publisher. 
 
triangulation is often associated with increased APD, it could also be induced by drugs that 
produce no change, or even shorten APD. The extent of action potential triangulation can be 
assessed by calculating the difference between APD measured at 30% and 90% repolarization 
time points; the larger APD90 to APD30 difference, the greater the triangulation.  
          Increased action potential triangulation has been found to occur upon the administration 
of agents with proarrhythmic profiles of action, such as IKr blockers (Hondeghem et al. 2001a, 
b; Lu et al. 2002; Frommeyer et al. 2011; Milberg et al. 2004, 2012a), activators of the late 
Na+ current (Lu et al. 2002), and torsadogenic non-cardiovascular drugs like quinolone or 
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macrolide antibiotics (Milberg et al. 2002, 2007b). In contrast, a rapid phase 3 repolarization  
is preserved upon the infusion of safe antiarrhythmics like amiodarone and dronedarone 
(Frommeyer et al. 2011; Milberg et al. 2004, 2012a).  
7.3 Reverse use dependence  
          A safe antiarrhythmic drug is expected to significantly prolong APD, and hence 
refractory period, at fast beating rates, while producing no effect on repolarization in normal 
or slowed heart rates. In contrast, the reverse use dependency refers to the preferential APD 
lengthening at slow heart rates, with a minimum effect produced in tachycardia. Most 
clinically used class III antiarrhythmic agents increase APD in a reverse use-dependent 
manner, which limits their therapeutic efficacy in tachycardia, and may facilitate 
arrhythmogenic EADs upon sudden prolongation of the cardiac cycle, for example, during 
post-extrasystolic pause, or upon conversion of atrial fibrillation to sinus rhythm (for review 
see Hondeghem & Snyders 1990; Dorian & Newman 2000). 
          The reverse use dependency could not be ascribed to changes in drug affinity to the IKr 
channel upon variations in cardiac pacing rate. In guinea-pig (Jurkiewicz & Sanguinetti 1993) 
and rabbit (Carmeliet 1992) ventricular myocytes, the sensitivity of IKr to the inhibiting 
effects of dofetilide, a selective IKr blocker, was found to be rate-independent. Instead, the 
attenuated APD response to class III antiarrhythmic agents in tachycardia could be attributed 
to K+ accumulation in extracellular clefts, which may reduce the drug potency at inhibiting IKr 
(Yang & Roden 1996). Alternatively, the reverse rate-dependency could be explained by 
rapid pacing-induced accumulation of IKs, the slow component of the delayed rectifier, an 
effect accounted for by incomplete deactivation of IKs at short inter-pulse intervals (Jurkiewicz 
& Sanguinetti 1993; Lu et al. 2001). The increased magnitude of IKs then may partially offset 
drug-induced APD prolongation resulting from IKr block. The putative contribution of IKs to  
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the reverse use-dependency, however, is likely to be variable, being of much higher 
physiological relevance in animal species with slow IKs deactivation kinetics, such as guinea-
pig (Jurkiewicz & Sanguinetti 1993; Lu et al. 2001) compared to those (e.g. canine, human, 
rabbit) that show a rapid IKs deactivation (Gintant 1996; Stengl et al. 2003), or exhibit only 
low (relative to IKr) IKs expression in cardiac myocytes (e.g. rabbit) (Lu et al. 2001).  
          Other factors contributing to the reverse use dependency include the rate-dependent 
variations in inward currents, such as ICa, INa/Ca, and late INa (Bril et al. 1998; Gjini et al. 1998; 
Wu et al. 2011), and the positive feedback relations between the IKr or IK1 currents and the rate 
of phase 3 repolarization (Virag et al. 2009). There is also the opinion that reverse use-
dependency represents an intrinsic property of cardiac cells (Banyasz et al. 2009; Barandi et 
al. 2010), meaning that drug-induced APD change, either an increase or reduction, is always 
greater in the presence of longer basal APD value, independently of the type of ion channel 
pharmacologically blocked or activated. 
7.4 Temporal instability of action potential duration  
          In cardiac patients, a spontaneous episode of VT is typically preceded by a short-long-
short sequence of cardiac cycles and associated beat-to-beat variations in QT interval (Kay et 
al. 1983; Lewis et al. 1983; Viskin et al. 1996). The temporal instability of repolarization is 
therefore recognized as an important marker of proarrhythmia. The drugs that increase APD 
instability, as evidenced by significant variations in APD in successive beats, are usually 
highly arrhythmic (for review see Varkevisser et al. 2012). The APD instability, also called 
short-term APD variability, can be quantified by constructing a Poincare plot wherein APD in 
each following beat is plotted vs. APD in the preceding beat. In the absence of instability, all 
APD pairs are identical and hence project to a single point. In contrast, if the APD in 
successive beats is highly variable, the plot represents a cluster of points which markedly 
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deviate from the diagonal line, and form complex polygons when connected. Random beat-to-
beat variations in APD could be detected at different levels, i.e. from recording 
transmembrane action potentials in single cardiac myocytes to assessments of repolarization 
in the whole heart or measuring QT intervals on the body surface ECG. The contributing 
mechanism is thought to be related to stochastic fluctuations in ionic currents that govern 
ventricular repolarization (Zaniboni et al. 2000; Wu et al. 2008, 2011).  
          Repolarization variability is considerably increased in conditions associated with 
reduced repolarization reserve, such as IKr blockade or an increase in late INa, with the effect 
being further accentuated at slow pacing rates (Zaniboni et al. 2000; Thomsen et al. 2004; Wu 
et al. 2006, 2008, 2011; Johnson et al. 2010; Szentandrassy et al. 2015). These changes are 
more prominent in M cells compared to epicardial and endocardial myocytes. Strengthening 
of repolarization reserve upon administration of IK,ATP opener levcromakalim both eliminates 
an increase in short-term APD variability and suppresses torsade de pointes caused by IKr 
blocker (Thomsen et al. 2004). 
          Increased repolarization variability is a better predictor of arrhythmogenic risk 
compared to QT interval prolongation alone. Based on a comparison of the 
electrophysiological effects of 702 chemicals with IKr blocking properties in perfused rabbit 
hearts, dynamic APD instability was found to precede drug-induced proarrhythmia in >69% 
of cases (Hondeghem et al. 2001a). Likewise, short-term APD variability was shown to 
accurately discriminate between safe and proarrhythmic drugs when testing in the canine 
model of chronic AV block (Thomsen et al. 2004, 2006a,b; Oros et al. 2010; Varkevisser et 
al. 2012).  
          In addition to being used for drug safety assessments, dynamic APD instability, and its 
clinical counterpart, QT interval variability, have been implicated as a marker of increased 
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arrhythmic susceptibility in patients with organic cardiac disease (Berger et al. 1997; Atiga et 
al. 1998; Hinterseer et al. 2010; Orosz et al. 2015), and congenital or drug-induced long QT 
syndrome (Hinterseer et al. 2008, 2009).  
7.5 Spatial dispersion of action potential duration 
          In perfused canine ventricular wedge preparations, drug-induced increase in transmural 
dispersion of repolarization, but not QT interval prolongation, was found to discriminate 
proarrhythmic agents from those with a safe profile (Said et al. 2012). Drug-induced 
arrhythmia is also often associated with increased interventricular repolarization gradients 
(Verduyn et al. 1997a, b; van Opstal et al. 2001; Milberg et al. 2002; Osadchii 2012e, study 
VI; 2013, study VII; 2014a, study VIII; 2014b, study IX), and apico-basal APD dispersion 
(Choi et al. 2002; Liu et al. 2005). Nevertheless, an increase in transmural APD dispersion is 
likely to be more arrhythmogenic, because in this case, APD changes occur over a shorter 
distance, determined by the thickness of LV wall, thus leading to considerably steepened 
repolarization gradient.   
          In contrast, spatially uniform APD prolongation is safe. For instance, torsade de pointes 
does not occur in the setting of QT prolongation evoked by IKs blockers (Shimizu & 
Antzelevitch 1998; Burashnikov & Antzelevitch 2002), because these agents produce a 
homogenous APD lengthening across the LV wall. When a drug decreases the transmural 
dispersion of repolarization by producing a greater APD lengthening in epicardial and 
endocardial myocytes than in M cells, torsadogenic risks can be markedly reduced, even in 
the presence of a prolonged QT interval. This profile of action is often observed with agents 
that inhibit multiple ionic currents (e.g. IKr, IKs, INa, ICa); examples of this are sodium 
pentobarbital (Shimizu et al. 1999), amiodarone (Sicouri et al. 1997; Drouin et al. 1998), and 
ranolazine (Antzelevitch et al. 2004). In the setting of long QT syndrome, amplified spatial 
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APD dispersion could be reduced by ICa blockers (Milberg et al. 2005, 2012b) or inhibitors of 
the Na+-Ca2+ exchanger (Milberg et al. 2008).  
8. Electromechanical window  
          The electromechanical window refers to the time difference between the end of 
ventricular contraction and the end of the QT interval on ECG (Figure 13). In healthy human 
subjects, the duration of mechanical systole is greater than the duration of ventricular 
repolarization, thus contributing to the positive electromechanical window (Boudoulas et al. 
1981; De Caprio et al. 1984; Ter Bekke et al. 2015). These relationships, however, could be 
reversed in cardiac disease, owing to either QT interval lengthening, or shortened ventricular 
systole, or both. Consequently, cardiac patients often present with a negative 
electromechanical window, wherein the QT interval exceeds the duration of ventricular 
contraction. The latter has been observed in various cardiovascular conditions including 
mitral leaflet prolapse (Chambers & Ward 1987), coronary artery disease (Boudoulas et al. 
1982), and congenital long QT syndrome (Vincent et al. 1991; Ter Bekke et al. 2015). 
Temporal mismatch between electrical and mechanical systole may develop as a consequence 
of electrical remodeling in diseased hearts, as suggested by studies on the canine model of LV 
hypertrophy induced by chronic AV block (Stams et al. 2014).  
          The negative electromechanical window is thought to facilitate cardiac electrical 
instability via the mechanisms related to abnormal Ca2+ handling (for review see Ter Bekke & 
Volders 2012). When electrical systole (i.e. QT interval) exceeds the duration of ventricular 
contraction, Ca2+ ions can continue to enter cardiac cells and trigger SR Ca2+ release, after 
completing muscular shortening. This leads to Ca2+ overload, thus facilitating both EADs and 
DADs. The negative electromechanical window, therefore, has been recently proposed as a 
novel preclinical marker of increased propensity to VT, especially in the setting of prolonged 
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Figure 13. Methodology of the electromechanical window assessments in perfused guinea-pig hearts  
Left ventricular (LV) developed pressure (Pres) and volume-conducted ECG were recorded in paced 
heart preparation. The dashed lines under the ECG trace indicate the moments of electrical stimuli 
application at the LV epicardium. In third cardiac cycle, the premature (S2) pulse was interpolated in 
between two regular (S1) pulses. The S1-S2 interval was chosen to exceed the effective refractory 
period by 5 ms, in order to evoke extrasystolic beat in early diastole immediately upon recurrence of 
excitability. Electromechanical window (c) in the regular and extrasystolic beats is determined by 
calculating the difference between the duration of mechanical contraction (a) and QT interval (b). 
Adapted from study XI (Osadchii, O.E. 2014. Impact of hypokalemia on electromechanical 
window, excitation wavelength and repolarization gradients in guinea-pig and rabbit hearts. 
PLoS One 9, e105599). 
 
cardiac repolarization (van der Linde et al. 2010; Guns et al. 2012a, b). 
          There are several lines of evidence in support of the role played by disturbed 
relationships between electrical and mechanical systole in the risk for sudden cardiac death.  
In patients with healed myocardial infarction, the long-term survival rate was found to be 2.6-
fold lower in a patient subgroup with a negative electromechanical window (Boudoulas et al. 
1982). Furthermore, in the setting of congenital long QT syndrome, the electromechanical 
window is more negative in symptomatic than arrhythmia-free patients (Ter Bekke et al. 
2015). These clinical findings are strongly supported by animal studies, which demonstrate 
76 
 
that the negative electromechanical window markedly increases susceptibility to VT upon 
infusion of drugs with IKr/IKs blocking properties, especially in the presence of concomitant β-
adrenergic receptor stimulation that shortens ventricular systole (van der Linde et al. 2010; 
Guns et al. 2012a, b). In a canine model of acquired long QT1 syndrome, a negative 
electromechanical window was found to be a prerequisite for initiating torsade de pointes; in 
contrast, the arrhythmia could have been prevented by agents (e.g. β-blocker or L-type Ca2+ 
channel antagonist) that made the electromechanical window less negative (van der Linde et 
al. 2010). In anesthetized guinea-pigs, the administration of drugs with known high 
proarrhythmic potential, such as quinidine, haloperidol, and domperidone, has been shown to 
induce a negative electromechanical window, whereas clinically safe antiarrhythmics such as 
amiodarone, verapamil and diltiazem produced no effect (Guns et al. 2012a, b). These 
observations suggest that assessments of the electromechanical window could be important in 
safety studies dealing with compounds that prolong the QT interval.      
          The contribution of the negative electromechanical window to the arrhythmic substrate 
has nevertheless been challenged in several studies. For example, it was shown that in 
perfused mini-pig and canine hearts, the electromechanical window remains positive even in 
the setting wherein IKr blockade, which prolongs QT interval, is combined with β-
adrenoreceptor agonist challenge, which abbreviates mechanical systole (Laursen et al. 2011).  
In the canine model of chronic AV block, although IKr blocker infusion causes the 
electromechanical window to change from a positive to a negative value, the subgroups of 
dogs with inducible vs. non-inducible VT could not be discriminated by measuring the 
electromechanical window (Stams et al. 2014). Also, because a reduction in the 
electromechanical window in this setting is entirely accounted for by the QT interval 
prolongation, without any change in duration of mechanical contraction, it appears that 
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electromechanical window does not add more specificity to assessments of proarrhythmic 
tendency compared to measuring the QT interval. Finally, recent studies suggest that the 
reversed relationships between the duration of electrical and mechanical systole do not 
contribute to arrhythmic substrate in the setting of hypokalemia (Osadchii 2014d: study XI). 
In perfused guinea-pig and rabbit hearts, although hypokalemia has been found to prolong 
repolarization and increase the occurrence of tachyarrhythmia, the duration of mechanical 
systole remained invariably longer compared to the QT interval, thereby contributing to the 
positive electromechanical window, both during regular beating and upon extrasystolic 
stimulation. Instead, in hypokalemic hearts, the abnormal changes in ventricular conduction 
times, refractoriness, excitation wavelength, and spatial repolarization gradients were found to 
be more important mechanistic determinants of arrhythmia, compared to the changes in 
electromechanical window. 
          Taken together, the aforementioned studies indicate that a negative electromechanical 
window is not always proarrhythmic, and vice versa, a positive electromechanical window 
does not necessarily exclude the chance to develop tachyarrhythmia. Therefore, in 
assessments of arrhythmogenic risks, this parameter should preferably be evaluated in 
combination with other surrogate markers of cardiac electrical instability. 
9. Impact of ventricular pacing site on arrhythmic vulnerability 
          The initiation of tachyarrhythmia is markedly facilitated when electrical stimulations 
are applied to the vulnerable pacing site. In a canine model of myocardial infarction, when 
programmed stimulation is applied at multiple LV and RV sites, the inducibility of sustained 
VT may vary from 44% to 19% (Michelson et al. 1981a). In human patients, electrical 
stimulations are more successful in provoking VT when at least two RV pacing sites (e.g. the 
apex and the outflow tract) are evaluated (Doherty et al. 1983, 1984; Somberg et al. 1987; 
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Klein et al. 1991; Martinez-Rubio et al. 1995). Moreover, in some patients with clinically 
documented arrhythmia, the LV stimulation is required in addition to RV testing, in order to 
reproducibly initiate VT (Michelson et al. 1979; Robertson et al. 1981; Page et al. 1983).  
          The most striking differences in arrhythmic vulnerability are observed when electrical 
stimulations are applied at the endocardium vs. the epicardium, and in the RV vs. the LV 
chamber. 
9.1 Endocardial vs. epicardial pacing 
9.1.1 Animal studies 
          In perfused guinea-pig hearts, the inducibility of APD alternans and tachyarrhythmia is 
higher when electrical stimulations are applied at endocardium compared to epicardium, in 
both RV and LV chamber (Osadchii et al. 2011; Osadchii 2012a: study II). Endocardial 
stimulations also require lower threshold current strength to induce VF. In previous works, 
the same difference was determined in canine LV (Horowitz et al. 1981). The epicardial-to-
endocardial difference in arrhythmic susceptibility is partly accounted for by transmural 
heterogeneities in the distribution of Na+ channels. The expression levels of Nav1.5 and/or INa 
current density are greater at the endocardium than the epicardium in guinea-pig (Osadchii et 
al. 2011), rat (Ashamalla et al. 2001; Rosati et al. 2006), and mouse (Remme et al. 2009), as 
well as in non-diseased human hearts (Gaborit et al. 2007). Consequently, tissue excitability 
is higher at the endocardium, as evidenced by the lower ventricular capture thresholds 
compared to the epicardium (Borggrefe et al. 1988). In the presence of higher tissue 
excitability, an ectopic pulse of a given strength may excite more ventricular myocytes, 
produce greater voltage gradients, and create a large area of slowly propagating graded 
responses, thus facilitating re-entry (Frazier et al. 1989).  The enhanced tissue excitability also 
contributes to the decreased size of a central core around which the spiral wave rotates during 
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VF (Mandapati et al. 1998; Pandit et al. 2010). This reduces the rotation period of the spiral 
wave, thus maintaining high-frequency activation in the fibrillating ventricle. Collectively, 
these mechanisms may account for direct correlation between the diastolic excitability 
threshold and the minimum current strength required to induce VF (Gaum et al. 1977; Chen 
1992).  
          A greater availability of Na+ channels contributes to the recurrence of excitability at 
earlier time points during repolarization, as evidenced by a lower ERP-to-APD ratio 
determined at the endocardium compared to the epicardium in guinea-pig heart (Osadchii 
2012a: study II). This ensures an increased window over which the LV can be re-excited by a 
premature ectopic pulse, thus facilitating VT initiation at the endocardium. Likewise, when a 
premature action potential is generated at earlier repolarization time points, it propagates with 
a longer conduction delay owing to incomplete recovery of INa from inactivation. 
Accordingly, transmural conduction time is longer when extrasystolic stimulations are applied 
at the endocardium compared to the epicardium (Osadchii 2012a: study II), an effect that can 
facilitate re-entry by reducing the excitation wavelength. 
          In addition to spatial non-uniformities in INa expression, a greater arrhythmic 
susceptibility upon endocardial pacing could be accounted for by electrotonic modulation of 
the intrinsic transmural repolarization gradient. Electrical stimulations are associated with a 
“downstream effect” wherein APD in cardiac myocytes close to the pacing electrode tends to 
be prolonged by electrotonic depolarizing current generated by more peripheral cells (Osaka 
et al. 1987, Laurita et al. 1997, Furukawa et al. 2000). This contributes to the longest APD at 
the pacing site, which then progressively reduces along the propagation path (see chapter 5 for  
more discussion). When these relationships are applied to LV wall (Figure 14), it follows that 
during endocardial stimulations, endocardial APD tends to be longer, and epicardial APD 
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Figure 14. Putative changes in the transmural repolarization gradient during endocardial (endo) and 
epicardial (epi) pacing 
Action potential duration (APD90) in spontaneously beating hearts is greater at the endocardium than 
epicardium. The magnitude of this intrinsic difference (as shown by double arrow) is subjected to 
modulation by electrotonic effects initiated upon endo and epi pacing. In both cases, APD90 at a given 
ventricular site tends to be longer than its intrinsic value when stimulations are applied close to the 
recording electrode, and tends to be shorter than its intrinsic value when stimulations are introduced 
from the opposite side of the ventricular wall. According to these relations, the intrinsic transmural 
difference in APD90 is amplified during endocardial stimulations, but reduced during epicardial pacing. 
Adapted from study II (Osadchii, O.E. 2012. Electrophysiological determinants of arrhythmic 
susceptibility upon endocardial and epicardial pacing in guinea-pig heart. Acta Physiol (Oxf.) 
205, 494-506), with permission from publisher. 
 
tends to be shorter, compared to their intrinsic values determined during spontaneous beating. 
In contrast, epicardial pacing is associated with increased APD at epicardium, but reduced 
endocardial APD. Transmural  APD  dispersion  therefore  becomes  greater  when  switching  
from epicardial to endocardial pacing (Osadchii 2012a: study II). In line with these findings, 
optical mapping of repolarization in rabbit hearts has revealed that transmural APD patterns 
are strongly determined by the activation sequence; even though a positive endocardial-to-
epicardial APD difference is invariably seen during endocardial pacing, the gradient is 
reversed when activation proceeds from the epicardium (Myles et al. 2010).   
          Finally, endocardial-to-epicardial difference in arrhythmic susceptibility could be 
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explained by a steeper slope of APD rate adaptation at the endocardium. The minimum pacing 
interval that allows 1:1 LV capture is shorter during endocardial stimulations, which 
contributes to the increased slope of the initial steep portion of the restitution curve (Osadchii 
et al. 2011; Osadchii 2012a: study II). The latter, according to the restitution hypothesis (see 
section 6.1), facilitates APD alternans and increases propensity to VF.  
          In sharp contrast to these findings from the guinea-pig model, studies on perfused 
ventricular wedge preparations from dog (Di Diego et al. 2003; Fish et al. 2004, 2005; Ueda 
et al. 2004; Xu et al. 2012) and rabbit (Medina-Ravell et al. 2003; Fish et al. 2005) have 
shown that the inducibility of tachyarrhythmia is higher when electrical stimulations are 
applied to the epicardium compared to the endocardium or midmyocardium, at least in the 
presence of drug-induced IKr block or activation of the late INa. In basal, drug-free conditions, 
although arrhythmia is not inducible at any stimulation site, the transmural dispersion of 
repolarization was found to be greater upon epicardial pacing. Importantly, in these studies, 
transmural APD values remained the same upon switching from endocardial to epicardial 
pacing, and therefore the aforementioned increase in transmural dispersion of repolarization 
time (a sum of activation latency and APD) was ascribed to a greater conduction delay when 
the activation proceeds from the epicardium to the endocardium compared to that determined 
with the opposite (i.e., endocardium to epicardium) sequence of activation. A significant 
delay in conduction between the epicardial and midmyocardial layers is likely accounted for 
by increased tissue resistivity in the deep subepicardium in the canine ventricular wall, an 
effect resulting from sharp transition of cell orientation in this area (Yan et al. 1998).  
9.1.2 Clinical studies 
          In cardiac patients, ventricular pacing may be either instituted acutely upon 
electrophysiological testing, or maintained permanently in order to treat symptomatic 
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bradycardia caused by sinus node dysfunction or severe AV block. The RV endocardium is 
commonly used as the preferred stimulation site, because it is easily accessible via 
transvenous catheterization, and shows no pacemaker lead dislodgements and stable 
excitation thresholds in the long-term (Sweeney & Prinzen 2006). Epicardial pacing is less 
common, and reserved only for selected groups of patients in whom it is applied either via 
coronary sinus, or directly upon thoracotomy. For example, epicardial pacing is often required 
in pediatric patients, in whom the placement of an RV endocardial lead via the transvenous 
route is not feasible because of a small body size, or vascular barriers, or congenital defects in 
cardiac anatomy (Cohen et al. 2001; Dodge-Khatami et al. 2005). In adults, LV epicardial 
pacing could be used in patients who have undergone tricuspid valve replacement, or it can be 
implemented for electrophysiological assessments during cardiac surgery, or post-operatively, 
using implanted epicardial leads.  
          Ventricular pacing may be associated with clinically important proarrhythmic effects. 
For example, permanent unipolar RV endocardial pacing has been shown to occasionally 
provoke a malignant tachyarrhythmia resulting from interference of the pacemaker rhythm 
and spontaneous ectopic beats. In this setting, sudden cardiac death was reported to account 
for 23% of all lethal outcomes noted in pacemaker-implanted patients during a 2-year 
observation period (Zehender et al. 1992). Non-fatal pacing-induced VT was documented in 
26% of patients with implanted cardioverter-defibrillator which incorporated a pacemaker 
feature to treat post-defibrillation bradycardia (Himmrich et al. 2003). When 
electrophysiological testing is performed after cardiac surgery, in about 40% of patients in 
whom VT is non-inducible upon epicardial stimulation, it could be provoked by endocardial 
stimulation (Sheppard et al. 1993). In a study that employed post-operative assessments of the 
efficacy of anti-tachycardia surgery, epicardial stimulation alone was found to underestimate 
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the number of patients at risk for recurrent tachyarrhythmia by 25% (Borggrefe et al. 1988). 
Accordingly, endocardial stimulations were reported to have a superior sensitivity and an 
improved negative predictive value in proarrhythmic assessments. 
          In contrast to the aforementioned observations, there is a line of evidence that indicates 
a greater proarrhythmic potential of epicardial compared to endocardial pacing. This evidence 
largely stems from studies on resynchronization therapy in heart failure (for review see Ray et 
al. 2007; Turito & El-Sherif 2007), wherein permanent RV endocardial pacing is 
implemented along with LV epicardial stimulation in order to eliminate interventricular 
electromechanical dyssynchrony. In this group of patients, LV epicardial stimulations are 
reportedly associated with a longer QT interval, a greater transmural dispersion of 
repolarization, and hence a greater chance to develop tachyarrhythmia, compared to either RV 
endocardial or biventricular stimulations (Medina-Ravell et al. 2003; Fish et al. 2005; Bai et 
al. 2006; Harada et al. 2006). 
          This notion, nevertheless, remains a matter of debate, as other studies have shown that 
transmural dispersion of repolarization is less during biventricular pacing compared to 
conventional RV endocardial pacing (Van Huysduynen et al. 2005; Santangelo et al. 2006). 
Moreover, VT inducibility by programmed stimulation in patients with ischemic 
cardiomyopathy was found to be lower during biventricular compared to RV endocardial 
pacing (Zagrodzky et al. 2001; Kowal et al. 2004). When applied alone, RV endocardial, RV 
epicardial, and LV epicardial stimulations were reported to yield concordant results (Dailey et 
al. 1989; Santangelo et al. 2006). There is also an indication of the low, or even reduced, 
occurrence of VT over a long-term follow-up during either a dual-chamber pacing (Higgins et 
al. 2000; Walker et al. 2000; Bhatia et al. 2007; Tereshchenko et al. 2011; Shahrzad et al. 
2012; Kutyifa et al. 2015) or LV epicardial pacing applied alone (Touiza et al. 2001; Blanc et 
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al. 2004; Wong et al. 2004). Hence, the question about the most optimal and clinically safe 
pacing algorithm is still open.  
9.2 Left ventricular vs. right ventricular pacing 
          Studies on anesthetized dogs demonstrate that RV stimulations are associated with 
lower VF threshold and higher inducibility of arrhythmia upon ectopic activation, compared 
to the spatially matched (either epicardial or endocardial) LV stimulations (Tamargo et al. 
1975; Horowitz et al. 1981; Hamer et al. 1984; Hunt & Ross 1990). In human patients with a 
documented history of spontaneous arrhythmia, a sustained ventricular tachycardia is more 
often inducible by programmed electrical stimulation applied to the RV compared to the LV 
endocardium (Lin et al. 1987). These findings therefore suggest a greater arrhythmic 
vulnerability in the RV vs. LV chamber, at least in canine and human hearts. It is noteworthy, 
however, that in 10-20% of patients, tachyarrhythmia is not inducible upon RV stimulations, 
but could be provoked by stimulations applied at the LV chamber (Michelson et al. 1979; 
Robertson et al. 1981; Kudenchuk et al. 1988; Chen et al. 1994).   
          In the perfused guinea-pig heart, the relationships between ventricular pacing site and 
arrhythmic vulnerability are different from those outlined above. In this model, the electrical 
stimulation protocols reveal similar arrhythmic susceptibility in the RV vs. LV epicardium 
during normokalemic perfusion (Osadchii et al. 2009). However, when extracellular K+ 
concentration is reduced, the VF threshold becomes lower, and inducibility of 
tachyarrhythmia by rapid pacing or extrasystolic stimulation is increased in the LV compared 
to the RV chamber. This effect is accounted for by hypokalemia-induced reduction in ERP in 
the LV but not RV epicardium. In a clinical context, these findings suggest that 
interventricular differences in arrhythmic susceptibility may be accentuated in the presence of 
systemic electrolyte abnormalities associated with cardiac disease, such as hypokalemia.    
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          Electrophysiological mechanisms that account for the stimulation site-dependent 
variations in arrhythmic vulnerability are likely determined by the relationships between the 
direction of the interventricular repolarization gradient, and inducibility of the conduction 
block upon ectopic activation. In the whole heart, the arrhythmia is typically provoked when 
premature activation is initiated from the site with short APD, an effect that is attributed to 
progressive conduction slowing that develops once the evoked action potential invades 
myocardial regions with a longer refractory period (Kuo et al. 1983, 1985; Bode et al. 2002). 
This contributes to unidirectional conduction block, thus precipitating re-entry. Stimulations 
applied at a site with long APD usually fail to induce arrhythmia. Based on this principle, in 
animal species showing greater APD in the LV chamber (e.g., canines: Verduyn et al. 1997a, 
b; van Opstal et al. 2001; Janse et al. 2005; Gallacher et al. 2007), inducibility of VT may be 
facilitated upon electrical stimulations applied at the RV site. However, the opposite relations 
could be found in animal species that exhibit a longer APD in the RV than LV (e.g., guinea-
pig: Poelzing & Veeraraghavan 2007; Osadchii et al. 2009); in this case, the aforementioned 
mechanism would facilitate VT induction when using the LV stimulation site. 
          Chamber-specific difference in arrhythmic vulnerability can be partly accounted for by 
non-uniformities in ion channel expression. For example, in the guinea-pig heart, a higher IK1 
density in LV vs. RV is thought to contribute to the reduced central core of the spiral wave, 
which results in a higher frequency of excitation during ventricular fibrillation, and hence 
favors stabilization of the rotor, a source of re-entrant activation, in the LV chamber (Samie et 
al. 2001; Warren et al. 2003). Apart from the electrical heterogeneities, the arrhythmic 
substrate can be strongly determined by tissue geometry and architecture. In this regard, a 
larger overall thickness of the LV vs. RV wall can account for more complex spatiotemporal 
activation patterns during VF in the LV chamber (Rogers et al. 2000). It is also noteworthy 
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that in patients with coronary artery disease, myocardial infarction and subsequent remodeling 
more often occur in the left ventricle, meaning that electrical activation initiated from LV 
stimulation site may have a greater chance of entering the re-entrant circuit and provoking 
VT.  
          The aforementioned considerations suggest that stimulation site-dependent variations in 
arrhythmic vulnerability are determined by a complex interplay of multiple factors. 
Depending on which mechanism prevails in the specific model chosen for 
electrophysiological assessments (animal species used, normal or diseased cardiac tissue, type 
of pharmacological treatment), arrhythmic vulnerability may be greater either in the LV or 
RV, or show no interventricular difference.    
10. Arrhythmogenic responses in hypokalemia  
10.1 Clinical impact of hypokalemia in cardiovascular disease 
          Hypokalemia refers to reduced serum K+ levels (less than 3.5 mM), and represents the 
most common electrolyte disorder seen in cardiac patients. Hypokalemia typically develops as 
a side effect of diuretic therapy prescribed to normalize blood pressure and reduce cardiac 
loads, or may be caused by neurohormonal derangements in heart failure, including over-
activation of the renin-angiotensin-aldosterone system and sympathetic nervous system.   
Aldosterone increases renal K+ excretion, whereas noradrenaline increases K+ uptake from 
blood plasma by skeletal muscles, an effect that is mediated via activation of Na+-K+ ATPase 
coupled to β2-adrenergic receptor on myocyte membrane (for review see Clausen 2010). 
Overall, it follows that hypokalemia may be promoted by abnormal K+ loss, or re-distribution 
of K+ between interstitial and intracellular compartments, or both.   
          Hypokalemia occurs in about 16% of patients admitted to the hospital (Jensen et al. 
2015), with the risk being about 12-fold higher in users of thiazide diuretics (Rodenburg et al. 
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2014). When diagnosed, hypokalemia is corrected by oral K+ supplements, or with K+-sparing 
agents such as aldosterone receptor antagonists (Vardeny et al. 2014). In the setting of 
myocardial infarction, the incidence of hypokalemia is markedly reduced upon the 
administration of β-blockers (Nordrehaug et al. 1985; Simpson et al. 1987).   
          Hypokalemia is an important contributing factor to cardiac electrical instability. The 
ventricular ectopic activity develops in about one-third of hypertensive patients treated with 
diuretics (Holland et al. 1981), and there is a strong inverse correlation between the number of 
extrasystolic beats on ECG and serum K+ levels (Medical Research Council Working Party on 
Mild to Moderate Hypertension 1983). The Multiple Risk Factor Intervention Trial (MRFIT) 
has shown that each 1 mM reduction in serum K+ is associated with a 28% increase in the risk 
of ventricular ectopy (Cohen et al. 1987).  
          Hypokalemia is an important arrhythmogenic factor in patients with acute myocardial 
infarction, whereby its degree is proportional to the elevated plasma catecholamine levels 
(Nordrehaug & von der Lippe 1983; Nordrehaug et al. 1985; Simpson et al. 1987; Clausen et 
al. 1988). In these patients, the occurrence of tachyarrhythmia over 24 hours upon admission 
to the hospital is inversely related to serum K+ concentrations, and ventricular fibrillation 
develops in more than 30% of patients when serum K+ drops below 3 mM (Nordrehaug & 
von der Lippe 1983). Although the incidence of arrhythmia is likely to be lower in 
contemporary clinical practice because of the widespread use of β-blockers, reperfusion 
therapy, and early invasive management, the casual links between serum K+ levels and VF in 
post-infarcted patients remain a matter of important clinical concern (Goyal et al. 2012).  
          Proarrhythmic effects of hypokalemia contribute to poor clinical prognosis. Diuretic 
therapy has been shown to substantially increase the risk of cardiac arrest in hypertensive 
patients (Siscovick et al. 1994), and eliminate the benefits associated with blood pressure 
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reduction (Franse et al. 2000). Large multicenter clinical trials indicate that hypokalemia is an 
independent risk factor that increases mortality in a wide spectrum of ambulatory patients 
with chronic heart failure (Cooper et al. 1999; Ahmed et al. 2007; Alper et al. 2009; Bowling 
et al. 2010). For example, in the SOLVD (Studies on Left Ventricular Dysfunction) trial, the 
incidence of arrhythmic death was reported to be about 80% higher in patients that received 
diuretic treatment, compared to controls (Cooper et al. 1999). These studies provide a strong 
argument for the notion that maintaining normal serum K+ levels is pivotal for improving 
survival in cardiovascular disease.  
10.2 Mechanisms of hypokalemia-induced cardiac arrhythmia 
10.2.1 Arrhythmic triggers  
          Hypokalemia can precipitate triggered arrhythmia by increasing firing rate in ectopic 
pacemakers. Low extracellular K+ levels contribute to the reduced background outward K+ 
current in Purkinje fibers, which results in steepening the slope of spontaneous diastolic 
depolarization (Lee & Fozzard 1979). In quiescent sheep Purkinje fibers, hypokalemic 
perfusion provokes depolarization of the resting membrane potential and subthreshold voltage 
oscillations, which facilitate the initiation of spontaneous electrical activity (Spiegler & 
Vassale 1995). In guinea-pig and cat papillary muscle, automaticity could be acquired upon 
the application of depolarizing constant current in the presence of low K+-perfusion (Katzung 
& Morgenstern 1977).  
          Another source for triggered arrhythmia in hypokalemia is constituted by early and 
delayed afterdepolarizations. An increased propensity for early afterdepolarizations in 
hypokalemia could be detected both at the cellular and tissue level (Killeen et al. 2007b; 
Madhvani et al. 2011; Bapat et al. 2012; Pezhouman et al. 2015), which is attributed to the 
excessive prolongation of ventricular APD owing to the inhibition of outward K+ currents, 
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such as IKr (Scamps & Carmeliet 1989; Sanguinetti & Jurkiewicz 1992), IK1 (Sanguinetti & 
Jurkiewicz 1992; Bouchard et al. 2004; Killeen et al. 2007a; Cordeiro et al. 2015), and Ito 
(Killeen et al. 2007a). The occurrence of EADs is substantially increased when hypokalemia 
is applied in combination with other factors that reduce repolarization reserve, such as slow 
pacing rates or drug-induced IKr block (Davidenko et al. 1989; Sicouri & Antzelevicth 1995). 
In addition to acute and reversible changes related to decreased K+ channel conductance, a 
reduction in the net outward current across myocyte sarcolemma in hypokalemic hearts could 
be related to decreased cell surface IKr protein expression caused by IKr internalization and 
subsequent endocytic degradation (Guo et al. 2009; Massaeli et al. 2010). These effects 
evolve upon long-term hypokalemic exposure, for example, after several weeks on a K+-
deficient diet.             
          Delayed afterdepolarizations are often promoted when hypokalemic ventricular tissue 
is subjected to rapid pacing rates (Ohta et al. 1987; Gilat et al.   1990). DADs are attributed to 
Ca2+ overload, which develops via at least two different mechanisms. Hypokalemia inhibits 
Na+-K+ ATPase on myocyte sarcolemma (Eisner & Lederer 1979; Aronsen et al. 2015), 
which results in increased intracellular Na+ levels. This in turn activates the reverse mode of 
the Na+-Ca2+ exchange, leading to increased cytosolic Ca2+ concentration. Second, 
hypokalemia-induced prolongation of APD implies an increased time for Ca2+ entry, which 
indirectly facilitates cytosolic Ca2+ accumulation (White & Terrar 1991). 
          Recent studies demonstrate a close interplay of the mechanisms leading to generation of 
EADs and DADs in hypokalemic hearts (Pezhouman et al. 2015). Hypokalemia-induced 
inhibition of Na+-K+ ATPase and subsequent Ca2+ overload, apart from being critical for the 
genesis of DADs, appear to play a role in the mechanism of EADs. Increased cytosolic Ca2+ 
activates Ca2+/calmodulin-dependent protein kinase II (CaMKII), which then phosphorylates 
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the L-type Ca2+ channels and fast Na+ channels, thus increasing ICa and late INa. This generates 
a positive feedback loop that further exacerbates intracellular Ca2+ and Na+ overload, and 
progressively impairs the repolarization reserve, leading to EAD-dependent arrhythmia. 
Targeting the CaMKII-mediated effects, therefore, can be considered an emerging 
antiarrhythmic strategy in hypokalemic patients. 
10.2.2 Effective refractory period and ventricular conduction  
          Although hypokalemia prolongs ventricular APD, it can reduce the effective refractory 
period, as shown in studies on perfused heart preparations from mouse (Sabir et al. 2007), 
guinea-pig (Osadchii & Olesen 2009; Osadchii et al. 2010: study I; Osadchii 2014d: study 
XI), and rabbit (Wolk et al. 1998, 2002; Osadchii 2014d: study XI). This change can be 
attributed to the increased availability of voltage-dependent Na+ channels in a setting of 
hypokalemia-induced hyperpolarization of the resting membrane potential. In support of the 
role played by this mechanism, the amplitude of phase 0 and the maximal velocity of action 
potential upstroke (Vmax) were shown to be increased in hypokalemic guinea-pig ventricles 
(Gjini et al. 1996; Marschang et al. 1998). In the presence of low extracellular K+ levels, the 
concentration of Na+ channel blocker that is required to reduce Vmax is enhanced by about 10-
fold, which again indirectly suggests  the increased activation of the Na+-carrying system 
(Singh et al. 1971). A reduction of ERP in hypokalemia could also be linked to triangulation 
of the action potential waveform (Osadchii & Olesen 2009), which imposes changes in 
membrane voltage profile for Na+ channel recovery from inactivation during repolarization.  
          Hypokalemia is associated with slowed conduction of the action potential. At the whole 
heart level, this effect translates to prolonged LV-to-RV transepicardial and LV transmural 
conduction times (Wolk et al. 1998, 2002; Osadchii & Olesen 2009; Osadchii 2014d: study 
XI). Hypokalemia-induced conduction slowing is thought to be caused by hyperpolarization 
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of the myocyte sarcolemma, which results in an increased excitation threshold and membrane 
input resistance in cardiac cells (Kishida et al. 1979; Ruiz-Ceretti et al. 1982). Likewise, Ca2+ 
overload in severe hypokalemia (K+ less than 1.5 mM) has been shown to promote subcellular 
alterations in the distribution of connexin-43, which results in impaired cell-to-cell coupling 
(Tribulova et al. 2001), thus providing another mechanism for slowed conduction velocity.  
          The aforementioned changes markedly increase arrhythmic vulnerability in 
hypokalemic hearts (Figure 15). Reduced ERP, along with slowed ventricular conduction, 
contribute to decreased excitation wavelength, and hence facilitate re-entry. An abbreviated 
ERP also accounts for the reduced size of the central core around which the spiral wave 
rotates, thus sustaining re-entry and increasing its rate (Uchida et al. 1999). In addition, ERP 
shortening in the presence of prolonged APD significantly increases the time window for LV 
re-excitation over late repolarization (Sabir et al. 2007; Osadchii & Olesen 2009; Osadchii et 
al. 2010: study I), which facilitates arrhythmia. 
10.2.3 Spatial repolarization gradients 
          Hypokalemia-induced APD lengthening is not uniform at distinct ventricular sites. For 
example, in perfused rabbit hearts (Osadchii 2014d: study XI), monophasic action potential 
recordings taken from six epicardial sites demonstrate that hypokalemic perfusion is 
associated  with  APD  prolongation  in  the  LV  anterior  and posterior wall (site 2 and site 3,  
respectively, in Figure 16, panel A) and RV anterior and posterior wall (site 2 and site 1, 
respectively, in Figure 16, panel B), while producing no APD change at the lateral wall in 
both ventricular chambers (site 1 in panel A and site 3 in panel B). The standard deviation of 
the mean epicardial APD value, an index of APD dispersion, was significantly increased in 
hypokalemic hearts. Increased RV-to-LV transepicardial repolarization gradients in 
hypokalemia have also been determined in perfused guinea-pig hearts (Poelzing & 
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Figure 15. Effects of hypokalemia on the inducibility of tachyarrhythmia by programmed stimulation 
in perfused guinea-pig hearts  
In fragments 1-5 in each panel, the upper trace is the volume-conducted ECG, and the lower trace is 
the LV epicardial monophasic action potential recording. The vertical deflections on ECG represent 
the regular pacing stimulus and the premature extrasystolic stimulus artefacts. The numbers above 
ECG traces indicate the duration (ms) of coupling stimulation intervals. Note that hypokalemic 
perfusion is associated with reduction of the effective refractory period from 97 to 73 ms (fragment 5, 
A vs. B), and that extrasystolic stimulation at coupling intervals close to the refractory period 
(fragments 2-4) elicits ventricular tachyarrhythmia during hypokalemic (B), but not normokalemic (A) 
perfusion. Adapted from Osadchii, O.E., & Olesen, S.P. 2009. Electrophysiological determinants of 
hypokalemia-induced arrhythmogenicity in the guinea-pig heart. Acta Physiol (Oxf.) 197, 273-287, 
with permission from publisher. 
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Figure 16. Effects of hypokalemia on the action potential duration at distinct epicardial sites in 
perfused rabbit hearts  
Monophasic action potential duration (APD90) was determined in basal (4.7 mM K+) and hypokalemic 
(2.5 mM K+) conditions at three LV recording sites (site 1 is the lateral LV wall, site 2 is the anterior 
LV wall, and site 3 is the posterior LV wall) and three RV recording sites (site 1 is the posterior RV 
wall, site 2 is the anterior RV wall, and site 3 is the lateral RV wall).  The assessments were made 
during steady-state pacing (S1) and extrasystolic stimulations (S2) applied at a coupling interval 
exceeding the effective refractory period by 5 ms. *P<0.05 vs. corresponding basal value. Adapted 
from study XI (Osadchii, O.E. 2014. Impact of hypokalemia on electromechanical window, 
excitation wavelength and repolarization gradients in guinea-pig and rabbit hearts. PLoS One 
9, e105599). 
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Veeraraghavan 2007; Osadchii & Olesen 2009; Osadchii 2014d: study XI). 
          On the other hand, the pattern of APD changes provoked by hypokalemia over the 
transmural plane is less clear. In perfused canine ventricular wedge preparations, lowering the 
extracellular K+ concentration has been reported to produce a substantially greater increase in 
APD in M cells compared to either epicardial or endocardial myocytes (Sicouri & 
Antzelevitch 1995), suggesting an amplified transmural repolarization gradient. In contrast, in 
guinea-pig, hypokalemia evokes a greater APD lengthening in epicardial vs. endocardial or 
midmyocardial myocytes (Wan et al. 2000), which implies a reduced transmural APD 
difference. A greater epicardial than endocardial APD prolongation by hypokalemia, and 
associated reduction in transmural repolarization gradient have been observed in perfused 
murine hearts (Killeen et al. 2007a). Therefore, the contribution of alterations in the 
transmural APD profile to arrhythmic substrate in hypokalemic hearts remains inconclusive.           
10.2.4 Electrical restitution  
          Hypokalemia has been shown to increase the occurrence of APD alternans during rapid 
cardiac pacing (Koller et al. 2000; Sabir et al. 2008; Osadchii et al. 2010: study I), which 
implies that a steepened slope of electrical restitution is likely to be one of the mechanisms 
that increases the vulnerability to VF in hypokalemic hearts. In support of this notion, both 
the inducibility of tachyarrhythmia and the maximum APD restitution slope were increased in 
murine hearts during hypokalemic perfusion (Sabir et al. 2008). These findings, however, 
could not be directly extrapolated to the hearts of larger mammalian species owing to the fast 
cardiac beating rates and specific features of repolarization in mice. In canine endocardial 
slices, no change in APD restitution was observed while varying the extracellular K+ 
concentration between 2.7 and 4.0 mM (Koller et al. 2000).  
          The impact of hypokalemia on electrical restitution was examined in perfused guinea- 
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pig hearts by taking monophasic action potential recordings and measuring effective 
refractory periods at multiple ventricular sites (Osadchii et al. 2010: study I). This study has 
shown that the value of electrical restitution at predicting hypokalemia-induced arrhythmia 
critically depends on whether APD or ERP is chosen as a variable reflecting the rate-
adaptation of ventricular repolarization. The APD restitution assessments by extrasystolic 
stimulation revealed that hypokalemia reduces the amount of APD shortening in premature 
beats generated over a range of short (less than 40 ms) diastolic intervals (Figure 17, panel A). 
As a result, the initial portion of the APD restitution curve was shifted upwards and flattened, 
thus contributing to reduced maximum slope (Figure 17, panels A, B and C). In contrast, the 
slope of ERP rate-adaptation was significantly increased in hypokalemic hearts (Figure 17, 
panels D, E and F). Owing to ERP reduction at fast pacing rates, ventricular capture was 
maintained at shorter diastolic intervals in hypokalemic compared to normokalemic 
conditions. Consequently, the initial portion of the restitution curve was extended towards 
ERP values less than 125 ms (Figure 17, panel D), which contributed to a steepened 
restitution slope (Figure 17, panels E and F). Contrasting changes in APD vs. ERP restitution 
kinetics are likely to reflect the different pattern of APD and ERP modifications in 
hypokalemia, wherein the prolongation of APD may be associated with abbreviated 
refractoriness. This raises the point that ERP restitution assessments should preferably  
complement the traditionally used testing of APD rate adaptation, in order to adequately 
address proarrhythmic changes provoked by diuretic-induced hypokalemia in cardiac patients. 
10.2.5 Activation-repolarization coupling  
          In normal conditions, spatial repolarization heterogeneities are minimized owing to the 
activation-repolarization coupling (see chapter 5). This mechanism, nevertheless, is impaired 
in the setting of hypokalemia (Osadchii 2014c: study X), as schematically illustrated in Figure 
96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Effects of hypokalemia on the restitution of action potential duration (A, B and C) and 
effective refractory period (D, E and F) in perfused guinea-pig hearts 
Monophasic action potential duration (APD90) (panel A) was assessed at the LV epicardium during 
premature extrastimulus application at variable S1-S2 stimulation intervals. The effective refractory 
period (ERP) (panel D) was assessed at the LV epicardium over a wide range of regular pacing rates. 
Both APD90 and ERP were plotted as a function of the preceding diastolic interval (DI). The restitution 
curves shown in panels A and D were differentiated in order to determine changes in the restitution 
slope over the range of DIs used (panels B and E). Mean values of the maximum restitution slope 
(panels C and F) were calculated using individual measurements from each experiment. *P<0.05 vs. 
basal value (in panels C and F). Adapted from study I (Osadchii, O.E. et al. 2010. Predictive value of 
electrical restitution in hypokalemia-induced ventricular arrhythmogenicity. Am J Physiol 
Heart  Circ  Physiol 298, H210-H220). 
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Figure 18. A schematic description of the electrophysiological mechanisms by which hypokalemia 
may impair the RV-to-LV activation-repolarization coupling in guinea-pig heart. 
Monophasic action potential durations (APD90) and local activation times (AT) were determined in the 
RV and LV epicardium during regular beating. See text for the comments on APD to AT relationships 
seen in normokalemic and hypokalemic conditions. Adapted from study X (Osadchii,O.E. 2014. 
Impaired epicardial activation-repolarization coupling contributes to the proarrhythmic effects 
of hypokalemia and dofetilide in guinea-pig ventricles. Acta Physiol (Oxf.) 211, 48-60), with 
permission from publisher. 
 
18. During normokalemic perfusion of guinea-pig hearts, there is an inverse relationship 
between APD and activation time over the RV-to-LV transepicardial plane (panel A and line 
a in panel D). In this setting, the intrinsic RV-to-LV difference in APD is compensated for by 
the appropriate difference in activation time, which allows the moments of final repolarization 
in the RV and LV chambers to be synchronized (as shown by vertical solid lines in panel A). 
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Hypokalemia produces two proarrhythmic modifications. First, hypokalemia prolongs APD in 
LV relative to RV (as shown by double arrow in panel B), which results in an increased 
interventricular difference in the final repolarization time (as shown by a dotted rectangle). In 
the graphical form, LV APD lengthening translates to flattening of the linear slope of APD to 
the activation time relationship (shown by line b in panel D), thus indicating attenuated 
activation-repolarization coupling. Second, hypokalemia increases interventricular conduction 
delay (as shown by double arrow in panel C), which again translates to increased RV-to-LV 
dyssynchrony in final repolarization time, in association with a flattened linear slope of the 
APD to activation time relationship (shown by line c in panel E). The aforementioned changes 
may be further exacerbated in extrasystolic beats (Osadchii 2014c: study X), wherein 
hypokalemia accentuates spatial non-uniformities in APD as well as conduction slowing 
provoked by premature ventricular activation.  
          Clinically, impaired activation-repolarization coupling in hypokalemia, and the loss of 
interventricular synchrony in repolarization time, are likely to lead to an increased delay in the 
onset of diastolic relaxation between the RV and LV chambers. This would set abnormal 
pressure gradients across the ventricular septum, and increase the propensity for stretch-
induced arrhythmia (Hardziyenka et al. 2009).  
11. Arrhythmogenic responses to antiarrhythmic drugs  
11.1 Classification of clinically used antiarrhythmic drugs  
          Antiarrhythmic agents are subdivided into four classes, according to the Vaughan 
Williams’ classification (Vaughan Williams 1984; for review see Singh 1999; Kowey et al. 
2000; Roden 2006; Shu et al. 2009).  
          Class I agents are Na+ channel blockers that reduce the maximum velocity of the action 
potential upstroke and prolong ERP. The former contributes to slowed conduction of both 
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sinus and ectopic beats, and the latter accounts for the suppression of premature ventricular 
contractions, and elimination of the excitable gap in the re-entrant circuit. Therefore, 
prolongation of ERP partly eliminates both the arrhythmic trigger and the vulnerable 
substrate. In the re-entrant circuit, conduction slowing by class I agents may cause the 
unidirectional conduction block to convert into the bidirectional block, which would suppress 
arrhythmia. On the other hand, slowed ventricular conduction also contributes to the reduced 
excitation wavelength, thus facilitating arrhythmogenesis. These drugs are subdivided into 
three subgroups according to the fast (class Ib), intermediate (class Ia), and slow (class Ic) 
kinetics of binding and dissociation from the Na+ channel.  
          Class II agents are beta-blockers that eliminate proarrhythmic effects associated with 
adrenergic over-activation. These agents abolish EADs and DADs induced by 
catecholamines, and suppress abnormal automaticity resulting from adrenergic-mediated 
increase in the slope of spontaneous diastolic depolarization in ectopic pacemakers. Beta-
blockers are commonly used to prevent sudden cardiac death in clinical conditions associated 
with sympathetic over-activation, for instance, in heart failure and acute myocardial 
infarction. 
          Class III includes agents that prolong ventricular repolarization via the blockade of 
outward K+ currents, primarily IKr. A drug-induced increase in APD accounts for prolonged 
ERP, which increases excitation wavelength and hence terminates re-entry. In contrast to 
class I drugs, the class III agents do not cause conduction slowing. Nevertheless, an excessive 
prolongation of APD may facilitate EADs, and hence favor cardiac arrhythmia, at least in 
some settings. 
          Class IV agents are the L-type Ca2+ channel blockers that suppress arrhythmogenic 
effects resulting from increased Ca2+ entry, such as EADs, DADs, and ectopic activity 
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resulting from the increased slope of phase 4 depolarization. As these agents also slow AV 
nodal conduction, they are used for ventricular rate control in atrial fibrillation. ICa inhibition, 
nevertheless, produces a negative inotropic effect, which imposes serious limitations for using 
these agents to treat arrhythmia in patients with heart failure.    
          The Vaughan Williams’ classification does not encompass the entire armamentarium of 
available antiarrhythmic therapies. For example, cardiac glycosides, adenosine, and 
magnesium, although possessing antiarrhythmic effects, are not included in this classification. 
The arrhythmia could also be corrected by eliminating detrimental structural changes in 
diseased hearts with non-antiarrhythmic medications, like inhibitors of the renin-angiotensin-
aldosterone system, fish oil, or statins. This approach, called upstream therapy, is beyond the 
scope of the Vaughan Williams’ classification.  
11.2 Antiarrhythmic drug-induced proarrhythmia: lessons from clinical studies  
          In susceptible patients, antiarrhythmic drugs at therapeutic concentrations may 
paradoxically aggravate existing cardiac electrical instability or even provoke new 
symptomatic arrhythmia (Velebit et al. 1982; Stanton et al. 1989; for review see Roden & 
Anderson 2006; Frommeyer & Eckardt 2016). The arrhythmogenic responses range from an 
increased number of ectopic beats, which is rarely perceived by the patient, to malignant VT 
that can lead to sudden death. While these adverse reactions have been recognized for many 
years (see e.g. Selzer & Wray 1964), the problem of drug-induced arrhythmia has attracted 
broad attention relatively recently in connection with the reports from two landmark, large-
scale clinical trials, CAST and SWORD. The Cardiac Arrhythmia Suppression Trial (CAST) 
involved patients with healed myocardial infarction in order to test the hypothesis that the 
suppression of ventricular ectopy with class Ic Na+ channel blockers, flecainide and 
encainide, can decrease the incidence of sudden death (CAST Investigators 1989). Contrary to 
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expectations, the mortality in the treatment group was found to be 2.5-fold greater compared 
to patients receiving placebo after a mean follow-up of only 10 months, and the study was 
discontinued. Another clinical trial, called Survival With Oral D-sotalol (SWORD), was 
designed to determine whether ERP prolongation by class III antiarrhythmic agent can reduce 
mortality in patients with LV systolic dysfunction and a prior myocardial infarction (Waldo et 
al. 1996). The SWORD trial, nevertheless, has shown that overall mortality in d-sotalol-
treated patients is higher than in the placebo group, with two-thirds of the deaths being 
interpreted as arrhythmic.    
          Overall, these trials demonstrate that an empirical approach for arrhythmia treatment is 
likely to be irrational, as the promising agent that eliminates one arrhythmic mechanism may 
nevertheless exacerbate others. For example, flecainide may suppress arrhythmia by reducing 
ectopic activity, but at the same time facilitates arrhythmia via conduction slowing. Sotalol, 
while producing antiarrhythmic effects owing to prolonged refractoriness, may nevertheless 
facilitate arrhythmogenic EADs. 
          Importantly, in some patients, the drug-induced arrhythmia could be more threatening 
to survival than the arrhythmia being suppressed. The clinical trials on atrial fibrillation, a 
relatively benign arrhythmia, have shown that Na+ channel blocker or class III agent therapies 
aimed at maintaining sinus rhythm may nevertheless induce adverse electrical changes in 
ventricles, and precipitate life-threatening VT (for review see Falk 1992; Shantsila et al. 2007;  
Camm 2012). The ventricular proarrhythmic responses are recognized as a serious limitation 
of existing opportunities in pharmacological control of atrial fibrillation.  
          Drug-induced arrhythmia can be attributed to either excessive conduction slowing (e.g., 
with class Ia or Ic Na+ channel blocker), or excessive prolongation of ventricular APD (e.g., 
with class III agent), or both (for review see Levine et al. 1989; Nattel 1998; Shu et al. 2009). 
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These effects are favored by many confounding factors, including the presence of organic 
heart disease, myocardial ischemia, contractile failure, elevated adrenergic tone, and 
hypokalemia. In many patients, however, drug-induced proarrhythmia is poorly predictable 
and occurs without any premorbid warning signs.  
11.3 Proarrhythmia induced by Na+ channel blockers  
11.3.1 Mechanism of action of class I agents at the ion channel level 
          Na+ channels may be found in closed (or rested) state (during diastole), open state 
(during phase 0 of action potential), or inactivated state (during plateau of action potential). 
INa blockers exhibit much higher affinity to either open (class Ia and Ic agents) or inactivated 
(class Ib agents) channels compared to the rested state (the modulated receptor hypothesis; for 
review see Hondeghem 1987). This means that the drug binding affinity substantially varies 
in the course of a cardiac cycle; during each action potential, the agent binds to Na+ channel 
and blocks it, and over the following diastolic interval, it dissociates from the channel, and the 
block is released. These binding properties translate into important practical implications (for 
review see Kecskemeti et al. 1991; Tamargo et al. 1992; Glaaser & Clancy 2006; Roden 
2006). First, the drug-induced INa block is much stronger at fast than normal cardiac activation 
rates, an effect that is termed the use-dependency. The reason for this is the increased time 
spent by the Na+ channels in the open/inactivated state during tachycardia, secondary to both 
the increased number of depolarizations per unit of time, and the shortened diastolic interval 
for drug unbinding and channel recovery. The use-dependency importantly contributes to 
antiarrhythmic effects, because it implies that class I agents produce the most prominent 
conduction slowing and prolongation of refractoriness during the rapid activation rates that 
occur in tachyarrhythmia.  
          Second, because the transition from open to inactivated states is promoted upon 
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depolarization, physiological factors that depolarize myocyte sarcolemma, such as ischemia, 
hyperkalemia, and acidosis, typically increase the number of inactivated Na+ channels. As a 
result, the inactivated state blockers, such as class Ib agents, can bind to a greater proportion 
of Na+ channels, and therefore produce more powerful blocking effects under these 
conditions.   
          Lastly, because the time spent by Na+ channels in the inactivated state is increased upon 
lengthening the plateau of action potential, the effect of class Ib blockers is likely to be 
enhanced in cardiac tissues with prolonged APD, such as Purkinje fibers. Class Ib agents are 
therefore more effective in suppressing ventricular rather than atrial tachyarrhythmia. These 
relations also provide a rationale for using inactivated state Na+ channel blockers in 
combination with class III agents that delay ventricular repolarization; the latter may 
accentuate INa blocking actions of class Ib agents, and hence result in the more pronounced 
lengthening of the refractory period. In contrast, class Ia and Ic agents are more effective in 
cardiac tissue with shorter APD, especially in the presence of fast firing rates, which increases 
proportion of open Na+ channels. These agents are therefore commonly used to treat 
supraventricular tachyarrhythmia, such as atrial fibrillation.  
          Class I includes drugs with variable kinetics of INa block. Class Ib agents exhibit fast 
onset/offset kinetics; the steady-state INa block is achieved in less than five cardiac beats, and 
the block dissipates in less than 0.5 s during diastole. These agents, therefore, have only a 
minimal, if any, effect on Vmax, and do not slow ventricular conduction at normal heart rates, 
at least in non-ischemic conditions. Class Ia agents exhibit slower onset/offset kinetics; it 
takes 5 to 20 cardiac beats to achieve a steady-state INa block, and the block then dissipates in 
a few seconds. For example, with quinidine, the time constant of INa recovery is 3-8 s (Varro 
et al. 1985; Hondeghem & Matsubara 1988). The latter means that drug unbinding in diastole, 
104 
 
and hence INa block, is not fully resolved till generation of the next action potential. These 
agents can therefore reduce Vmax and provoke some conduction slowing at normal beating 
rates, with the effect being accentuated in tachycardia. Class Ic agents exhibit the slowest 
kinetics of action; it takes more than 20 cardiac beats to achieve a steady-state INa block, and 
the drug dissociation from the channel requires more than 10 s. Because this by far exceeds 
diastolic time over the range of clinically relevant heart rates, the INa block may persist and 
cumulate over successive cardiac beats. Class Ic agents, therefore, markedly depress Vmax and 
slow ventricular conduction, even at normal heart rates.  
          The three subgroups of class I agents are also different with regards to their effects on 
ventricular repolarization. Class Ib agents are pure INa blockers that may cause a slight APD 
shortening by reducing the late Na+ current during the plateau phase. In contrast, class Ia 
agents typically prolong ventricular APD, as they (in addition to blocking INa) can inhibit 
outward K+ currents. With class Ic agents, such as flecainide, the effects on ventricular 
repolarization are traditionally thought of as being modest. Nevertheless, there is emerging 
evidence to demonstrate that a prolongation of ventricular APD, in connection with resulting 
arrhythmia, should be considered an important attribute of class Ic profile of action (Osadchii 
2015). 
          Clinically, proarrhythmic responses have been largely observed while using class Ia and 
Ic Na+ channel blockers, whereas class Ib agents are recognized as safe antiarrhythmics 
(Frank et al. 1991; Shimizu & Antzelevitch 1997; Sims et al. 1997; Wyman et al. 2004; Lu et 
al. 2010). The following sections will discuss the mechanisms that may potentially contribute 
to the dissimilar safety profile of INa blockers. 
11.3.2 Ventricular electrophysiological effects induced by class Ia and Ic vs. class Ib agents 
11.3.2.1 Transmural gradients in refractoriness 
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          Proarrhythmic effects produced by Na+ channel blockers are commonly explained by 
slowing of ventricular conduction, which could be particularly detrimental in post-infarcted, 
structurally remodeled myocardium (Coromilas et al. 1995; Restivo et al. 1995). This 
stimulated the attempts to develop “good” (i.e. lidocaine-like) INa blockers with no or minimal 
effects on conduction, as opposed to the “bad” (i.e. flecainide-like) agents that provoke 
substantial conduction slowing (Lu et al. 2010). Nevertheless, the slowed conduction would 
be unlikely to account for the whole range of arrhythmogenic effects produced by INa blockers 
in a clinical setting. Indeed, when used to treat atrial fibrillation, class Ia and Ic agents may 
often provoke ventricular proarrhythmia in patients with no history of angina or clinical signs 
of myocardial ischemia, as evidenced by exercise tests or coronary angiography (Prystowsky 
1996). The mechanism of drug-induced arrhythmia in normal hearts, free of ischemia and 
structural remodeling, remains incompletely understood. 
          In study IV (Osadchii 2012c), the hypothesis was proposed that the difference in safety 
profile with class Ia and Ic vs. class Ib agents is determined by the reciprocal distribution 
pattern of INa and IKr channels across the ventricular wall. The latter sets a  basis for dissimilar  
changes in transmural ERP dispersion, and hence diverse drug effects on arrhythmic 
vulnerability. Figure 19 schematically illustrates this principle. In normal hearts, action 
potential duration, and hence ERP, is longer at the endocardium than the epicardium (panel 
A). Transmural ERP dispersion could be modified upon drug administration by 
changingeither Na+ channel availability, and hence the recurrence of excitability in phase 3 
(panel B), or changing IKr channel availability, and hence APD, at the endocardium vs. the 
epicardium (panel C). The expression of INa was shown to be greater at the endocardium than 
the epicardium (Ashamalla et al. 2001; Rosati et al. 2006; Gaborit et al. 2007; Remme et al. 
2009; Osadchii et al. 2011). Because of the lower INa reserve, epicardial myocytes are likely 
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Figure 19. The putative role of transmural distribution of INa and IKr in shaping electrophysiological 
profile of action of class Ia and Ic vs. class Ib agents 
APD, action potential duration; ERP, effective refractory period; LV, left ventricular; Endo, 
endocardium; Epi, epicardium, INa, the fast Na+ current; IKr, the rapid component of the delayed 
rectifier K+ current. Filled and open circles within the LV wall (panels B and C) illustrate the 
epicardial-to-endocardial difference in expression levels of INa and IKr. See text for more details. 
Adapted from study IV (Osadchii, O.E. 2012. Impact of Na+ channel blockers on transmural 
dispersion of refractoriness and arrhythmic susceptibility in guinea-pig left ventricle. Eur J          
Pharmacol  691, 173-181), with permission from publisher. 
 
to be more susceptible to ERP lengthening by INa blocker, than endocardial cells. A greater 
increase in ERP at the epicardium than the endocardium would contribute to reduced 
transmural ERP difference, indicating an antiarrhythmic effect (panel B). In contrast, IKr 
expression levels are greater at the epicardium than the endocardium (Bryant et al. 1998; 
Main et al. 1998; Wan et al. 2003). Because of the lower IKr reserve, ventricular endocardium 
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typically exhibits a greater prolongation of APD, and hence ERP, upon selective IKr blocker 
administration (Yan et al. 2001b; Kozhevnikov et al. 2002). This would contribute to 
increased transmural ERP dispersion, indicating a proarrhythmic effect (panel C). Overall, 
these arguments raise the possibility that the antiarrhythmic effect of selective INa blockers, 
such as class Ib agents, resulting from reduced transmural ERP dispersion, may be eliminated, 
or even reversed to proarrhythmia, in the presence of concomitant IKr blockade (e.g. caused by 
class Ia or Ic agents).  
         In support of this hypothesis, lidocaine and mexiletine, class Ib agents with selective INa 
blocking effects, were found to increase ERP at the epicardium, while producing no effect at 
the endocardium, in perfused guinea-pig hearts (Osadchii 2012c: study IV). These changes 
translated to reduced transmural ERP dispersion. No spontaneous or extrasystolic stimulation-
induced VT was observed upon the infusion of lidocaine and mexiletine. In contrast, class Ia 
(quinidine, procainamide) and class Ic (flecainide) agents that possess both INa and IKr 
blocking effects produced a greater ERP prolongation at the endocardium than the 
epicardium, thus increasing transmural ERP dispersion, and facilitating arrhythmia. 
Spontaneous episodes of short-lasting monomorphic VT were observed in about 40% of heart 
preparations during the infusion of class Ia or Ic Na+ channel blockers. Similar changes in 
both transmural ERP dispersion and the occurrence of spontaneous VT were observed upon 
the administration of dofetilide, a selective IKr blocker, thus lending support to the notion that 
arrhythmogenic responses to class Ia and Ic agents could be partially accounted for by the 
presence of IKr-blocking properties in their electrophysiological profile. 
11.3.2.2 Ventricular action potential duration and conduction times upon premature ectopic 
activation 
          The assessment of INa blocker effects on APD and conduction of premature ectopic  
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beats can be critical for understanding the mechanisms contributing to the distinct safety 
profile of class Ib vs. class Ia and Ic agents. The rationale for this contention is two-fold. First, 
fatal VT is often initiated by premature ectopic activation superimposed on the T wave of the 
preceding sinus beat (the “R-on-T” phenomenon) (Lewis et al. 1983; Panidis & Morganroth 
1983; Kempf & Josephson 1984; Milner et al. 1985; Locati et al. 1995). In survivors of acute 
myocardial infarction, the presence of frequent closely coupled extrasystolic beats on ECG 
has been shown to independently predict the increased risk of sudden arrhythmic death 
(Ruberman et al. 1981; Mukharji et al. 1984; Kostis et al. 1987). Second, the increased 
propensity to develop VT following ectopic activation is thought to be accounted for by 
amplified regional non-uniformities in ventricular conduction and APD (Kuo et al. 1983, 
1985; Laurita et al. 1996, 1998; Osadchii 2014b: study IX). When premature stimulus is 
applied immediately upon the recurrence of excitability in phase 3, the induced extrasystolic 
beat propagates with an increased conduction delay owing to the incomplete recovery of Na+ 
channels from inactivation. The amount of conduction slowing can be variable in different 
myocardial regions, partly owing to the spatial heterogeneities in Na+ channel expression. The 
premature activation is also associated with APD shortening (see section 6.2), which is non-
uniform at different ventricular sites owing to heterogeneities in the distribution of 
repolarizing K+ currents. The amplified dispersion of local conduction times and APD 
contributes to markedly increased vulnerability to re-entry following ectopic activation. 
          These considerations imply that the safety profile of a Na+ channel blocker can be 
importantly determined by the ability to either reduce or further exaggerate proarrhythmic 
changes associated with ectopic activation. In contrast to class Ib agents, class Ia and Ic drugs 
possess IKr-blocking effects, which translates to APD prolongation, possibly leading to 
increased spatial repolarization gradients. Furthermore, in contrast to class Ib agents, class Ia 
109 
 
and Ic drugs exhibit much slower Na+ channel unbinding rates, and hence provoke substantial 
conduction slowing; this would likely exacerbate conduction abnormalities imposed by 
ectopic activation. In study IX (Osadchii 2014b), these possibilities were addressed by 
measuring local activation latencies and APDs in six LV and RV epicardial recording sites in 
perfused guinea-pig hearts, both during regular pacing and extrasystolic stimulations applied 
immediately upon the termination of ERP. Both flecainide and quinidine were found to 
produce non-uniform conduction slowing throughout the ventricular epicardium in 
extrasystolic beats, thus further accentuating an increase in dispersion of the conduction time 
imposed by premature activation. Likewise, both flecainide and quinidine were found to 
prolong repolarization in extrasystolic beats, as compared to values determined prior to drug 
infusion. The increase in APD was spatially non-uniform, being greater at LV than RV sites, 
contributing to increased transepicardial APD dispersion. In contrast, lidocaine and 
mexiletine, class Ib agents, had no significant effects on either conduction time or APD 
dispersion in extrasystolic beats.  
          These results support the notion that the proarrhythmic potential of class Ia and Ic Na+ 
channel blockers in a clinical setting may be partly attributed to the aggravation of electrical 
derangements associated with premature ectopic activation. Hence, the risk for drug-induced 
arrhythmia can be particularly high in patients that exhibit frequent ventricular ectopic beats.   
11.3.3 Cardiac arrhythmia and repolarization abnormalities provoked by individual Na+ 
channel blockers 
11.3.3.1 Quinidine 
          Quinidine therapy is recognized as one of the most common causes of acquired long 
QT syndrome; this agent is estimated to prolong QT interval and provoke torsade de pointes 
in up to 5% of treated patients (Bauman et al. 1984; Roden et al. 1986). The clinical risk 
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factors for quinidine-induced arrhythmia include hypokalemia and bradycardia resulting from 
the high-grade AV block. The arrhythmia is often precipitated by abrupt changes in cardiac 
cycle length, which could be exemplified by a sudden heart rate slowing upon conversion of 
atrial fibrillation to sinus rhythm. In connection with these relations, quinidine therapy in 
atrial fibrillation is often associated with increased mortality rates, especially in patients with 
organic heart disease (Coplen et al. 1990; Flaker et al. 1992).  
          Quinidine has a complex electrophysiological profile. Apart from reducing INa, it 
inhibits several repolarizing K+ currents, including the delayed rectifier (both IKr and IKs) 
(Roden et al. 1988; Balser et al. 1991; Yang et al. 2001; Paul et al. 2002; Iost et al. 2003; Wu 
et al. 2008), the inward rectifier (IK1) (Salata & Wasserstrom 1988), and Ito (Imaizumi & Giles 
1987; Slawsky & Castle 1994; Iost et al. 2003). Quinidine also decreases inward currents that 
contribute to the plateau of action potential, such as L-type ICa (Nawrath 1981; Hiraoka et al. 
1986; Salata & Wasserstrom 1988), and the late INa (Salata & Wasserstrom 1988; Wu et al. 
2008). Collectively, these changes translate to APD prolongation, with the effect being greater 
at slower than at faster heart rates. Quinidine also modifies the configuration of ventricular 
action potential; as quinidine shortens the plateau phase, but delays the late repolarization, it 
contributes to triangular action potential waveform (Hondeghem & Hoffmann 2003; Guerard 
et al. 2008; Wu et al. 2008; Osadchii 2013: study VII). As a result, quinidine significantly 
increases the time spent over the voltage window for ICa recovery from inactivation, thus 
facilitating the occurrence of EADs. The EADs, predominantly originating in Purkinje fibers, 
are thought to serve as a trigger for torsade de pointes in quinidine-treated hearts (Roden & 
Hoffman 1985; Davidenko et al. 1989; El-Sherif et al. 1989).  
          Much less is known about the mechanisms by which quinidine therapy may contribute 
to the vulnerable arrhythmogenic substrate. Indeed, quinidine effects on spatial repolarization 
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gradients are reportedly inconclusive. Although quinidine was shown to increase the 
dispersion of ventricular repolarization in perfused rabbit heart (Zabel et al. 1997; Wu et al. 
2008), other studies reported no effect (Dhein et al. 1993) or reduced repolarization gradients 
(Milberg et al. 2007a) in the same animal model. Quinidine was found to reduce the 
transmural dispersion of refractoriness in a mouse heart (Martin et al. 2011), and had no effect 
on APD dispersion in canine RV (Brugada et al. 1987); these changes suggest an 
antiarrhythmic (rather than proarrhythmic) profile of action.  
          The role played by repolarization abnormalities in the mechanism of VT produced by 
quinidine was further examined in studies on perfused guinea-pig hearts (Osadchii 2013: 
study VII). During dynamic pacing, quinidine produced a reverse use-dependent increase in 
APD, with the effect being significantly greater at long compared to short diastolic intervals. 
As a result, both the amplitude (i.e., the maximum to minimum APD change) and maximum 
slope of the restitution curve were increased by quinidine (Figure 20, panels A, B and C), 
indicating     a   proarrhythmic   tendency.    Throughout   the   ventricular   epicardium,  APD  
lengthening by quinidine was found to be non-uniform (Figure 20, panel D), with the greatest 
effect produced at the LV posterior wall (LV epi site 3), and the minimum effect produced at 
the RV lateral wall (RV epi site 2). Epicardial APD dispersion was significantly increased in 
quinidine-treated hearts (Figure 20, panel E). At slow cardiac pacing rates, quinidine elicited a 
greater increase in APD compared to refractory period, thereby markedly extending the 
vulnerable window (i.e., the APD90-to-ERP difference) for LV re-excitation by premature 
ectopic activation during late repolarization. This change was accounted for by modifications 
in the time course of ventricular repolarization; quinidine was found to produce a greater APD 
prolongation at 90% than 30% repolarization time points, thus increasing triangulation of the 
action potential waveform. Over the transmural plane, quinidine elicited a greater 
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Figure 20. Effects of quinidine on electrical restitution (A, B and C) and spatial dispersion of 
action potential duration (D and E) in perfused guinea-pig hearts 
Mean left ventricular (LV) epicardial (epi) monophasic action potential duration (APD90) was 
determined over a wide range of progressively reducing pacing cycle lengths (S1-S1 from 550 ms to 
160 ms), and then plotted as a function of the preceding diastolic interval (DI) in panel A. Panel B 
shows changes in APD90 restitution slope upon dynamic pacing, and panel C shows the maximum 
(Max) restitution slope values determined before and after quinidine infusion. Panel D shows 
quinidine effects on APD90 measured in six individual recording sites throughout the ventricular 
epicardium at S1-S1 pacing interval of 550 ms (LV: site 1 is the lateral LV wall, site 2 is the anterior 
LV wall, and site 3 is the posterior LV wall; RV: site 1 is the posterior RV wall, site 2 is the anterior 
RV wall, and site 3 is the lateral RV wall). The standard deviation (SD) of the mean epicardial APD90 
value determined at baseline and upon quinidine infusion is shown in panel E. *p<0.05 vs basal value 
(in panels C, D and E). Adapted from study VII (Osadchii, O.E. 2013. Quinidine elicits 
proarrhythmic changes in ventricular repolarization and refractoriness in guinea-pig. Can J 
Physiol Pharmacol 91, 306-315), with permission from publisher. 
 
prolongation of endocardial than epicardial ERP, which translated to the amplified dispersion 
of refractoriness. Taken together, these findings strongly suggest that multiple derangements 
in ventricular repolarization and refractoriness can importantly contribute to the 
113 
 
arrhythmogenic substrate during quinidine treatment. 
11.3.3.2 Procainamide 
          Procainamide is class Ia Na+ channel blocker with an electrophysiological profile 
similar to quinidine. It is widely used to control hemodynamically stable VT and various 
supraventricular arrhythmias, including atrial flutter and fibrillation. The important 
pharmacokinetic feature of this agent is that it is extensively metabolized via acetylation in 
the liver, thus producing an active metabolite, N-acetylprocainamide. The metabolite 
contributes about 70% of the antiarrhythmic activity of the parent drug.   
          The therapeutic effects of procainamide are often offset by adverse electrical changes 
which either reduce its clinical efficacy or even translate to drug-induced arrhythmia. In 50-
70% of patients with organic heart disease, intravenous procainamide infusion fails to prevent 
the induction of VT by programmed stimulation, or even facilitates it (Engel et al. 1980; 
Kang et al. 1982; Gallagher et al. 1986; Furukawa et al. 1989; Stevenson et al. 1990; Buxton 
et al. 1991; Sager et al. 1992). This refers to the increased number of trials with inducible 
arrhythmia, to the conversion of non-sustained to sustained VT, or to arrhythmia induction 
with a fewer extrastimuli. These findings lend support for the suggestion that procainamide 
can unmask potential re-entry circuits (Stevenson et al. 1990), thus providing a rationale for 
using intravenous procainamide as a provocative challenge that increases the sensitivity of 
electrophysiological testing in detecting arrhythmic vulnerability  (Schreibman et al. 2004).   
          Procainamide was found to occasionally precipitate monomorphic VT when 
administered to restore sinus rhythm in atrial fibrillation (Fenster et al. 1983), or to suppress 
ectopic activity (Bhandari et al. 1986). There is also increasing evidence to show that 
procainamide, or its active metabolite, N-acetylprocainamide, can prolong QT interval and 
increase the risk for torsade de pointes (Sclarovsky et al. 1979; Strasberg et al. 1981; 
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Olshansky et al. 1982; Chow et al. 1984; Tzivoni et al. 1984; Herpe & Thompson 1985; 
Stevenson et al. 1985; Stratmann et al. 1985; Nguyen et al. 1986; Habbab & El-Sherif 1990; 
Prystowsky 1996). Patients characterized as rapid acetylators may have higher than expected 
plasma levels of N-acetylprocainamide, and hence exhibit an increased propensity for drug-
induced arrhythmia. It is therefore recommended that similar to quinidine or class III agents, 
procainamide therapy should preferably be initiated in the hospital, wherein QT interval 
monitoring is performed, and the drug dose is appropriately titrated in order to eliminate the 
chance of developing arrhythmia.  
          The arrhythmogenic responses to procainamide have been ascribed to drug-induced 
conduction slowing, an effect that contributes to the increased excitable gap within the re-
entrant circuit, and hence sustains arrhythmia (Furukawa et al. 1989). Nevertheless, the same 
mechanism may be employed to explain the antiarrhythmic effect of this agent. For example, 
it was pointed out that procainamide-induced conduction slowing in the depolarized portion 
of the re-entrant pathway can potentially result in conversion of the unidirectional conduction 
block to a bidirectional one, thus terminating VT (Giardina & Bigger 1973). These changes 
are likely to account, at least in part, for the inter-individual variability of cardiac responses 
(antiarrhythmic, proarrhythmic, or neutral) to procainamide seen in a clinical setting. In this 
context, careful consideration should be given to physiological factors that critically 
determine the amount of procainamide-induced conduction slowing, such as myocardial 
ischemia, fast heart rates, high extracellular K+ levels, and the concomitant administration of 
other antiarrhythmic drugs (Myerburg et al. 1982; Cascio et al. 1987; Steinberg et al. 1992).  
          Another mechanism for procainamide-induced arrhythmia could be related to the non-
uniform prolongation of refractory period, an effect shared with other class Ia (quinidine) and 
class Ic (flecainide) Na+ channel blockers (see section 11.3.2.1 for discussion). In the perfused 
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guinea-pig heart, procainamide was found to increase the dispersion of refractoriness in the 
LV wall (Osadchii 2012c: study IV). In infarcted hearts, procainamide can impair spatial 
gradients in ERP by producing non-uniform changes in refractoriness in ischemic vs. normal 
myocardial regions (Michelson et al. 1981b).  
          Finally, procainamide may promote arrhythmia by inducing multiple repolarization 
abnormalities. Procainamide has been shown to inhibit IKr in rabbit ventricular myocytes (Iost 
et al. 2003) and human embryonic kidney cells expressing the HERG channel (Ridley et al. 
2003), an effect translating to the dose-dependent prolongation of ventricular APD in human 
patients (Platia et al. 1988; Lee et al. 1992) and various animal models (Myerburg et al. 1982; 
Kirchhof et al. 1998). This change can also contribute to excessive QT lengthening and 
increased torsadogenic risks during procainamide treatment, as mentioned above. In study 
VIII (Osadchii 2014a), procainamide-induced APD lengthening was associated with a 
steepened electrical restitution slope upon dynamic pacing in perfused guinea-pig hearts 
(Figure 21, panels A, B and C), thus indicating a proarrhythmic tendency. Furthermore, the 
effect of procainamide on APD was found to be non-uniform across the ventricular 
epicardium, being greater in the LV than the RV chamber (Figure 21, panel D). This 
translated to increased spatial APD dispersion (Figure 21, panel E) and impaired RV-to-LV 
transepicardial activation-repolarization coupling (Figure 22, panels A and B). Notably, 
lidocaine, a class Ib INa blocker with a clinically safe profile, had no effect on 
electricalrestitution, spatial APD dispersion, and activation-repolarization coupling (Osadchii 
2014a: study VIII). 
11.3.3.3 Flecainide 
          The overall incidence of arrhythmic events upon flecainide therapy is about 7%, of 
which three quarters take the form of sustained VT (Morganroth et al. 1984, 1986; Fish et al. 
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Figure 21. Effects of procainamide on electrical restitution (A, B and C) and spatial dispersion of 
action potential duration (D and E) in perfused guinea-pig hearts 
The data are presented as explained in the legend for Figure 20. Adapted from study VIII (Osadchii, 
O.E. 2014. Procainamide and lidocaine produce dissimilar changes in ventricular 
repolarization and arrhythmogenicity in guinea-pig. Fundam Clin Pharmacol 28, 382-393), 
with permission from publisher. 
 
1991). Because the Cardiac Arrhythmia Suppression Trial demonstrated a high risk for 
flecainide-induced proarrhythmia (CAST Investigators 1989), this agent is no longer 
prescribed to control arrhythmia in patients with organic heart disease and/or systolic 
dysfunction. Flecainide, nevertheless, remains one of the first line treatments for symptomatic 
atrial fibrillation in patients with structurally normal hearts (for review see Apostolakis et al. 
2013). This practice, however, is increasingly challenged by clinical observations indicating 
that flecainide can induce VT, often in the form of torsade de pointes, in patients without 
coronary artery disease or severe heart failure (Muhiddin et al. 1982; Nathan et al. 1984; Falk 
1989; Sihm et al. 1990; Prystowsky 1996; Ohki et al. 2001; Thevenin et al. 2003; Asensio et 
al. 2007; Hayes et al. 2013; Kim et al. 2013; Oguayo et al. 2014; Nasser et al. 2015). The 
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Pediatric Electrophysiology Group reported on the relatively high incidence of flecainide-
induced proarrhythmia in young cardiac patients, presumably in the absence of advanced 
coronary atherosclerosis which is commonly seen in the elderly (Fish et al. 1991). 
Importantly, in a recent clinical trial in Sweden, flecainide treatment in patients with atrial 
fibrillation and no structural heart disease was found to be associated with a fourfold 
increased risk of cardiovascular mortality compared to the general population (Almroth et al. 
2011). As the mechanism of VT is thought to involve repolarization abnormalities that set a 
stage for re-entry, the aforementioned studies imply that flecainide, in addition to its 
traditional INa blocking effects, could also adversely affect ventricular repolarization. There 
are several lines of evidence in support of this notion. 
          Firstly, patch-clamp recordings in single cardiac cells suggest that flecainide can 
significantly reduce repolarizing K+ currents. Over a range of micromolar concentrations 
corresponding to its therapeutic plasma levels, flecainide has been found to produce up to 
50% reduction in IKr in hERG-expressing cell lines (Paul et al. 2002; Du et al. 2011; Melgari 
et al. 2015), and ventricular myocytes from guinea-pig (Wang et al. 1996) and cat (Follmer & 
Colatsky 1990; Follmer et al. 1992). This change is likely to contribute to the prolongation of 
ventricular APD seen in different animal models (Borchard & Boisten 1982; Ikeda et al. 
1985; Varro et al. 1986; Yabek et al. 1987; Osadchii 2012e: study VI), and human stem cell-
derived cardiac myocytes (Gibson et al. 2014). In human patients, flecainide increases the RV 
monophasic action potential duration (Olsson et al. 1981), and prolongs QT interval (Katritsis 
et al. 1995; Sarubbi et al. 1998; Lim et al. 2010). Arrhythmogenic responses to flecainide are 
facilitated in the presence of well-known torsadogenic risk factors, such as bradycardia (Kim 
et al. 2013), hypokalemia (Ohki et al. 2001), and previously unsuspected long QT syndrome 
gene mutations (Lehtonen et al. 2007), which is in support of the role played by reduced 
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repolarization reserve in adverse effects associated with flecainide therapy.  
          Another contributor to flecainide-induced arrhythmia in structurally normal heart 
appears to be the increased spatial repolarization gradients. Flecainide-induced INa block 
results in a decreased amplitude of the action potential upstroke, which has an effect on the 
subsequent activation of Ito, the transient outward K+ current. This translates to altered action 
potential morphology (an accentuated notch) and duration, with both modifications being 
more prominent at the epicardium than the endocardium owing to a greater epicardial Ito 
expression (Krishnan & Antzelevitch 1991, 1993). Non-uniform APD changes in the 
epicardium vs. the endocardium upon flecainide infusion then contribute to the increased 
transmural dispersion of repolarization, and promote re-entry (termed “phase 2 re-entry”) in 
the canine heart (Krishnan & Antzelevitch 1991, 1993). Flecainide has also been shown to 
amplify transmural gradients in refractoriness in mouse (Martin et al. 2011) and guinea-pig 
heart (Osadchii et al. 2011; Osadchii 2012c: study IV), which can be accounted for by 
epicardial-to-endocardial non-uniformities in the distribution of INa. Alternatively, flecainide-
induced arrhythmia can be attributed to increased repolarization heterogeneities at the level of  
the Purkinje fiber-ventricular muscle junction. Indeed, although flecainide delays 
repolarization in ventricular cells, it shortens APD in Purkinje fibers (Ikeda et al. 1985; Varro 
et al. 1986; Yabek et al. 1987), presumably via reduction of the late Na+ current. 
          Spatial non-uniformities in the expression of IKr channels may predispose to dissimilar 
APD lengthening by flecainide at distinct epicardial sites. In study VI (Osadchii 2012e), 
flecainide has been shown to produce a more prominent increase in APD in the LV than the 
RV chamber, thus causing a reversal of the normal interventricular repolarization gradient in 
the guinea-pig heart. This change, in turn, translated to impaired epicardial activation- 
repolarization coupling (Figure 22, panels C and D) and amplified spatial dispersion of 
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Figure 22. Effects of procainamide (A and B) and flecainide (C and D) on the activation-
repolarization coupling in perfused guinea-pig hearts 
Monophasic action potential durations (APD90) and the corresponding local activation times were 
determined in three left ventricular (LV) and three right ventricular epicardial recording sites in 
spontaneously beating heart preparations before and after drug infusions (procainamide: n=7, 42 data 
points in total; flecainide: n=10, 60 data points in total). At baseline (panels A and C), an analysis of 
all data points by a least squares linear fit yielded the inverse correlation between APD90 and 
activation time values. The RV-to-LV epicardial activation-repolarization coupling was lost after drug 
infusions (panels B and D). Adapted from study VIII (Osadchii, O.E. 2014. Procainamide and 
lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in 
guinea-pig. Fundam Clin Pharmacol 28, 382-393) and study VI (Osadchii, O.E. 2012. 
Flecainide-induced proarrhythmia is attributed to abnormal changes in repolarization and 
refractoriness in perfused guinea-pig heart. J Cardiovasc Pharmacol 60, 456-466), with 
permission from publishers. 
 
repolarization time, which contributed to the increased occurrence of VT. 
          In a clinical setting, arrhythmogenic responses to flecainide are often precipitated upon 
exercise-induced heart rate acceleration (Anastasiou-Nana et al. 1987; Falk 1989), which 
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raises the possibility that an inadequate rate adaptation of ventricular repolarization may 
contribute to arrhythmic substrate. In normal conditions, an abrupt acceleration in heart rate is 
associated with immediate APD (and QT interval) reduction over the next few cardiac cycles, 
which is followed by a slow phase of monotonic APD shortening until a steady-state is 
reached after a few hundred beats (Franz et al. 1988; Seethala et al. 2011). The rate-
dependent APD reduction ensures a sufficiently long diastolic interval, thus eliminating the 
possibility of superposition of the next ventricular depolarization on the T wave of a 
preceding beat (the “R-on-T phenomenon”), which would otherwise serve as an arrhythmic 
trigger. An attenuated shortening of APD during tachycardia is therefore maladaptive (Gill et 
al. 1993; Pueyo et al. 2010). With flecainide, a protracted adaptation of repolarization to 
sudden cardiac acceleration was observed in perfused guinea-pig hearts (Osadchii 2016).  
Flecainide was found to reduce the amount of QT interval and ventricular APD shortening 
upon an abrupt increase in activation rate, and to prolong the fast and slow time constants of 
the rate adaptation (Figure 23). Therefore, it appears  that  a  drug-induced  decrease  in IKr  in  
cardiac cells (Follmer & Colatsky 1990; Follmer et al. 1992; Wang et al. 1996) may translate 
to the impaired capacity to develop appropriate APD reduction upon sudden variations in 
cardiac cycle length, for example, during exercise, or the spontaneous onset of atrial 
fibrillation.  
11.4 Proarrhythmia induced by class III antiarrhythmic agents   
11.4.1 Electrophysiological basis for class III agent effects on ventricular repolarization  
          Class III agents are methanesulfonanilide compounds that produce open-state block of 
IKr channels (for review see Tamargo et al. 2004). The blocking effect is amplified in 
depolarized cardiac tissue, i.e. at membrane potentials of -60 to -40 mV that yield the 
maximal outward current via IKr channels. The drug binding site is located inside the pore of 
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Figure 23. Effects of flecainide on adaptation of the QT interval and ventricular action potential 
duration to an abrupt acceleration of cardiac beating rate in perfused guinea-pig hearts 
A train of 100 regular pulses at pacing interval of 300 ms (total stimulation time is 30 s) was applied in 
spontaneously beating, AV-blocked heart preparations with a running cycle length of about 600 ms.  
The QT interval (panel A), and LV epicardial (epi) monophasic action potential duration (APD90) 
(panel C) were measured in each cardiac beat and plotted vs. time from the beginning of stimulation. 
The plots obtained at baseline (squares) and upon flecainide infusion (circles) were fitted by a double-
exponential function. The fast and slow time constants (τ) of the rate-dependent shortening of QT 
interval (panel B) and APD90 (panel D) were determined from the exponential fits. Note that the rate 
adaptation plots were shifted upwards upon flecainide infusion (panels A and C), indicating drug-
induced prolongation of ventricular repolarization. Also note a slowed kinetics of the adaptation of 
ventricular repolarization to an abrupt increase in cardiac beating rate, as evidenced by increased τ 
values (panels B and D). *P<0.05 vs. corresponding basal value (in panels B and D). Adapted from 
Osadchii, O.E. 2016. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig 
heart. Scand Cardiovasc J 50, 28-35, with permission from Taylor & Francis Ltd 
(www.tandfonline.com). 
 
the IKr channel, and the blockers typically gain access to it upon channel opening from the 
intracellular side of the membrane, after crossing the lipid bilayer. Once the activation gate is 
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closed, the drug can be trapped inside the channel, and the block is not released until the 
channel re-opens. The IKr blockers therefore slowly dissociate from the binding site. These 
agents are commonly characterized as the fast onset/slow offset IKr blockers, as the time 
constant for onset of the block (ranging from 1 to 6 s for different agents) is by far shorter 
than the time constant for channel recovery (several minutes) (for review see Nair & Grant 
1997). As such, class III agents may develop cumulative IKr blocking effects, thus increasing 
the risk of excessive APD lengthening. The APD is typically prolonged by class III agents in 
a reverse use-dependent manner (see section 7.3), which may facilitate the EAD-dependent 
arrhythmia at slow cardiac activation rates. 
          The IKr amplitude is counterintuitively reduced upon decreasing extracellular K+ 
concentration, despite the associated increase in electrochemical driving force for K+ efflux. 
This change is accounted for by the reduced IKr channel conductance, an effect that causes 
prolonged ventricular APD. Hypokalemia may therefore synergistically interfere with drug-
induced IKr block, meaning that the proarrhythmic potential of class III agents can be 
significantly increased in patients treated with diuretics. In contrast, elevated extracellular K+ 
levels contribute to the increased IKr, indicating that the APD-prolonging effect of class III 
agents and resultant antiarrhythmic action are likely to be attenuated in clinical conditions 
associated with K+ accumulation in intercellular clefts, such as myocardial ischemia, or 
exercise-induced tachycardia. Adrenergic stimulation can reduce class III-induced APD 
prolongation both by accelerating heart rate, and via the direct activation of IKs.  
          Apart from specific IKr blockers (e.g., dofetilide), class III also includes agents that 
block both IKr and IKs (ambasilide, azimilide), block IKr and Ito (tedisamil), or produce multiple 
ion channel blockade (amiodarone, dronedarone). Ventricular proarrhythmic responses are to  
much less common when using agents with a complex electrophysiological profile compared 
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to the specific IKr blockers (for review see Frommeyer & Eckardt 2016). 
11.4.2 Cardiac arrhythmia and repolarization abnormalities provoked by dofetilide 
          Dofetilide is a highly selective IKr blocker that prolongs cardiac APD and ERP, but in 
contrast to class I agents, has no effect on conduction velocity. Another advantage of 
dofetilide is that it does not reduce cardiac contractility and systemic blood pressure, which 
are quite common side effects of other available antiarrhythmics. Selective prolongation of 
refractoriness results in a reduction of the excitable gap in the re-entrant circuit, thus favoring 
the termination of tachyarrhythmia. Intravenous or oral dofetilide is therefore useful in 
converting sustained atrial fibrillation or flutter to sinus rhythm, and in preventing arrhythmia 
recurrence over the long-term follow-up (Falk et al. 1997; Torp-Pedersen et al. 1999; Singh et 
al. 2000). 
          Dofetilide, nevertheless, may provoke arrhythmogenic responses in susceptible 
patients. The DIAMOND clinical trial (Danish Investigations of Arrhythmia and Mortality on 
Dofetilide) has shown that in patients with profound systolic dysfunction due to either 
congestive heart failure (Torp-Pedersen et al. 1999) or recent myocardial infarction (Kober et 
al. 2000), dofetilide therapy is associated with a greater incidence of torsade de pointes 
compared to the placebo group. The major risk factors for dofetilide-induced arrhythmia are 
female gender, recent myocardial infarction, severe heart failure, and prolonged basal QT 
value (Pedersen et al. 2007). About 76% of arrhythmic episodes occur within three days after 
the initiation of therapy (Torp-Pedersen et al. 1999), indicating that clinical outcomes can be 
significantly improved by initiating treatment in the inpatient setting for close 
electrocardiographic monitoring of the QT interval response and renal function, in order to 
adjust the dose of dofetilide.  
          The mechanisms contributing to dofetilide- induced arrhythmia remain incompletely 
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understood. The arrhythmic responses provoked by IKr blockade are commonly attributed to 
the excessive prolongation of APD and therefore an increased propensity for EADs. However, 
the clinical value of this mechanism could be questioned because these proarrhythmic 
changes are likely to occur only at non-physiological slow beating rates (e.g. those observed 
in complete AV block), whereas at faster beating rates, APD prolongation by dofetilide is 
significantly attenuated (the reverse rate-dependent effect). Cardiac patients often exhibit a 
tendency toward increased rather than slowed resting heart rates due to the sustained 
sympathetic activation which occurs in heart failure, thus providing no favorable grounds for 
inducing EADs. Notably, no evidence of EADs was obtained upon monophasic action 
potential recordings in patients with ischemic heart disease that received intravenous 
dofetilide (Sedgwick et al. 1992; Yuan et al. 1994). 
          There is a possibility that the development of torsade de pointes in dofetilide-treated 
patients is precipitated by an abrupt slowing of ventricular activation rate after the conversion 
of atrial fibrillation to sinus rhythm, which may enhance sensitivity to QT interval 
prolongation by IKr blocker (Choy et al. 1999). However, clinical studies revealed no reverse 
use-dependency of dofetilide effects over the range of heart rates (75-150 beats/min) close to 
those determined in these patients (Sedgwick et al. 1992; Yuan et al. 1994; Bashir et al. 
1995), thus challenging the role played by this mechanism. 
          Proarrhythmic modifications of ventricular repolarization by dofetilide were analysed in 
experimental studies. Consistent with spatial heterogeneities in the distribution of IKr, 
dofetilide was found to produce non-uniform lengthening of APD and/or the refractory period 
in canine (Van Opstal et al. 2001; Bauer et al. 2002; Kozhevnikov et al. 2002; Wu et al. 
2005; Meijborg et al. 2015), rabbit (Wu et al. 2005; Dhein et al. 2008; Qi et al. 2015), and 
guinea-pig hearts (Osadchii 2012c; 2012d, 2014c: studies IV, V, and X, respectively). Over 
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the transepicardial plane, dofetilide evokes a greater APD lengthening in LV than RV 
chamber, an effect that contributes to attenuated RV-to-LV activation-repolarization coupling, 
as evidenced by markedly reduced slope of the local APD-to-activation time linear 
relationships (Figure 24). This change results in increased epicardial dispersion of 
repolarization time in dofetilide-treated heart preparations, both during regular pacing and in 
extrasystolic beats (Osadchii 2014c: study X). Across the LV wall, dofetilide provokes a 
greater prolongation of refractory periods at the endocardium compared to the epicardium, 
thus increasing the transmural dispersion of refractoriness (Bauer et al. 2002; Osadchii 2012c, 
2012d: studies IV and V, respectively). Two other important attributes of dofetilide-induced 
arrhythmogenicity appear to be the steepened electrical restitution, and abnormal temporal 
relations between ventricular APD and refractory period. Because dofetilide evokes a greater  
APD prolongation at long compared to short diastolic intervals, it increases the amplitude of 
maximum-to-minimum APD change upon dynamic pacing, which steepens the slope of the 
restitution curve (Figure 25, panels A, B and C). Monophasic action potential recordings at 
multiple epicardial sites revealed spatially non-uniform dofetilide effects on electrical 
restitution in perfused guinea-pig hearts, with steepening of the maximum restitution slope 
being greater in the LV than the RV chamber (Osadchii 2012d: study V). As a result, 
dofetilide was found to increase the spatial variability in the distribution of maximum 
restitution slope value throughout the epicardial surface. The contribution of this effect to 
proarrhythmia is underscored by computational and clinical studies demonstrating that 
amplified spatial heterogeneities in electrical restitution can promote a wavebreak and initiate 
VF independently from the absolute value of the restitution slope measured at individual 
recording sites (Nash et al. 2006; Pak et al. 2004).  
          Dofetilide- induced IKr block results in a reduced slope of the phase 3 repolarization, 
126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Effects of dofetilide on the epicardial activation-repolarization coupling in perfused 
guinea-pig hearts 
Monophasic action potential durations (APD90) and the corresponding local activation times (AT) 
were determined in three left ventricular (LV) and three right ventricular epicardial recording sites in 
spontaneously beating heart preparations before and after infusion of dofetilide. Panel A shows mean 
RV and LV APD90 values plotted vs. mean activation times. Panels B and D show linear regression 
relations obtained by plotting individual APD90 vs. activation time values (48 data points in total from 
8 perfused heart preparations).  The mean linear regression slope values are shown in panel C. Note 
that dofetilide prolongs APD90, with the effect being greater in LV than RV (panel A). Also note that 
the inverse correlation between APD90 and activation time (i.e., the activation-repolarization coupling) 
seen in basal conditions (panel B) was lost after infusion of dofetilide (panel D). *P<0.05 vs. basal 
value (in panel C). Adapted from study X (Osadchii, O.E. 2014. Impaired epicardial activation-
repolarization coupling contributes to the proarrhythmic effects of hypokalemia and dofetilide 
in guinea-pig ventricles. Acta Physiol (Oxf.) 211, 48-60), with permission from publisher. 
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Figure 25. Effects of dofetilide on electrical restitution (A, B and C) and temporal relations between 
the action potential duration and effective refractory period (D, E and F) in perfused guinea-pig hearts 
Monophasic action potential duration (APD90) determined at the LV epicardium over a wide range of 
progressively reducing pacing cycle lengths (S1-S1 from 550 ms to 160 ms) was plotted as a function 
of the preceding diastolic interval (DI) in panel A. Panel B shows changes in APD90 restitution slope 
upon dynamic pacing, and panel C shows the maximum (Max) restitution slope values determined 
before and after dofetilide infusion. In panels D and E, basal and dofetilide-induced APD90 and 
effective refractory period (ERP) values are plotted in the same coordinates. Panel F shows dofetilide 
effect on the difference between APD90 and ERP (i.e., the critical interval for LV re-excitation). 
*P<0.05 vs. corresponding basal value (in panels C and F). Adapted from study V (Osadchii, O.E. 
2012. Dofetilide promotes repolarization abnormalities in perfused guinea-pig heart. 
Cardiovasc Drugs Ther 26, 489-500), with permission from publisher. 
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thus contributing to more triangular action potential waveshape. Quantitatively, this change is 
evidenced by a greater APD lengthening by dofetilide at 90% vs. 30% repolarization time 
points (Lu et al. 2002; Dujardin et al. 2008; Osadchii 2012d: study V). Secondary to 
modification of the action potential voltage profile, dofetilide can prolong APD to a greater 
extent than ERP, thus widening the vulnerable window (i.e., the APD90-to-ERP difference) 
for LV re-excitation over late repolarization (Figure 25, panels D, E and F).    
          The increased propensity for torsade de pointes upon dofetilide treatment could be 
partially accounted for by the increased beat-to-beat APD (and QT interval) variability 
(Thomsen et al. 2006b; Dujardin et al. 2008; Oros et al. 2010; Champeroux et al. 2015; 
Szentandrassy et al. 2015), which fully complies with the TRIaD concept (see section 7.4 for 
discussion) 
12. Summary and conclusions  
12.1 Methodological aspects of ventricular repolarization assessments (studies II and III)  
          The outcomes of electrical restitution assessments depend on whether the standard (S1-
S2) or dynamic (S1-S1) pacing protocol is used to examine the APD rate adaptation. In 
perfused guinea-pig hearts, the maximum restitution slope, a commonly used proarrhythmic 
determinant, is greater upon standard extrasystolic stimulations compared to dynamic steady-
state pacing, both at the epicardium and endocardium (Osadchii 2012b: study III). This 
difference has been attributed to both the impact of previous pacing history, and the ability to 
preserve ventricular capture at shorter diastolic intervals during extrasystolic stimulations 
compared to dynamic pacing. The latter is explained by shorter ERP than APD90 relationships 
in ventricular myocytes, which allows the early premature pulse to encroach the repolarization 
phase of the previous regular beat. An increase in ERP-to-APD90 ratio produced by Na+ 
channel blocker both eliminates early premature beats generated at critically short diastolic 
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intervals, and flattens the standard restitution curve, while producing no change in dynamic 
restitution. Furthermore, in hypokalemic hearts, increased arrhythmogenicity is paralleled by 
the increased maximum slope of the dynamic, but not standard APD restitution curve. These 
findings challenge the value of electrical restitution assessments based on extrasystolic 
stimulation alone, as commonly performed in human patients with cardiac arrhythmia. 
          Arrhythmic susceptibility is partially determined by the location of ventricular pacing 
site. In the guinea-pig heart, ventricular fibrillation threshold is lower, and the inducibility of 
tachyarrhythmia by extrasystolic stimulation is higher at the endocardium than the epicardium 
(Osadchii 2012a: study II). This difference is accounted for by at least two contributory 
mechanisms. First, the direction of transmural activation sequence can modulate ventricular 
repolarization via electrotonic effects. This modulation amplifies the intrinsic endocardial-to-
epicardial APD difference during endocardial stimulation, while minimizing it upon 
epicardial pacing. Activation sequence-dependent electrotonic effects also result in the 
increased steepness of electrical restitution during endocardial vs. epicardial pacing. Second, a 
greater expression of Na+ channels at the endocardium than the epicardium may contribute to 
the recurrence of excitability at earlier repolarization time points in endocardial cells, which 
increases the vulnerable window for LV re-excitation by premature ectopic activation. 
Likewise, electrical responses elicited at earlier repolarization time points propagate with 
increased conduction delay, thus favoring re-entry. Collectively, these findings provide 
insight into the electrophysiological mechanisms of cardiac pacing-induced arrhythmic 
responses that could be observed in a clinical setting.   
12.2 Arrhythmogenic responses in hypokalemia (studies I, X, and XI)  
          Hypokalemia provokes non-uniform APD lengthening at distinct epicardial regions, 
thus increasing spatial repolarization gradients (Osadchii 2014d: study XI). Hypokalemia also 
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contributes to slowed conduction and shortened refractory period; these changes result in 
reduced excitation wavelength, which sets a stage for re-entry. Prolongation of APD in 
association with reduced ERP results in widening of the vulnerable window for LV re-
excitation over late repolarization. Importantly, the RV-to-LV transepicardial activation-
repolarization coupling, a mechanism that coordinates recovery times in two ventricular 
chambers under normal conditions, is impaired upon hypokalemic perfusion (Osadchii 2014c: 
study X). Another contributor to arrhythmic substrate in hypokalemic hearts is the steepened 
electrical restitution. Hypokalemia has been shown to increase the slope of the ERP restitution 
curve, and facilitate persistent beat-to-beat oscillations in APD (i.e., APD alternans), thus 
increasing the propensity for ventricular fibrillation (Osadchii 2010: study I). Proarrhythmic 
responses in hypokalemia, nevertheless, could not be accounted for by a negative 
electromechanical window, or increased transmural repolarization gradients.  
12.3 Arrhythmogenic responses to antiarrhythmic drugs (studies IV-X)  
          Class Ia (quinidine, procainamide) and class Ic (flecainide) INa blockers, as well as the 
class III agent dofetilide (specific IKr blocker) produce multiple proarrhythmic modifications 
in ventricular repolarization and refractoriness. In the guinea-pig heart, these agents prolong 
APD in a spatially non-uniform manner, with the effect being greater at LV vs. the RV 
epicardium. This change leads to impaired RV-to-LV transepicardial activation-repolarization 
coupling, and increased spatial variability in the distribution of repolarization time. With 
dofetilide, quinidine, and procainamide, but not flecainide, APD lengthening is more 
pronounced at long compared to short diastolic intervals (the reverse use-dependent effect), 
which translates to the increased steepness of the electrical restitution curve. At a given LV 
recording site, quinidine and dofetilide have been found to prolong APD90 to a greater extent 
than ERP, thus increasing the vulnerable window for LV re-excitation over late repolarization 
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(Osadchii 2012d, 2013: studies V and VII, respectively). This effect was likely attributed to 
the increased triangulation of ventricular action potential waveshape, as evidenced by a 
greater APD prolongation by both agents at 90% vs. 30% repolarization time points. Over the 
transmural plane, quinidine, procainamide, flecainide, and dofetilide produce a greater ERP 
lengthening at the endocardium than the epicardium, which results in the increased transmural 
dispersion of refractoriness (Osadchii 2012c: study IV). In contrast, class Ib Na+ channel 
blockers such as lidocaine and mexiletine, the agents with a clinically safe antiarrhythmic 
profile, were found to reduce the endocardial-to-epicardial ERP difference. Finally, during 
extrasystolic stimulation, flecainide and quinidine have been shown to accentuate spatial 
heterogeneities in ventricular conduction and repolarization associated with premature 
activation, thus facilitating arrhythmia (Osadchii 2014b: study IX). In contrast, lidocaine and 
mexiletine had no effect on electrical derangements produced by extrasystolic stimulation. 
Taken together, the multiple repolarization abnormalities outlined above may provide an 
electrophysiological basis for ventricular tachyarrhythmia upon the initiation of therapy with 
Na+ channel blockers or class III agents. 
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Dansk resume 
          I hjertepatienter er livstruende takyarytmi ofte forårsage af unormale forandringer i 
ventriklens repolarisering og refraktærperiode. Repolariserings-abnormiteter udvikler sig 
typisk som følge af nedsat funktion af K+ ionkanaler i hjertemyocytterne, hvilket kan være 
forårsaget af genetiske defekter eller skyldes forskellige erhvervede patofysiologiske 
tilstande, herunder elektrisk remodeling som følge af hjertesygdom, ionkanal ændringer som 
følge af brug af læge-midler, samt systemiske elektrolyt forstyrrelser som ses ved hjertesvigt, 
såsom hypokaliæmi. Elektrisk ustabilitet i hjertet som følge af unormal repolarisering er 
afhængig af det komplekse samspil mellem en  arytmisk trigger og et sårbart arytmisk 
substrat. Her spiller hjertets forlængede aktionspotentiale, forkert intracellulær Ca2+ 
håndtering, samt den sænkede ledningshastighed i ventriklerne en vigtig rolle. Denne 
afhandling beskriver den elektriske aktivitet i ventrikelmyocytter under normale forhold og 
ved hjertesygdom. Den beskriver også de klassiske elektrofysiologiske mekanismer ved 
hjertearytmi, og  giver en opdatering af de repolariserings-relaterede surrogat parametre, som 
i øjeblikket anvendes til vurdering af den arytmiske tilbøjelighed, herunder den spatialle 
dispersion af repolariseringen, aktiverings-repolariserings koblingen, den elektriske 
restitution, TRIaD (aktionspotentiales triangulering,  reverse use dependency, ustabilitet, og 
dispersion), samt det elektromekaniske vindue. Efterfølge diskuteres de mekanismer, der 
afgør den arytmiske sårbarheds afhængighed af stedet for den ventrikulære pacing. Endelig 
præciseres det elektrofysiologiske grundlag for hjertearytmi som følge af hypokaliæmi, og der 
gives et indblik i den kliniske og patofysiologiske betydning af lægemiddel-induceret arytmi, 
med særligt fokus på klasse Ia (quinidin, procainamid) og Ic (flecainid) Na+ kanal blokkere, 
samt klasse III antiarytmiske midler, som blokerer IKr kanaler (dofetilid). 
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